#version: 0.2
i n
▁ a
▁ t
r e
o n
t i
h e
a l
e n
t e
▁ o
▁ s
▁ in
▁ c
e s
n d
▁ p
▁t he
a r
▁ m
▁ d
▁o f
o r
. 

i s
▁ w
e r
▁a nd
a s
ti on
▁ f
i t
r o
a n
in g
i c
e d
e c
▁ re
a t
▁ b
▁t o
u s
v e
i a
▁ h
o m
l e
i d
▁ e
a te
en t
o s
a tion
▁ (
a c
l y
▁t h
l o
▁ v
u r
i m
c e
u l
t h
o d
▁ n
i l
it h
▁ P
te d
▁ A
▁w ith
▁w e
ar ia
▁f or
▁s t
i r
i g
▁ C
▁ T
u m
te r
▁ g
it y
t s
q u
u n
▁a s
i on
f ec
ti c
al aria
e l
▁a n
▁c on
o l
e m
u t
e t
▁p ro
▁m alaria
v er
r a
▁ l
u d
i f
r i
▁th at
▁d e
▁ S
▁c om
▁re s
▁ is
▁p re
u c
u e
▁ I
a m
g e
ti ve
▁ on
▁ 2
▁we re
o p
s .

u nd
▁ M
s t
▁ 1
o c
re n
en g
o t
o w
▁w as
▁T he
▁ D
▁ us
r an
ro m
en ce
y s
ate d
in e
m ent
▁ im
▁in fec
es s
▁d is
eng ue
▁in c
a b
▁c h
▁e x
ic al
i p
▁b e
re s
i v
i es
▁a c
▁ W
▁f rom
▁ R
p or
i te
▁st ud
s ion
a d
s ,
e as
▁p ar
ig h
▁a re
▁b y
0 .
he r
▁as s
p ec
re d
▁c o
t ing
▁ he
s e
▁com p
a in
ran s
▁ r
an t
▁d engue
▁con t
u b
▁a l
t or
▁m os
▁ H
u g
▁n e
an ce
▁infec tion
▁t rans
▁s e
▁ B
▁g en
o us
l as
en ti
▁m od
m is
y p
al th
ir us
0 0
if ic
u p
▁P .
v en
a ti
v al
▁a t
d uc
▁ lo
o re
i ti
▁stud y
a nd
i z
▁d at
is t
▁w h
▁2 0
▁a d
on g
▁mod el
▁e f
▁c l
u re
▁p er
p l
il l
qu it
ti m
▁W e
a y
ro l
lo g
quit o
▁c as
p ro
▁I n
ig n
▁o r
▁he alth
mis sion
▁in ter
) .

▁mos quito
▁ E
▁in d
e ar
en s
a k
) ,
1 9
as ite
r ic
ul ation
o log
i k
▁h igh
▁dat a
▁dis eas
▁ le
▁re g
▁th is
▁s h
e th
ar y
▁ 3
c ip
▁ O
c h
▁ F
▁h a
ro s
es .

▁o ut
▁par asite
▁ N
as ed
▁c a
tion s
ent s
ve l
▁trans mission
et w
▁an al
▁v irus
f e
i al
or m
p h
en d
el l
o g
p er
oc ia
es t
▁cont rol
las m
u al
▁ k
id e
▁a p
ul ts
5 %
a g
en c
te c
a ge
er s
fe ren
i um
▁ass ocia
eth od
▁ und
id ence
f ic
I D
al cip
ar um
alcip arum
is k
il d
em ic
▁ y
▁ L
m un
es ,
p id
t her
os t
▁ef fec
▁f ac
▁f alciparum
O V
od ium
▁s p
lasm odium
e en
i b
▁s er
▁us ing
etw een
a x
v i
▁d if
OV ID
e ver
ec tor
▁ 0.
▁b etween
om e
▁und er
▁P lasmodium
p le
▁anal ys
g n
at h
▁ es
▁ ra
▁s ign
▁re c
f orm
▁s pec
i ed
▁diseas e
ros s
a tive
as e
ab le
l es
▁st r
al ly
- s
▁ un
▁s ur
ic h
op ulation
\ n
▁t re
▁inc re
os e
L I
al l
▁r isk
▁a r
▁c ell
▁ id
por t
▁p ati
▁ha ve
o und
▁ it
in d
▁n ot
N V
▁cas es
p t
▁p opulation
▁lo w
▁id enti
- b
il ity
▁ 9
lo p
▁wh ich
ac h
ate s
v ed
ac c
ve lop
▁C OVID
▁a m
te m
▁an ti
▁dif feren
▁re l
ation s
▁ G
at ing
▁ex p
i ve
n ow
▁ch ild
▁v ector
t al
▁a g
a red
▁h um
▁ U
E NV
un t
l ic
ac k
▁us ed
▁sh ow
▁d ur
l ud
ug h
ific ant
▁s am
▁s ub
▁in t
a tic
▁ Z
ac t
▁T h
ol d
d i
lo w
▁es tim
b o
▁ 4
▁b lo
▁v acc
▁de velop
▁v iv
▁y ear
e w
▁a f
▁w he
▁c an
ri b
▁in s
ven tion
▁sign ificant
▁t im
▁m on
▁identi f
▁hum an
p on
id ual
l l
o ur
- 19
r im
▁m ore
▁inc lud
▁le vel
▁child ren
▁ en
▁sur ve
▁in v
▁k now
as t
in ation
▁h ig
ul d
▁de tec
olog ical
▁viv ax
▁A f
▁associa ted
in ical
▁g ro
ethod s
a p
▁h as
▁reg ion
▁ qu
l us
- 2
▁analys is
▁dur ing
val ence
▁ac c
e g
▁res ist
▁s c
▁b ut
▁comp ared
or k
y n
te in
v ity
▁m an
iti es
▁blo od
▁the se
ro und
ia gn
▁e pid
▁im p
▁20 2
▁pati ents
▁o ver
▁o b
▁tre at
tion al
enti al
i an
▁e v
ys tem
▁co unt
▁pro v
▁ 5
▁Af ric
▁pre d
e .

▁H e
iagn os
ar d
▁am ong
0 %
b er
▁res pon
▁D ENV
iv idual
▁A n
ind ing
a il
▁COVID -19
y m
▁the ir
▁cl inical
re ak
▁treat ment
- 1
ur ren
▁C on
ul ar
ot yp
▁ 6
▁ca us
▁resist ance
ul ti
▁ass ess
▁pro tein
it al
lus ion
h old
▁t es
▁dis t
▁stud ies
▁ind ividual
▁fac tor
b reak
e p
▁p os
▁d r
▁th an
▁p ub
▁20 1
w o
ve re
▁pre s
▁re por
▁res ults
▁lo c
▁Th is
N A
▁inc idence
ul t
▁f ound
▁n o
▁R es
i ver
▁pred ic
▁m or
▁re duc
▁out break
▁ap pro
▁p o
▁us e
▁gen e
s o
▁d iagnos
l ed
▁s ystem
c lusion
res sion
▁hig her
a ,
▁ac ross
▁b o
ter m
qu enc
u te
ate g
i le
ar ge
▁h ad
- t
▁t wo
▁n um
▁mos t
s er
▁s et
u th
ac ter
igh t
▁al so
▁par tic
- d
l ec
▁m ulti
▁v aria
▁n on
▁pre valence
▁dr ug
T he
re e
▁s uc
▁se vere
g en
▁ 7
▁d ec
▁sam pl
. 1
▁d em
ra ph
▁be en
in ed
▁o ther
pt om
m er
iz ed
- p
▁tim e
▁p ot
at or
og raph
▁ ro
os p
th ro
▁C I
▁ins ec
ir al
a ys
g round
l d
▁differen t
ack ground
▁pub lic
▁ K
▁a ge
ec on
▁h ous
res s
inding s
▁in f
an ts
- c
a re
▁imp act
▁infection s
mun ity
▁it s
u res
▁al l
pl ic
urren t
▁B ackground
O R
▁m eas
▁d es
al e
i re
LI N
ur al
st r
ri al
▁M ethods
▁im port
. \n
t ain
u tion
▁s ug
tive ly
▁im pro
ik e
▁m ic
▁f ever
▁con s
▁spec ies
-b ased
▁Z ik
ym ptom
osp ital
e hold
▁ V
iz ation
- S
▁ 8
▁ up
an ti
▁de ath
ill ance
tic al
olog y
o ut
or d
ir st
▁year s
▁gro up
▁c ol
at ure
▁ne w
.\n \n
b le
i o
an g
▁are as
▁ag ain
▁mon th
▁factor s
▁p rim
▁re m
00 0
▁str ateg
▁bo th
= 0.
om ic
ation al
▁per form
▁set ting
ar acter
▁again st
▁model s
▁ob ser
▁suc h
re l
▁p l
▁m et
▁comp le
c t
lo b
y te
ate r
▁v ar
▁sug g
c om
ro ugh
st and
▁Res ults
% )
- in
i tive
un g
▁parasite s
▁Con clusion
A R
r ac
ar g
▁m ed
▁f ol
▁f irst
▁com b
▁1 .
e f
h an
re ad
uc t
ow ever
▁ne ed
vi ew
▁surve illance
ra m
▁af ter
▁t ra
▁c or
▁con duc
▁includ ing
▁num ber
v irus
val u
▁ind ic
▁hous ehold
▁s up
ed es
▁b i
▁A s
▁insec tic
▁t em
qu ine
▁9 5%
▁p h
▁on e
▁co uld
▁vacc ine
▁ -
he n
▁the re
ter n
- m
▁s im
▁p ath
ac y
▁count ri
▁fol low
e x
▁m ay
▁we ll
▁mosquito es
▁Zik a
b od
d en
▁epid emic
. 4
f ore
▁with in
▁r ate
0 1
▁th ree
▁ch aracter
on str
▁gen er
yp ti
▁incre ased
▁identif ied
eg ypti
n e
▁col lec
c c
c es
ti g
▁e valu
▁th rough
% ,
e an
s )
▁a egypti
ar k
is tic
▁de term
▁repor ted
▁( 9
▁( P
▁A edes
▁se ver
▁O ur
C R
r y
ar ial
▁level s
▁pot ential
owever ,
a .

r on
em i
▁l ong
▁p e
ur den
▁g am
un c
▁de p
▁ =
▁ end
al arial
ab ility
▁ef fic
tal ity
▁prov id
- C
K V
▁to tal
iti vity
-s pec
▁dem onstr
z o
al ity
▁( D
▁cas e
I KV
▁th ose
▁C h
▁con c
▁mor tality
▁v iral
▁infec ted
▁significant ly
j ec
es tig
▁res pec
▁inter vention
▁t rial
▁s el
_ LI
i x
i ted
n ess
▁s ens
▁identif y
▁ev idence
▁c urrent
ro p
▁h ospital
▁wh o
▁anti bod
▁int o
yn am
▁conduc ted
- f
l u
v ing
he s
▁b urden
ly ,
▁v al
▁pro g
▁D engue
eas on
v ail
as s
▁f indings
. 6
W e
e ,
{ m
▁ca re
l is
or ld
▁ex t
▁ex per
▁o ur
ir c
▁inv estig
ynam ic
▁in form
is ed
um m
▁under stand
▁develop ment
▁c ross
or t
▁ac ti
▁loc al
▁sampl es
-spec ific
o x
vi ous
▁spec ific
▁ar bo
ator y
a j
▁a b
ir on
b ia
▁w ill
▁e l
▁whe re
▁import ant
▁obser ved
▁to ol
▁pro tec
m on
▁con f
▁l ike
▁M alaria
og en
▁respec tively
. 8
c ess
▁im mun
ib le
▁detec tion
▁partic ip
▁tem per
o uld
r ation
▁ ur
▁f re
▁( 1
▁rem ain
aj or
c ri
e k
he d
▁o p
▁o cc
im ate
uth or
▁w ork
▁re p
▁P f
▁whe n
- l
r al
▁a vail
▁m ajor
▁d ynamic
ver age
ograph ic
. 3
▁g e
▁g lob
▁af fec
▁strateg ies
arg et
h ib
in es
▁h ost
▁cell s
▁s ymptom
▁s eason
▁c y
▁str uct
▁low er
D T
▁S t
duc tion
. 7
ra z
▁show ed
n ing
▁H owever,
▁gene tic
econ d
umm ary
b an
i od
▁t arget
er y
▁f e
▁re qu
di tion
▁He alth
▁respon se
c op
o ugh
▁ [
he m
▁re view
ation ,
ur ther
i ent
o ver
v es
▁ ran
▁f unc
u ce
v iron
▁re d
oc yte
▁cl us
▁(9 5%
raz il
. 2
o od
▁ J
▁s oc
▁p ri
em ia
ra in
▁B razil
ven tions
▁diseas es
▁sp read
iver s
viron ment
▁( 2
ens ity
▁L LIN
▁incre ase
▁multi ple
m ed
▁on ly
op he
▁out com
▁clus ter
. 9
m it
▁d o
▁com munity
▁individual s
▁diagnos tic
m s
un y
▁a bo
nd om
us t
▁pre vious
o zo
ing le
▁e ach
las s
▁comple x
on e
▁C H
▁inter ventions
▁He re
▁appro ach
▁a im
▁t est
▁m ain
▁per iod
ik ung
ag es
▁rel ated
otyp e
ikung uny
0 ,
▁The se
▁high ly
les i
led ge
ar t
▁I g
▁se quenc
ear ch
▁estim ated
▁en vironment
▁know lesi
▁pos itive
▁sel ec
M C
ti ven
or ne
▁l im
▁com mon
▁ne ts
i qu
r in
▁s econd
▁m ethod
an c
em ent
▁wh ile
▁ra pid
▁epid emi
i enc
u red
▁p =0.
▁( A
▁( C
▁an tim
▁anal y
▁effec t
rib ution
▁man y
mer g
▁sens itivity
t en
▁( p
▁effec ts
▁respon s
▁pres ent
y re
ar ly
▁d ue
▁im ple
▁ac ute
iz e
▁fac il
AR S
▁arbo virus
i ly
▁s ingle
id ity
ati s
▁associa tion
▁cor rel
f er
s on
ve al
▁exp os
▁qu anti
▁countri es
o f
▁b ased
▁( S
▁incre as
-b orne
▁know ledge
▁CI :
▁collec ted
ozo ite
I V
ic ro
ed ing
▁re veal
ra p
▁inter ac
▁rec ent
▁prim ary
▁temper ature
tiven ess
a h
▁ ill
▁t yp
▁c irc
▁The re
▁sugg es
▁particip ants
▁avail able
▁glob al
▁abo ut
s .
in ing
▁t r
▁ch all
▁effic acy
e y
h ip
i tion
▁pre vention
▁ra ndom
▁non -
-C o
▁ur ban
l p
ti t
▁m o
em b
op le
ment s
▁effec tive
▁gro w
▁varia b
▁inf lu
▁impro ve
▁var i
▁pe ople
▁s us
it or
ro gen
▁T o
▁l arge
and emic
▁pati ent
▁region s
▁occ ur
R NA
g an
en ted
▁in te
▁c ri
▁d el
▁h yp
▁( n
▁Conclusion s
ophe les
C T
M I
m in
▁c ar
▁e merg
▁pre gn
am e
▁cl imate
etw ork
▁detec ted
▁end emic
o k
▁re ce
▁estim ate
▁death s
▁el im
▁dynamic s
▁antim alarial
ARS -Co
. 5
2 ,
V -2
a v
s ing
y d
re en
te mis
ation .

▁( I
▁dis c
▁ass ay
▁gen ome
▁ap p
▁sp ati
▁includ ed
▁no vel
1 ,
l ing
▁in hib
▁p andemic
▁m ark
iv ed
▁caus e
▁ro le
ire ct
▁fre quenc
- st
a quine
▁p ost
is ion
om en
ts .

▁malaria .

ess ential
▁ex am
▁Z IKV
▁prov ide
▁Afric a
▁analy z
ARS-Co V-2
temis in
▁w orld
▁f em
▁I nd
▁surve y
▁tes ting
▁prog ram
temisin in
a emia
w ide
ar an
at al
op re
ab or
▁ch an
ill ion
▁develop ed
< 0.
▁ essential
▁g re
-in fec
▁like ly
ti l
▁d id
ec tional
ac e
▁r ates
▁reg ression
▁acc ur
▁pri or
a f
i red
ti ous
lo y
▁n etwork
el d
ol ic
▁1 2
▁comp ar
▁dist ribution
▁reduc tion
thro id
-S ah
▁insectic ide
h a
ar ch
▁f our
▁P ro
▁st atis
▁pro por
▁cont rib
▁An opheles
▁understand ing
yre throid
-Sah aran
c ome
f ul
v ent
▁o val
▁s ch
▁N S
▁virus es
cri p
- re
3 ,
i eld
l ine
o uth
at us
▁( R
▁for m
qu ent
▁COVID 19
▁know n
▁assess ed
▁dist ric
▁diagnos is
▁expos ure
- L
C I
d le
▁s ite
▁c lass
▁the rap
it ing
▁h ow
▁( a
▁pro f
▁ch ikunguny
ros cop
ag ement
▁sc reen
ivers ity
▁grow th
o or
t y
▁the y
▁m illion
id dle
▁e m
▁v s.
▁l ine
ab lis
▁R NA
end ent
▁insectic id
▁follow ing
{m icro
{micro }
0 2
P CR
n er
▁s m
▁p a
▁p at
▁d ose
ts ,
di tional
▁outbreak s
▁varia tion
▁gam bia
= 1
in al
▁t arge
▁m ean
▁S ARS-CoV-2
▁des ign
- 3
4 ,
v ant
▁m ethods
▁f oc
it s
▁C om
▁high l
est ablis
-s ectional
▁sever al
▁outcom es
p ite
ia .

▁A m
▁effec tiveness
▁inv ol
▁red uce
1 )
w ard
ing ,
▁st rain
▁C o
▁le ad
▁exp ression
▁estim ates
econ omic
▁sugg est
ha vi
P D
▁p yrethroid
is ing
▁A d
ol ec
▁l abor
ad e
▁F or
▁sever ity
▁long -
▁elim ination
P T
c are
in ce
te s
▁s yn
▁w omen
lo c
▁pro p
▁res earch
▁1 5
ow n
▁k ey
▁rel ative
▁month s
▁antibod ies
3 %
T h
b idity
c le
▁ ent
▁m at
▁m ut
▁v is
im um
▁infec tious
▁be ing
▁be havi
▁he te
▁cont in
▁perform ed
▁setting s
▁acti v
▁conf ir
ery thro
▁pat tern
g o
y .

he st
▁re le
▁pre vent
▁cont ain
▁ne g
▁at t
▁vacc ination
▁acc ess
▁household s
▁respectively .

N S
e ous
x t
▁c ost
is m
ec han
le vel
ver se
op h
▁infection .

▁gen es
▁ad d
▁rec om
▁remain s
▁ill ness
b ility
▁m echan
▁f urther
at ures
▁A l
ol ution
▁l ess
▁1 0
▁H IV
ist ent
▁count ry
▁Afric an
▁cross -sectional
▁frequenc y
▁chan ge
olec ular
. 0
S T
▁s u
▁d ri
as is
an z
ia ,
▁( L
▁r ural
▁se qu
rop ical
▁imple ment
▁oval e
erythro c
M P
c rib
f or
h yd
▁ establis
in k
▁s ome
▁b ec
os ts
▁( m
▁A p
▁pro cess
if ied
▁1 8
▁1 9
▁im munity
▁health care
fic ient
▁man agement
▁tes ted
▁meas ure
tain ed
▁Ig G
▁propor tion
Th is
h n
t ro
y ,
y ing
▁ u
▁ ed
▁b ir
os om
il ar
ter s
▁M al
▁1 4
ical ly
▁high -
▁ha em
▁transmission .

ial ly
end ed
feren ce
fic ation
▁sub -Saharan
▁hig hest
▁caus ed
▁tes ts
▁po ol
▁increas ing
▁foc us
O _LI
l or
y l
▁d ays
is e
▁A e.

▁st ate
▁C _LI
▁malaria ,
ak e
▁sh ould
▁exp lo
▁character istic
▁demonstr ate
▁(D ENV
mit ted
▁respons es
▁labor atory
al ys
te red
▁m ix
ec hn
▁e arly
▁g u
▁1 6
▁ch ang
▁be fore
duc ed
▁ra ti
our ce
▁dec re
plic ation
▁mic roscop
▁met ab
▁determ ine
▁inform ation
▁(a OR
A T
▁ Y
re at
en e
▁d irect
▁f ive
ing .

ce p
▁we ek
▁al le
▁protein s
▁mor bidity
▁partic ular
▁sup port
▁path ogen
▁antibod y
▁previous ly
▁environment al
- 0.
. 5%
ti d
▁p rac
ar m
▁e p
▁( 3
et y
▁com mun
▁ne ut
▁population s
▁conc ent
▁ge ograph
- 4
5 0
v ic
▁t echn
ar ning
▁m e
at a
id er
ent al
▁st and
▁pro b
▁S outh
iv ing
por al
igh ts
▁ca p
▁U n
▁sam e
▁pos s
▁system atic
▁Methods We
.\n\n A
▁inte g
▁m olecular
▁d ensity
as es
om ological
▁with out
▁par t
▁Afric a.

▁meas ures
ymptom atic
▁comb ined
▁acti vity
▁ran ge
▁cri tical
▁gambia e
- level
0 5
6 PD
j us
in t
▁c al
▁w ould
ed ,
▁( OR
ul ated
▁S ummary
▁1 ,
▁W h
▁str ong
▁inv as
▁comb ination
▁reveal ed
▁hete rogen
w ay
▁p hen
▁m in
▁d ay
er n
ul ating
▁l if
ally ,
ations hip
▁sim ilar
▁variab les
▁NS 1
alys is
B C
I I
S A
T N
en y
▁s ummary
▁m emb
▁d ot
ed .

th ough
▁con di
▁I m
ip er
▁R DT
pec ially
▁infection ,
iz ing
▁F indings
▁U sing
otyp es
ep endent
▁perform ance
▁provid es
▁demonstr ated
▁protec tion
▁immun e
▁epidemi ological
-st age
▁condi tions
5 ,
a us
▁d os
or s
▁re pro
▁( M
▁st atus
▁dengue ,
▁20 19
▁ap ic
▁rel ationship
▁qu ality
▁gam et
{m iddle
▁symptom s
▁soc io
▁bir th
▁dot }
7 ,
S P
i e
l and
o -
▁the m
▁f it
▁an y
st anti
▁R eg
▁co verage
▁per s
▁sp p
▁differen ti
▁int ro
▁202 0
▁cy t
F R
b r
o quine
▁in iti
▁m ale
▁f ore
▁to ward
om in
▁( H
▁n at
▁1 00
las ting
▁ad min
▁es pecially
▁des crib
▁group s
▁med ian
▁lim ited
▁chall eng
▁sm all
b ach
▁d iversity
▁A uthor
▁T anz
ol bach
▁co h
▁le ast
▁differen ces
▁sub stanti
▁(n =
▁spati al
▁ed uc
▁stand ard
.\n\nA uthor
▁Tanz an
A S
h ood
o ly
v iral
▁a verage
▁the n
ce pt
▁an n
ut ri
am m
ax imum
▁vector s
▁reduc ed
▁appro ac
▁impro ved
rel ated
▁investig ate
▁sequenc ing
PT p
▁neg ative
T S
u es
▁ >
er g
▁C D
▁as ymptomatic
ut ine
▁de f
▁is ol
res hold
iv en
▁W olbach
▁par ame
▁analys es
▁acc o
▁ro utine
.4 %
▁LLIN s
rin cip
▁fem ale
▁pattern s
▁add ress
▁p lasm
▁n ational
op las
▁1 1
▁co -infec
▁ad dition
▁ef for
▁K eny
▁met a
▁gener al
▁func tion
▁second ary
▁pregn anc
opre valence
▁chang es
- 6
a ve
d s
p ar
p ati
t yp
v id
▁t er
re g
en ge
▁f ew
it her
▁e qu
▁( 5
im en
▁P re
▁qu es
mer ic
▁specific ity
▁rep res
▁struct ure
▁aim ed
▁gre ater
▁ent omological
▁Wolbach ia
% ),
1 1
A P
c ent
l av
r isk
▁ if
▁c r
▁c hem
▁d i
is ting
▁re ac
ia te
id ate
▁( N
▁th reshold
ul f
▁C am
▁con te
▁l ack
▁2 00
▁1 7
▁ex pl
▁study ,
▁ad ults
▁202 1
▁dem ographic
▁mic ro
▁pl an
▁chikunguny a
lav iv
- related
I n
d er
y tic
▁a ut
ti vity
er ate
os ph
▁( 0.
ut ure
▁l ink
▁ha ving
end emic
▁detec t
▁po or
ef fec
hen s
▁evalu ated
▁season al
▁facil ities
▁interac tion
▁sugges ting
tit ud
▁world wide
▁insecticid al
▁targe ted
▁long- lasting
B S
R P
g /
i ence
m e
t ative
v aria
w e
w i
x y
▁o ld
er o
ic ip
▁re t
▁( 6
un icip
oc k
▁R e
pec ted
▁trans crip
▁rec ord
▁vacc ines
▁pres ence
▁follow ed
▁car ri
▁confir med
▁recom m
▁rati o
1 2
E P
H 5
I R
R I
▁ ens
in fec
▁s ound
▁f ind
ic k
▁ass ays
▁or gan
▁F urther
orm al
▁ra in
▁whe ther
▁over all
▁system s
▁exper im
▁affec ted
▁ran g
▁Here ,
▁u til
▁integ r
- M
- h
- an
D H
D engue
H O
c k
o ve
o id
o ts
p re
y ear
ti s
is on
▁b et
os is
ur ve
ig er
por ted
▁al low
▁mosquito -borne
▁control led
atic al
ew ork
▁202 3
▁predic t
▁up t
ram ework
▁evalu ate
▁trial s
hem atical
▁CH W
iqu e
▁arbovirus es
hyd ro
▁particular ly
rincip al
▁bet ter
3 4
B O
n al
o ol
▁a round
al es
▁re al
▁h is
ly m
▁P ar
et her
▁I PTp
▁are a
▁ad ult
▁G han
▁G 6PD
▁mon itor
▁reduc ing
-t rans
jec tive
▁op tim
▁vari ous
▁analyz ed
▁em p
tro duction
▁neut ral
▁invas ion
▁gamet ocyte
oplas t
- res
- endemic
8 %
9 9
c ed
g and
i ter
▁ <
he ast
▁s ix
▁c ult
▁f ramework
▁n et
▁A r
▁st age
▁g iven
▁pro jec
▁res ul
▁pre ven
▁I t
ific ance
ist ration
▁disease .

▁ar temisinin
▁anti gen
▁ag ed
▁U gand
▁meas ured
▁month ly
▁dep loy
▁func tional
▁apic oplast
▁fore c
▁ann ual
▁approac hes
0 6
4 %
s et
w n
▁ Q
▁ z
▁f ield
it ud
▁v ia
▁A .
▁pro duc
ific ation
▁N iger
fic ial
▁sp ra
▁ser vic
▁ser oprevalence
▁tre nd
▁assess ment
▁predic tive
▁pe ak
▁provid ed
▁val ue
▁mat hematical
jus ted
▁toward s
▁conte xt
- effec
- year
3 )
4 2
8 ,
M alaria
d own
f en
i er
i res
u ted
▁ erythroc
re ated
ti f
he ren
nd er
▁m unicip
▁b en
ia b
id es
▁n ec
▁P er
▁A meric
▁an aemia
▁M od
▁D es
▁D ata
▁ch lor
pec tive
▁gen omic
iti es.

▁data .

▁human s
rim eth
urren ce
▁import ance
▁cons ider
▁ph ase
▁current ly
▁protec tive
▁influ ence
▁accur ate
▁screen ing
▁characteristic s
C D
e u
n a
y rimeth
▁s ulf
▁e le
▁e ither
▁A N
▁S out
ist osom
▁ad ditional
▁per son
ay ed
▁cas es.

▁In troduction
▁ind oor
▁sam ple
-c on
▁conc ern
▁target ing
▁requ ired
▁statis tical
▁coh ort
- P
- R
1 ).

p lo
t rol
w a
▁t ropical
▁c le
▁p an
▁p olic
▁d er
▁w ater
▁f uture
▁b as
▁st ages
am ine
ran e
▁O r
▁cons istent
▁strateg y
▁med ical
▁exper ienc
▁cy cle
▁soc ial
▁selec tion
ienc y
<0. 00
▁pool ed
▁mix ed
cep ti
laviv irus
yrimeth amine
. 0%
N T
d ds
h ie
i asis
t oc
u ary
on a
▁s por
▁p ast
▁m ap
▁e ven
▁th reat
▁v er
ce ll
tic s
▁1 3
▁D e
▁inc or
ab it
▁ac hie
ad ox
▁he lp
▁comp ound
tor s
▁B ang
▁gen otype
▁E n
▁3 0
▁falciparum ,
▁blood -stage
▁Afric a,
▁An .

▁caus es
▁prim aquine
▁var ian
▁As s
▁determ ined
▁accur acy
▁contrib ute
go ing
▁(DENV )
▁geograph ical
▁poss ible
▁meta -an
▁ques tion
0 3
2 1
6 )
S )
b ri
e re
m ented
p r
q PCR
t he
t hes
is s
is od
▁w ide
▁( 7
▁P CR
▁C ol
▁pro ble
ot her
▁W orld
▁co un
se quent
▁dat ab
▁model ling
▁out come
▁ser otype
▁tim es
▁201 5
▁drug s
▁parasites /
▁bi as
▁tool s
▁J an
▁epidemi ology
▁chall enge
▁mark ers
▁distric t
▁invol ved
▁nat ural
▁upt ake
heren ce
adox ine
bri le
0 4
7 %
D A
H F
a z
b ers
m an
m ore
o ,
o ung
p s
t le
en ar
▁c and
▁d a
is ms
ic ation
▁b ite
us ,
ir d
▁res idual
▁I TN
▁2 6
▁M arch
▁comp re
▁comp lic
▁sh ort
▁un c
▁repor ting
▁dec ision
-p yrimethamine
▁95% CI
fore ,
▁ab ility
▁rep e
▁fe brile
▁p=0. 00
▁correl ated
▁pregn ant
▁(L LIN
▁explo re
▁ep isod
▁pregnanc y
▁his tor
▁nec ess
▁incor por
adoxine -pyrimethamine
/ 1
/ P
i os
k in
o tic
ti ll
▁s till
▁c ur
ar temisinin
▁m er
▁f am
an eous
▁re port
us ion
▁e ver
ac ity
▁v ol
ur ing
▁C l
▁S T
▁pre -
▁trans mitted
▁cas es,
▁In s
ak ing
▁tre ated
now n
▁blo ck
▁ev olution
▁tra vel
over y
▁sus cepti
gan ization
▁compar ison
▁C_LI O_LI
▁cap acity
vid 19
toc ol
- 9
c ale
l amm
y nd
in ct
▁o dds
▁c osts
▁d iver
▁of ten
or y
as et
▁f und
▁f ail
ro ad
▁h al
▁( 4
▁v ery
el ine
em ographic
▁res ult
iv al
ad es
▁ne on
enti ally
▁mod erate
▁at titud
iti z
▁In ter
▁E th
▁ind ependent
▁G u
▁int ensity
▁develop ing
▁species .

▁obser v
▁countri es.

ron ic
-l ike
▁selec ted
▁quanti f
▁Al though
▁prac tic
aus e
omin ant
▁educ ation
▁effor ts
▁Or ganization
more ,
▁compre hens
e ity
g ent
k nown
v ate
re c
al s
al ities
▁s ec
▁m ass
ro ph
▁b road
▁v it
el low
▁S er
▁S MC
am in
▁2 5
▁D is
▁ass um
▁se ek
▁dat aset
▁health y
▁reg ard
▁O ver
ethod ology
▁y oung
ib ility
▁0. 7
all ,
▁identi fication
▁rel ap
▁show n
▁en han
▁predic ted
.1 %
▁path way
▁investig ated
▁fre quent
▁quanti tative
▁occur red
▁hyp er
▁site s
{micro} L
▁sequ ence
▁implement ation
▁microscop y
ero on
▁spra ying
7 )
; ]
C on
E R
M A
m ia
o res
r ast
▁s te
or ph
er tain
ic t
▁b ar
▁b acter
os ed
ol es
uc le
▁comp are
▁lo g
ign ificance
▁mosquito es.

end ing
og lob
ide red
▁exp ress
▁U nder
▁sub sequent
▁surve ys
▁sc enar
▁202 2
▁repor ts
▁des pite
▁cons idered
▁setting s.

lis hed
▁symptom atic
▁distric ts
▁pa per
▁lif e
iper aquine
▁Reg ion
▁erythroc yte
▁ben ef
▁sulf adoxine-pyrimethamine
▁spor ozoite
2 4
s p
in ated
▁c ity
▁d oc
it ation
os ome
ul ate
▁g o
uc ial
▁M ed
▁us age
▁R ec
her n
▁H ospital
▁infection s.

▁lo ad
▁ad verse
▁cl on
▁control .

▁cell ular
▁ins ights
-2 01
▁ev ents
▁dist inct
▁pub lished
▁num bers
ator s
thro p
plic ated
▁mic e
ord ing
rac tion
-m ed
▁sel f
▁prog ress
▁ab s
▁facil it
▁There fore,
▁random ized
▁app ear
▁therap eu
▁strain s
▁behavi or
▁establis h
▁high- risk
▁metab ol
▁direct ly
▁concent r
▁Cam eroon
▁Further more,
▁preven tive
▁varian ts
ynd rom
▁comprehens ive
. ,
1 7
6 5
8 8
E S
b or
e qu
f ficient
i ous
o te
p a
r h
t o
z ym
▁ i
▁ er
▁ ec
▁ enti
▁a ble
re es
▁c ent
▁m aximum
is tered
tion ,
le t
▁( G
▁( i
ly ing
ul l
▁n or
▁l iter
▁S ub
▁res id
▁on going
▁2 4
op os
▁M ore
▁D ist
▁R H5
▁par as
ub lic
▁se arch
▁inter val
▁ind ex
▁le arning
▁ap pl
▁ser ological
▁sur v
our ces
▁region al
▁pot entially
ord er
▁there fore
▁gener ated
▁determ in
▁influ enc
▁Am ong
▁contin u
ene tic
▁memb rane
▁carri ed
EP 1
hydro artemisinin
▁emp loy
iab e
▁meta-an alysis
▁proble m
- se
- up
- of
R )
U S
re st
▁c ateg
ia ted
om p
▁th us
▁v ir
ul in
▁pro mis
▁de g
▁D NA
ab il
▁gen otyp
▁ad mission
▁ca pt
ocia ted
enc y
▁ser um
tem poral
▁resist ant
▁Pf C
▁ge ographic
▁cluster s
art ment
▁correl ation
son i
▁emerg ence
▁inhib ition
▁Wh ile
▁spp .

▁admin istration
▁Tanzan ia
▁plasm a
▁cr ucial
▁expl ain
ona virus
▁hal f
oglob in
▁enti re
- A
- ass
6 ,
C )
M )
P )
i op
k e
r up
u ro
▁ economic
▁p ur
▁f at
▁re plication
▁h om
▁h abit
▁pro m
▁l ar
▁M o
ow er
ies ,
val ent
▁or der
▁ser opos
LI SA
▁cell s,
▁suc cess
▁need ed
▁identify ing
▁requ ires
▁do ub
▁sch ool
▁gu id
▁parame ters
▁repres ent
pre t
▁Sout heast
thes is
+ /
- 5
1 ),
A L
g i
p ut
p read
on th
▁o wn
▁s af
▁s yndrom
ic e
▁( E
ul ner
▁P h
▁A ll
un ting
tic ally
▁con dition
▁l iver
▁S .
▁res t
▁2 3
▁stud ied
▁comp on
▁E f
ens ive
▁associa tions
ple x
-s cale
▁population s.

▁en zym
▁respon d
▁201 8
-d e
▁Methods A
.\n\n Con
▁pl ate
▁val id
.6 %
▁major ity
.9 %
▁imple mented
lp C
▁prof il
▁alle les
▁challeng es
▁substanti al
▁plan ning
▁link ed
▁Per u
▁Des pite
▁Col om
▁cand idate
▁PfC lpC
, 000
- tim
1 3
6 %
8 0
D S
Q -L
a wi
b i
in ate
▁a ver
on d
on s
he l
▁s out
▁d iabe
is h
er v
ic ity
▁re ference
▁b inding
▁b iting
▁h owever,
om ain
▁( 8
▁v i
▁v ary
▁v ulner
▁pro per
ra d
▁l ight
▁l arg
ri x
▁S ystem
▁I R
▁I FR
▁R BC
▁ne ar
▁se x
▁O b
▁ser ies
act ate
▁ob tained
-t ub
-t reated
▁tra ining
▁bi ology
▁epidemic s
▁affec t
▁struct ural
.7 %
▁fe atures
▁do es
▁(A OR
▁vari ant
▁program s
opre vention
▁line ar
▁establis hed
▁Mal awi
▁metab olic
▁commun ities
▁heterogen eity
▁describ e
varia te
▁forec as
▁parasites/ {micro}L
▁Eth iop
▁vit ro
▁concentr ations
▁liter ature
▁appl ied
▁fat ality
▁habit at
.\n\nCon clusion
Q-L NS
- on
1 0
2 )
d uce
i et
l ades
y log
re eding
▁s o
es is
▁m ight
▁h our
om et
os quito
ly .

▁th ough
um an
▁g l
▁l iving
▁S c
▁S urve
uc h
am b
▁ac cept
▁W HO
▁al b
▁per cent
▁E x
▁O n
▁dif fic
▁0. 9
▁ra d
▁G en
▁acc ording
▁dec l
-S P
▁up on
.\n\n M
stand ing
▁bi om
▁ph arm
▁ab und
▁St ud
▁fe eding
▁requ ire
▁pri vate
▁lim it
▁interac tions
▁circ ulation
▁sugges ts
▁mo bility
▁emerg ing
▁highl ight
tid e
▁cal c
pr iate
▁(LLIN s)
+/ -
-tub ulin
lades h
- D
/ 2
2 %
N G
T -
i ents
o v
p ir
r ing
t am
u rop
w are
{ +/-
▁s a
▁s ince
▁m id
▁d et
or rh
▁w ave
▁re f
om es
ation s,
▁n ucle
▁A CT
▁st ress
▁g ly
em ble
▁pro tocol
▁de fic
▁pre valent
op ict
▁ex hib
por ting
▁co -c
iti g
▁inter view
ric t
▁N ational
og ens
ers hip
▁0. 8
▁un ique
▁un known
▁cell s.

▁analysis .

▁201 7
▁incidence ,
▁po int
lec t
▁age ,
▁inf lamm
plic ations
▁comple te
▁indic es
▁As ia
▁sim ulation
▁evalu ation
▁through out
-f old
▁work ers
▁sequenc es
▁circ ulating
▁del ayed
▁prof ile
▁decre ased
▁concent ration
▁di hydroartemisinin
▁experim ental
▁IPTp -SP
▁monitor ing
▁municip alities
▁question na
▁log istic
▁alb opict
{+/- }
- cell
/ S
1 5
F V
L DH
c ence
d eg
e q
n es
o u
w ent
{ deg
he i
al le
▁s ize
▁c ure
es ian
▁m itig
er s,
as c
▁f lu
an s
at her
▁b erg
os s
▁( W
▁v ers
▁n ow
▁n ormal
▁P M
▁C ent
un e
▁pro te
▁malaria e
▁I s
▁M ay
▁M ost
▁ex isting
▁cont rast
▁trans cri
▁B y
iti es,
▁study .

iz es
▁or ig
ak en
▁reg imen
▁ha plo
ph al
▁ap plication
ag ing
▁y et
ther n
▁ser otypes
▁sign s
▁rec r
▁un com
▁population .

▁dur ation
▁resistance .

▁loc k
▁Res earch
▁use ful
▁sampl ing
io tic
▁areas .

ater nal
▁indic ate
▁path ogens
ex ual
▁exper ience
▁respectively ,
▁avail ability
▁CH IKV
▁common ly
of t
▁circ um
▁tr ack
▁program m
▁lead ing
▁rele vant
▁cost -effec
▁chem oprevention
▁recomm ended
▁rain f
ides pread
▁cle ar
▁Bang ladesh
▁da ily
▁mer ozoite
▁practic es
rees }
▁Colom bia
-on ly
▁diffic ult
{deg rees}
▁berg hei
- 7
6 4
7 9
S S
_ A
_ ST
n ec
o b
s is
t t
t in
w ays
▁ j
▁ -tubulin
in ally,
▁s kin
▁c yn
▁p ower
ar ily
▁w idespread
as h
an sion
▁re ad
at rix
om ol
▁( b
im al
▁n utri
▁as exual
tic ip
▁con ser
em ber
▁2 9
ess ion
▁dis s
ab ly
▁H C
▁ne uro
▁infection s,
▁B ay
▁ad v
▁model ,
▁cl ose
▁E s
▁E ast
▁exp ansion
▁vivax ,
▁region s.

▁imp ac
▁appro priate
-p iperaquine
▁Zik a,
▁indic ated
▁Ch ikunguny
▁who le
▁val ues
over n
▁aim s
▁rele ase
▁su it
▁decre ase
▁techn iqu
▁repro duc
▁repro duction
▁socio economic
▁Mod el
▁episod es
▁sec re
▁therapeu tic
-ass ociated
_ST _A
▁Bay esian
3 0
k ing
p o
x imate
y br
▁ enc
in ic
en se
▁c all
es tern
▁m al
er ation
▁b est
▁v ill
ul ative
▁g ood
▁2 8
ot a
▁ac id
▁W ith
▁R io
▁he m
▁se en
▁E urop
▁O f
▁N o
▁y ellow
▁U S
▁year s.

▁children ,
▁en rol
▁sc ale
▁man soni
0% )
▁DENV 2
▁201 6
▁predic ting
▁reduc tions
▁inf ants
▁Background The
▁med ic
▁indic ating
▁tem poral
▁ph osph
▁gener ate
ron t
▁provid ing
▁Ch in
▁intervention s.

▁hospital ised
▁[ &
▁typ es
▁exam ine
▁chikunguny a,
▁Ad dition
▁mut ations
▁activ ation
▁mechan ism
▁heterogen eous
▁resul ting
▁necess ary
▁ever y
▁regard ing
▁bar ri
▁doc um
▁surv ival
▁determin ants
▁categ or
▁saf ety
▁rest ric
-tim e
▁rad ical
▁uncom plicated
▁cyn omol
atrix -M
ybr id
, S
- val
- term
- wide
/ M
1 4
3 9
5 )
5 9
6 ).

B P
f ace
m ost
n ational
u le
y t
▁ 0
▁s emi
▁c um
▁m is
▁m aternal
▁d ate
or ing
is ts
er i
tion .

▁f ree
it ative
▁b u
▁( K
▁( r
▁th ird
ur se
od e
▁pro s
▁l ate
▁S Q-LNS
▁2 2
▁M ethodology
▁1 .1
▁ex pected
▁ac tive
▁co -
▁gen us
▁dat ase
▁ad ap
▁cl im
▁E LISA
▁data ,
ag ic
▁fac ility
ib r
▁differen ce
▁int ra
▁region .

▁ob jective
▁pred ominant
0% ,
▁201 4
▁pres ented
▁po lym
▁non -f
▁insec t
▁cor onavirus
▁arbo viral
▁temper atures
▁CH MI
▁Ig M
▁del iver
▁highl igh
▁syn thesis
▁prop ose
▁behavi our
erythroc ytic
▁bec ause
▁Mal ays
▁dos ing
g/ m
▁record ed
-trans mission
▁95%CI :
/P rincipal
▁fam ily
▁Cl inical
▁neon atal
▁promis ing
▁capt ure
▁pharm ac
▁abund ance
▁vers us
overn ment
_ST_A BS
-val ue
▁cum ulative
- B
- gen
. g
/ /
/ or
1 %
3 2
: //
R s
a u
a pt
c RNA
d oor
l ation
l if
o e
y ri
▁ qPCR
in c
ti al
▁o per
▁s le
▁in oc
▁c at
▁c am
▁m ac
▁m ild
▁m ade
▁and /or
▁f lavivirus
▁re -
▁b ed
▁b reeding
ve ment
ia ble
ur ally
▁P i
▁P v
▁P BO
▁A t
▁A ug
▁pro duction
ver s
▁l and
▁l ag
res tim
▁co urse
▁comp r
▁al loc
▁H igh
▁ne igh
▁model ing
pro xy
▁diseas es,
▁F inally,
▁N or
▁control s
▁und e
ild ren
OVID -19
▁rec urrent
▁rec overy
▁ar m
▁am pl
▁ag ent
▁predic tion
▁outbreak s.

ress ive
tain ing
▁areas ,
▁Results A
-m alarial
▁op en
▁J une
▁recent ly
▁hyp n
ok ine
▁disc rim
▁exam ined
▁Am az
▁contain ing
▁mechan isms
▁su fficient
▁haem at
▁focus ed
▁phen otyp
▁initi al
▁100 %
oly sis
▁acco unt
RP 2
▁integr ated
ove red
▁chlor oquine
▁pan el
▁Jan uary
pa ign
▁RH5 .1
▁lar val
▁success ful
▁Ef fec
▁sout hern
▁biom ark
orrh agic
▁co-c irc
▁polym orph
yri proxy
▁sle ep
▁Amaz on
yriproxy fen
- ph
4 9
D s
M E
P F
P I
R es
V )
] ,
c l
g reg
i tic
o A
y r
▁t orm
on es
on otic
te or
▁s ource
▁m y
or b
▁w arning
an ces
▁re infec
at in
▁h osts
od ing
il ir
▁A R
▁st ates
▁g ain
▁con nec
▁S ince
oc h
▁D HF
ies .

▁W est
ub in
▁al ong
▁ad justed
▁ad apt
ric h
▁O ne
▁out door
▁parasite s.

ell ular
▁L ong
▁low est
vention al
▁tim ing
▁mon ke
▁includ e
▁children .

▁qu al
▁DENV -2
ail and
▁caus ing
▁dec line
▁ro b
▁Background Malaria
▁impro ving
▁Results The
▁ph ylog
-m onth
.8 %
▁remain ed
▁affec ting
▁typ e
▁cri ter
▁Conclusions The
▁rece p
▁rece ive
▁(I R
▁disc us
▁fem ales
▁prior itiz
▁sch istosom
▁prop osed
▁activ ities
▁prob ability
▁RDT s
▁dos es
▁addition ,
▁Keny a
▁ens emble
▁Ugand a
▁bas eline
▁diver se
▁Over all,
▁enhan ced
▁frequent ly
oles te
▁scenar ios
▁abs ence
pret ation
▁dihydroartemisinin -piperaquine
oft ware
{degrees} C
▁-tubulin -1
▁cynomol gi
▁Aug ust
teor ological
ilir ubin
- H
- pro
0 )
5 ),
B A
I )
O ur
c o
h ance
n el
u k
u ts
v ated
▁ X
▁ zo
▁ {micro}
in s
▁t it
▁t iss
▁p ep
▁d iv
▁d one
er s.

an k
ation s.

▁( T
im ens
▁P o
▁A cc
▁we ight
▁st ar
un te
el i
▁con st
▁l actate
▁res ource
▁res pir
▁I F
ge ;]
▁2 ,
▁2 7
und red
▁ch ain
▁R ep
red ic
▁dengue .

▁al ign
▁mosquito es,
▁E pid
▁3 5
▁virus ,
▁control ,
▁0. 00
▁0. 05
▁under went
▁exp and
▁Th ailand
▁year s,
▁level s.

▁en hance
▁5 0
▁DENV -1
▁6 0
▁201 3
▁appro ximate
rac ellular
▁1. 0
▁countri es,
▁Ch ildren
▁hospital ization
ox ide
▁strategies .

ocyte s
▁Brazil ,
▁outcom es.

▁increas es
▁knowledge ,
tit ute
▁hyp ot
▁network s
-L LIN
▁insecticid es
▁vis its
▁bec ome
▁week ly
▁Un iversity
▁substanti ally
typ es
imen sion
▁reac tive
▁Ghan a
▁deploy ment
itud inal
▁Niger ia
▁wide ly
▁suscepti bility
▁seek ing
▁ste p
▁express ed
US $
▁seropos itivity
▁doub le
▁questionna ire
▁rainf all
▁diss em
▁Chikunguny a
▁Addition ally,
▁torm ota
▁qual itative
▁rob ust
oleste rol
- g
1 6
4 )
E D
a e
a i
f usion
l ap
t ,
u tions
▁ lym
in es.

▁a wa
on yl
ti es
ti ce
en ter
▁s ter
▁d omain
▁f low
it tle
at ric
▁b le
▁h ybrid
om plex
os itive
os ition
▁A c
▁st ra
▁C are
▁T B
▁g ap
▁malaria -endemic
▁l ed
▁l ast
▁l ater
▁S al
▁S oc
▁pre c
▁M in
▁M ulti
▁D ec
▁ch o
▁ex cess
▁ac qu
▁R A
▁he re
▁he at
▁al tern
▁3 4
▁O R
▁O ut
▁0. 2
▁0. 5
▁disease ,
▁un til
▁ar ri
port un
ach ing
▁show s
▁show ing
▁vivax .

▁sc al
▁studies .

▁factor s,
▁po ly
▁bo os
-t o
-p LDH
omic s
▁pl ac
▁(P f
▁mortality .

▁where as
.3 %
▁affec ts
over ,
▁rece ived
▁inhib itor
▁analyz e
▁Ind ia
af en
▁compar ing
▁therap y
▁screen ed
▁highl ights
▁recom b
iper onyl
o- temporal
▁intro duced
▁def ined
▁parame ter
▁recomm end
▁datab ase
▁vol unte
▁fund ing
▁Under standing
▁Rec ent
▁More over,
▁Dist rict
▁own ership
▁respond ents
▁plate let
▁vary ing
▁percent age
▁mid g
▁albopict us
/S ignificance
▁lock down
▁enrol led
▁clim atic
▁deliver y
g/m L
▁cam paign
▁lym ph
G D
M M
Q R
R O
R DT
g ue
p ression
r il
s y
u ly
v ation
▁ "
▁ %
on al
en ous
▁s w
▁s al
▁s oftware
ar asite
▁m ust
▁d on
▁w ay
as tern
▁f il
▁b od
▁b rain
▁b order
▁h ots
▁h undred
▁( B
▁( F
▁( s
ac tive
▁P redic
▁C or
ol ar
▁de ep
▁S ch
▁2 000
oc ys
ren g
ren ess
▁D F
▁us ers
▁ass emb
▁co up
▁al most
▁ne ural
▁trans port
▁cl inic
▁O .
ch arge
ch ron
▁0. 3
▁ar tic
▁estim ating
▁viv o
▁tim e.

▁region s,
-2 02
▁An alysis
▁6 5
▁resistance ,
▁loc ations
▁incidence .

▁diagnos ed
▁varia tions
-S eq
▁prim arily
▁var ied
▁1. 2
▁tra ditional
▁path ways
▁follow -up
▁character ized
▁collec tion
▁long er
▁dep endent
IKV )
▁sens itive
▁val u
▁op portun
▁glob ally
▁St ate
.2 %
▁variab ility
▁(n =1
▁pandemic .

▁contrib uted
▁class ified
▁targe ts
▁confir m
▁(m ean
▁(m aximum
▁Ap ril
▁me teorological
▁part ner
▁2021 .

▁worldwide .

we ight
▁rang ing
▁2023 .

-res ist
▁polic y
▁experienc ed
▁compound s
▁fail ure
▁Dis eas
▁er r
▁syndrom e
▁compon ent
▁enzym e
▁det ail
▁orig in
▁conser ved
/M atrix-M
▁inoc ulation
▁unde restim
▁awa reness
▁ble eding
- T
- w
1 .

6 9
8 ).

9 5%
b s
e i
g ens
i atric
l es.

m al
n am
n ormal
o ber
p ing
r uct
y ond
z a
z amb
▁ ve
ti ves
▁p ay
▁p iperonyl
ar n
▁m alarial
▁m other
▁d ig
▁d ens
▁d own
▁of fer
▁w ild
▁f ar
le ts
▁( Z
▁C C
▁T rans
▁con se
▁pro duce
▁pro lif
▁l ittle
▁S D
▁S h
▁S pec
▁M an
ys ical
▁ch olesterol
▁be yond
▁R TS
▁at ten
▁ad herence
▁ind irect
▁3 ,
▁N e
ag es.

▁y ield
▁L e
▁effec tively
▁under st
▁sur face
ach ine
velop ment
▁anti -
▁anti gens
▁child hood
▁hum idity
▁U K
▁sub set
our c
▁analysis ,
▁but oxide
▁man ner
▁Con trol
▁studies ,
▁individual s,
ult aneous
▁predic tors
▁prevalence ,
-p arasite
▁time ,
plic on
▁V iet
▁8 -
▁8 0%
▁indic ators
▁sim ultaneous
▁effic ient
▁conf idence
▁ur gent
▁respons ible
▁tr ig
▁tr ue
▁mo b
▁large -scale
▁patient s,
▁mark er
▁statis tically
crip tive
▁gu ide
▁differenti al
▁co-infec tions
▁rang ed
-h ost
▁CHW s
▁cult ure
▁resul ted
tif ied
-R DT
▁coun ts
▁repe at
▁incorpor ating
▁relap se
▁facilit ate
▁employ ed
▁Mo zamb
▁contrast ,
▁alloc ation
▁hypn ozoite
▁schistosom iasis
▁hypot hes
▁RTS ,S
▁Viet nam
- th
- ra
/ 3
1 8
6 ),
8 7
= 2
A N
B D
N F
P K
R A
S t
a em
c her
e .g
g s
i ety
l er
l ess
m ber
n ock
n cRNA
▁a ir
▁s ough
▁m ess
▁m aking
▁of f
or in
is ation
▁re plic
id al
▁( med
ce phal
▁T EP1
▁g on
▁as pec
▁an emia
em ory
ver sion
▁res ources
▁is s
oc yt
▁infec t
▁dis rup
▁inc lusion
▁ch ronic
▁be low
▁W NV
▁he p
▁comp ut
▁cont act
▁al though
▁trans mit
▁se ven
▁B i
▁per ip
pl ac
▁In c
▁In te
▁reg ul
eth rin
ch lor
▁transmission ,
▁virus .

og n
▁sp ace
OVID 19
▁rec urrence
▁low -
▁int racellular
▁4 9
▁An ti
▁treatment .

-1 7
▁dr y
-d ependent
▁multi variate
▁varia ble
▁inf er
▁V ector
▁setting s,
▁met ric
ct ober
rac ted
▁bi ological
▁sim ple
▁dep end
▁effic iency
▁ext ent
▁development .

-l ine
▁struct ures
▁func tions
▁Brazil ian
med iate
▁knowlesi ,
▁rapid ly
fer red
▁improve ment
▁sus tain
rogen ase
▁patient s.

<0. 000
▁prior ity
▁insecticide -treated
▁class ification
▁Com p
hyd rogenase
▁process es
.5% )
▁prob abil
▁Wh at
▁memb ers
▁fit ted
▁isol ates
▁co-infec tion
▁micro cephal
ove mber
▁projec ted
itud e
▁servic es
▁AN D
the tic
ps ://
▁Inter pretation
▁bacter ial
▁profil es
.\n\nConclusion s
▁hour s
▁Stud y
▁interview s
▁flu id
▁transcri ptom
tt ps://
▁suit able
▁reproduc tive
ront line
▁barri ers
▁semi -
▁Pi wi
▁zo onotic
▁respir atory
▁approximate ly
▁altern ative
▁arri val
▁midg ut
▁sal iv
▁sough t
- v
4 3
4 7
6 3
A MP
E V
I O
I S
T H
a per
b ral
h orin
t ent
y c
▁ ub
in om
es cence
▁m ax
▁m iddle
▁w all
er c
▁and ,
ic s
▁h and
▁h ist
▁h yd
os yn
▁( e.g
▁v ire
im mun
▁P MI
▁for ms
ig ible
▁T rial
▁con ventional
ol ved
▁l ip
▁res ear
▁2 1
ad justed
yp ox
▁model s.

▁In fec
▁E l
olog ic
ik eli
▁3 3
▁F und
ros is
▁parasite s,
▁N ovember
per s
ual ly
▁falciparum .

▁0. 6
▁under lying
▁analys ed
▁population ,
di i
▁4 5
▁level .

▁Af ter
▁sc op
▁assess ing
▁pos es
arge ted
-d is
-d emographic
-p ositive
▁time ly
▁group s,
▁rem ote
▁indic ates
▁long itudinal
-f ive
▁ext ensive
▁ab normal
▁will ing
▁el uc
cop horin
▁J uly
ten atal
▁(p =0.
▁inhib it
▁prof ession
▁million s
▁design ed
▁invol ving
▁Co vid19
▁relative ly
▁vis ual
oph ag
▁Ap oA
▁explo red
▁mix t
▁week s
▁alle le
▁prac tice
▁ep it
▁me al
▁Un ited
▁intro duction
▁CD PK
▁isol ate
▁sound s
▁Par ticip
ether ,
▁optim al
▁der ived
▁ver sion
ere bral
▁bite s
▁unc ertain
▁assum p
▁benef its
-med iated
▁nor thern
▁continu ous
▁genotyp ing
▁accept able
▁close ly
▁techniqu es
▁bu ild
▁phylog enetic
▁tiss ue
▁Rep ublic
afen oquine
sy ch
▁hots p
-resist ant
▁(med ian
▁gon dii
ikeli hood
- 8
/ C
4 5
8 )
8 ),
A )
B GD
E N
R C
T )
T P
W s
a o
a pid
b a
c ing
c hed
e ti
e br
r ine
▁ her
▁ rol
▁t e
▁t aken
re ct
re me
te ad
▁s it
▁s outh
▁in duced
▁c ertain
▁p ass
▁m uch
▁m RDT
▁m achine
▁d am
▁d imension
▁of ficial
or ity
er ous
as on
▁f ul
▁to p
▁h ome
▁h owever
id ities
▁e ight
ate ly
▁( d
▁( US$
lo od
th al
▁A D
▁st reng
ir ing
▁C R
▁an imal
▁con clusion
ut aneous
▁S p
ran ge
▁he ad
▁H RP2
▁ne xt
▁B o
ous e
▁ad j
▁ad op
▁ad vant
▁diseas es.

▁le uc
▁3 7
▁O ctober
▁parasite ,
▁und ers
▁L o
▁dif fer
▁un ivers
▁risk .

▁ar ch
▁9 0%
▁anti viral
▁sub s
bo virus
rib uted
▁over lap
▁ob tain
▁dec ad
▁fever ,
▁month s.

▁Results O
▁Results We
-in come
▁Conclusion The
read y
▁need s
▁character ize
ix ed
▁burden .

▁care g
▁cross -re
ogen icity
▁occ urrence
▁work ing
▁Pf E
▁season ality
.7 %)
▁response .

▁(C H
▁present ing
▁reveal s
▁typ h
▁rece iving
▁gre at
-infec ted
▁em ph
▁syn chron
▁Y FV
▁acco un
typ e
▁few er
▁aut om
▁ens ure
▁trend s
▁Americ as
▁AN C
▁bas ic
▁achie ve
▁Ass ess
▁repe ated
▁benef it
▁load s
▁(i .
-se q
▁guid el
▁condition s.

▁diabe tes
▁larg er
▁IR S
omet ric
.\n\nM ethods
T- PCR
▁Cent ral
▁recr u
▁biomark ers
▁monke ypox
▁recep tor
▁volunte ers
▁coup led
▁artic les
▁dig ital
inom ial
▁scop ing
▁Particip ants
ebr uary
▁sit u
) ;
/ s
/ AS
2 2
4 0
5 ).

7 0
9 %
9 0
= 3
B V
C C
T o
W S
c r
c er
e red
i )
i enti
o qu
o red
o unt
o tide
p os
s es
t r
t .

v idence
▁ iron
in ter
in ary
in ating
▁a uthor
▁t en
on e.

ti lis
▁in feren
▁p <0.00
▁p yriproxyfen
▁m ar
▁m ales
▁d ra
er ived
▁f atal
▁f usion
▁f ull
ro up
at form
▁b el
▁b asis
ia ge
om a
id ent
▁( V
im e
▁g overnment
▁l ikelihood
▁de hydrogenase
▁is land
am bia
▁M ean
oc on
▁ac tion
▁he l
▁r ash
▁H M
▁H uman
▁ne arly
▁se par
▁gen otypes
▁mod ified
ati ves
ati gue
iz on
▁model s,
quit os
▁or th
▁inter national
▁3 8
▁F R
ell ing
▁k ill
ag en
▁fac e
▁sp ots
▁ser ious
▁0. 01
▁rec ogn
▁risk s
▁anti b
▁vector -borne
▁ag ents
▁estim ation
▁year .

-d erived
lec ted
▁sampl ed
▁pot ent
▁sug ar
▁mic ron
▁group s.

▁new ly
▁pl ay
▁pl atform
▁comb ining
▁well -
▁Aedes -borne
▁ext reme
▁multiple x
▁main tained
MC )
▁spati o-temporal
<0. 05
-re g
▁line age
▁sm ear
▁pyrethroid -only
▁long- term
▁dri vers
▁rati os
▁(aOR =0.
▁min imum
▁fit ness
▁nat urally
▁routine ly
pati ent
▁old er
▁transcrip tion
▁ele ments
▁resid ents
▁hom olog
hel ial
▁Ob jective
▁Is land
▁programm es
▁(b y
▁[& ge;]
▁neigh bor
▁AR DS
▁opportun ity
▁dens ities
▁underst ood
▁ApoA 1
▁ful ly
▁unders c
/AS 01
- age
5 7
9 ,
? 

A G
D )
L C
M S
N P
T E
U sing
a qu
b ial
b ining
c al
f ort
g et
g ressive
j ector
m ature
m ark
n ed
s ).

y cle
▁ ult
in ts
in es,
he re
al se
te st
▁o uts
▁s l
▁s ources
▁c atal
▁c erebral
▁p ack
▁p lus
▁p sych
ar .

▁m en
▁m emory
as ing
▁f atigue
ic o
▁b ound
▁to g
▁h ttps://
▁e g
ate rial
os es
ac ific
ac tivity
▁n ine
▁P b
▁P BGD
▁A U
▁C urrent
ity ,
▁an ophe
▁an tenatal
▁malaria e,
▁l oss
▁l ncRNA
ud escence
▁S ep
▁on line
▁on set
▁2 .1
op en
op lasm
▁M osquito
▁D el
▁D uring
▁D emographic
▁ex c
▁W hen
ad herence
▁he ating
▁comp artment
▁B en
▁B ur
iti s
iz ations
▁cl os
▁cl ients
tim al
ak art
▁reg istered
▁sh ap
▁3 6
▁F ever
▁F ebruary
ros pective
▁N T
▁N ew
▁associa te
▁L O
▁0. 4
▁under -five
▁ra re
▁ar ms
▁population s,
▁9 3
tem ber
▁vacc inated
ap yr
▁qu in
lus ive
▁acc omp
▁sc ienti
▁202 3,
▁5 0%
▁COVID-19 .

▁pos i
-d ri
▁non -c
▁7 0%
▁ro om
▁Background Dengue
str uct
▁Methods This
▁impro ves
▁V irus
▁death s,
.\n\n Res
▁perform ing
▁tra ined
▁character ised
▁demonstr ates
jec tives
▁hospital ized
▁investig ating
umm ar
▁rep ell
▁Pf H
▁struct ured
ocyte s.

▁Brazil .

▁community -based
▁sugges ted
▁mo vement
▁sus tained
▁large ly
▁genome -wide
▁pandemic ,
▁mark ed
▁world .

▁compar ative
▁mut ation
▁prevent ing
▁increasing ly
▁(aOR =1
reat ment
▁pathogen esis
▁phen otype
▁socio -
▁pers ist
▁def in
▁Pre vious
▁chem ical
osph ate
g/ k
▁transcrip tional
tis i
▁real -time
▁forec ast
▁Q u
fen apyr
istosom a
.0% ,
▁achie ved
▁datab ases
▁cur tisi
▁block ing
▁suscepti ble
▁quantif y
roph il
▁Med ical
▁appear s
▁establish ment
▁Sub -Saharan
▁paras itic
▁vulner ability
▁circum c
▁cost-effec tiveness
▁Es tim
▁highligh ting
▁compr ising
▁RH5.1 /Matrix-M
▁successful ly
▁align ment
▁Epid emi
▁valu able
▁mob ile
▁perip her
▁lip id
▁resear cher
▁Fund ing
ophag y
▁FR EP1
▁accomp an
/ A
/ d
2 3
4 .

5 6
H ME
I P
R BC
S 3
\ "
c he
c hes
g or
h ap
l f
l es,
n ot
o le
p ed
p ose
r p
s ),
w est
▁ eng
in ol
in ant
ti le
ti mis
al ,
▁o ocys
▁c ities
▁p ric
▁m iss
as ting
▁f un
it ine
ed iatric
ia tion
▁e ar
os in
▁( >
ce ived
▁n ature
ith ub
▁A b
▁C .
▁C O
▁C r
▁C lp
▁T .
▁T NF
um ef
ter ing
▁an throp
ra nd
ra tic
if e
▁de ad
▁S P
▁S e
▁S m
▁S pati
▁S CD
▁com orb
▁pre cip
uc ose
▁M S3
▁1 %
ren t
▁D em
▁D iagnos
▁ch aper
ical ly,
▁R apid
ad ic
▁co ord
▁comp et
ant rine
▁cont ribution
▁al tered
tor y
▁trans l
▁gen omes
▁ad equ
ong o
▁model .

ens or
olog ies
▁this ,
▁sh ar
▁sh if
▁3 1
▁3 2
▁F rom
▁N PI
fe red
est ration
▁k nock
ag ed
▁ser otyp
▁am plicon
▁anti -malarial
▁rel iable
▁af f
rim ary
▁includ es
▁acc um
▁ev ent
▁treatment ,
▁Con s
▁individual s.

▁pres ents
▁results .

▁reduc es
▁outbreak .

▁sampl es.

▁sampl es,
thro ugh
▁V alle
ef ficient
-m alaria
ex isting
▁epidemic .

.4 %)
fore st
▁rate ,
▁character ization
▁evalu ating
▁conc lud
▁prog ression
.6 %)
▁ext raction
▁ext racted
▁detection .

▁Pf G
▁dynamic s.

▁cy c
▁St ates
▁outcom es,
▁main ly
0, 000
iqu ity
▁(p <0.00
atis tical
▁expos ed
▁typ ically
▁vari ety
▁sus pected
▁occur s
▁chan nel
▁contrib ut
▁NS 4
▁(R DT
{micro} m
▁gambia e,
▁Com par
▁contain ers
▁mechan istic
▁country .

▁dri ed
▁sequ estration
▁haem olysis
▁haem orrhagic
yl ation
▁neut rophil
jus ting
▁strong ly
▁invas ive
▁day s.

II I
▁2019 ,
▁pers istent
▁spp .,
▁2020 .

oly tic
▁general ized
pati tis
▁ter ms
▁repres ents
▁threshold s
▁poor ly
▁allow s
▁Ghan a.

▁ele vated
▁Jan ei
▁complic ations
▁Ins titute
throp od
▁metabol ite
▁Cameroon .

▁cent ral
▁paras it
▁continu ed
AL Y
▁forecas ting
▁On ly
▁calc ulated
▁sa fe
▁nucle otide
▁gly cophorin
▁defic iency
▁mitig ate
▁impac ts
▁call ed
▁vill age
▁Chin a
▁docum ent
▁pros pective
▁Methodology /Principal
▁non-f alciparum
▁Nor th
▁div ision
▁IF N
▁dissem ination
▁Dec ember
▁cho ice
▁assemb ly
▁detail ed
▁conse quenc
▁8- amin
▁RTS,S /AS01
chlor oquine
▁Comp ared
▁max im
▁vire mia
▁willing ness
▁dam age
▁conclusion ,
▁univers al
▁cross-re activity
▁PfE MP
▁accoun ted
▁Sep tember
-dri ven
▁peripher al
gor ith
▁fun est
umef antrine
▁Janei ro
2 .

4 ),
D 42
F I
O _ST_ABS
T M
U P
a ir
c ents
i ,
k ill
k ok
o ir
o adherence
p ly
r ug
t hen
u loc
v as
▁ ide
in o
▁a v
▁a id
▁t w
▁t afenoquine
ti ficial
te br
▁s il
▁s ummar
▁in n
▁c op
▁p ose
▁m A
▁m eth
▁d iagn
as ter
▁f eas
▁f old
▁f ood
▁f alse
ing s
▁re verse
▁b ene
us c
om ing
le ;]
▁e lect
▁( c
▁( h
lo id
▁v s
ur ity
im ination
il lo
▁P PF
▁A nd
▁st ak
▁C ar
▁T H
▁T r
qu ate
tic uloc
▁an other
et ine
ra ined
▁de v
▁de le
▁S U
▁res idence
▁res erv
▁res ourc
▁pre term
uc tion
▁I L
▁M ic
eng th
▁us es
▁im ported
▁im plications
▁par tial
▁are a.

▁co ver
▁r RNA
▁r ise
▁al ready
ance ,
▁B L
▁gen es.

ati al
ati ents
ist ance
ist ry
ign ificant
▁inter mit
▁E PCR
ens is
ik eri
▁high .

▁3 9
▁3 .4
▁out lets
▁N ot
ell a
ag es,
enc es
ib ly
ib ration
▁analys e
▁sign al
▁spec if
▁un s
▁9 8
tem ether
▁G o
▁ag re
atic ally
▁4 1
pon d
▁en ab
▁clinical ly
▁factor s.

▁loc i
▁predic tions
osp atial
▁Background C
▁Background P
▁fever .

▁V acc
-in duced
▁tra jector
▁cor rect
▁sup ple
▁sup ported
▁As ian
ex p
▁gener ation
▁gener ally
-f or
eason al
cri pt
▁op timis
▁LLIN s.

▁abo ve
▁period ,
▁related ness
▁p=0. 01
▁(C I
▁analy tical
▁temperature ,
min th
▁car ry
▁emerg ency
▁exam ple
▁(R R
▁form ation
▁therap ies
▁mean s
▁Co unt
ade quate
▁vis it
▁contin ent
▁att ending
▁u tilis
cep tion
▁cal ibr
▁min im
▁socio -demographic
▁birth s
▁cyt oadherence
▁admin istered
▁Tanzan ia.

▁ret ail
▁ret rospective
▁Re view
▁organ ism
▁util ity
▁Par asite
▁neutral ization
▁servic e
-con trol
▁consistent ly
▁De velopment
▁Bang kok
▁Ass ocia
▁ST AT
▁quantif ied
▁ec ological
▁vir aemia
▁deg ree
▁deg rad
▁entire )
▁aver ted
▁larg est
▁forecas ts
▁habitat s
▁Surve y
▁Surve illance
▁exhib ited
▁inflamm atory
▁neuro log
▁co-circ ulation
▁tit res
▁star ting
▁acqu ired
▁recomb inant
▁Sch istosoma
▁ve get
▁mother s
-ra ndom
aem oglobin
▁aspec ts
▁comput ational
▁metric s
▁microcephal y
IO N
▁ub iquity
▁middle -income
▁wall ikeri
▁hyd ro
▁epit op
▁recru ited
oqu inol
▁Ben in
▁posi tively
.\n\nRes ults
▁accompan ied
▁oocys ts
▁cyc les
▁NS4 A
▁consequenc es
▁8-amin oquinol
▁PfEMP 1
▁diagn ose
▁stak ehold
ticuloc yte
▁reserv oir
▁intermit tent
- risk
1 .1
2 /
3 ).

4 ).

5 00
7 1
7 6
7 ),
8 6
9 )
A n
E ,
E s
L A
W h
f ac
l ated
l ier
n utri
o un
o int
p yre
r it
t a
u f
y an
▁ &
▁ /
in ations
▁a ra
en za
te en
▁in adequate
▁c re
▁p i
▁p ut
▁m RNA
▁m ouse
▁d omin
▁d ominant
or n
is ted
is son
er al
er ved
as tic
as tal
tion s.

▁f in
▁f ib
▁f inding
▁b io
▁b ilirubin
▁b inomial
▁to ok
▁h ard
le x
id a
▁e uk
os cop
os ts.

▁( f
▁v enous
ce ed
ul osis
▁P oc
▁P rincipal
▁P ublic
▁we ather
▁st art
▁C Q
▁g ra
un ate
ra g
▁l ig
▁S L
▁S ao
▁com mer
▁pre p
▁I d
▁M V
oc ratic
▁D .
▁infec ting
▁dis ad
ab ly,
▁ex cell
iv aria
▁ac t
▁R em
sion s
0. 9
ub erc
▁al one
▁al gorith
▁se g
▁B ased
yp an
00 ,000
iti ves
and s
ist an
▁ad justing
▁model led
tim alarial
ens us
▁reg imens
▁3 .
▁O p
▁F FR
▁virus es,
og ether,
ag n
▁L DH
▁L ank
▁0. 1
form ation
▁un cle
▁low -transmission
ive red
▁sub -t
▁Th us,
▁4 2
▁human s.

pon se
▁detec ting
▁region ,
▁sc an
▁sc ore
▁over come
▁An timalarial
▁protein s,
▁individual -based
▁mor ph
▁system s.

-t o-
▁hous es
▁Background S
▁Background In
▁des criptive
ire c
▁species ,
▁up d
▁up reg
anti tative
▁month s,
▁rem ark
▁setting .

▁comple ment
▁Results P
AR Y
▁1. 3
▁sup porting
▁(P .
▁dep ression
jec t
▁intervention s,
▁care ,
▁investig ation
▁el igible
mon ella
▁conf er
▁immun o
▁immun ogenicity
▁(1 4
▁dynamic s,
.3 %)
▁requ iring
▁cluster -random
▁period .

▁selec tive
▁quanti fication
icro bial
▁random ised
▁inte rest
▁del ivered
▁Conclusions /Significance
▁disc overy
▁post -dis
af f
▁Pro g
▁Pro v
▁Com munity
▁lead s
loc k
▁behavi ors
oph ysical
ink ed
▁measure s.

▁high- through
▁commun ication
▁density ,
▁measures ,
▁apic omplex
▁pers pective
▁differenti ation
▁acco unting
xy chloroquine
▁rain y
▁experim ents
▁util ization
▁neutral ising
▁gametocyte s
▁cult ures
▁projec tions
▁chlor fenapyr
▁map s
▁contribute s
▁ITN s
▁decision -m
▁fam il
▁pre- existing
▁observ ational
▁scenar io
▁erythrocyte s
▁go al
▁self -med
▁explain ed
▁valid ated
bi ensis
▁vi ew
▁vulner able
▁proper ties
▁parasites/{micro}L .
▁Ethiop ia
omet ry
nes s.

asc ular
▁(W HO
▁haplo types
▁predominant ly
-B ar
▁PBO -LLIN
▁sleep ing
▁criter ia
▁Po isson
▁expand ed
▁Sal monella
▁boos ter
▁bod y
▁(Z IKV)
▁hist olytic
▁mixt ure
▁uncertain ty
▁streng then
▁Bo th
▁careg ivers
▁typh oid
▁hel minth
▁outs ide
▁catal ytic
▁C. I
▁comorb idities
▁Dem ocratic
▁funest us
tebr ate
▁bene ficial
yan m
▁ara biensis
▁euk ary
▁commer c
▁disad vant
uberc ulosis
▁post-dis charge
▁high-through put
- n
- per
0 19
1 00
2 7
3 D
5 .

5 .2
7 ).

A C
C _ST_ABS
F )
L 1
M DA
b on
c us
d e
d iagnos
g d
g ed
j ur
p ear
s c
t ropical
u el
u vant
v cr
w w
z e
▁ ul
▁ rib
in ,
in form
▁t ri
▁t rac
▁o okine
▁s an
▁s ick
▁s izes
▁in verse
▁in ference
▁in jur
▁c ode
es ic
▁p -value
▁m ak
er m
er ing
▁f l
▁f raction
▁re aching
▁re plac
▁to x
▁h rp
▁e lic
ate ll
▁( Y
▁( the
▁v ital
▁v esic
▁P atients
▁A ut
▁st able
▁st unting
▁C M
▁C al
▁T wo
ion s
▁con gen
ut ral
▁pro ph
ra tive
▁l at
▁l ab
▁l ive
▁l ength
if est
▁de forest
▁S E
▁S im
▁S econd
▁S NT
▁S lf
▁I N
▁I II
▁I QR
op ath
op timal
▁M on
▁M DA
▁1 0.
▁1 000
ot helial
▁D ep
▁im per
▁R T
▁R isk
igh ted
▁co varia
▁co efficient
▁comp eti
▁r ather
▁cont ent
▁H AT
▁trans fusion
▁ad mitted
pro tec
▁health ,
ens itive
▁3 %
ch ing
▁N ile
▁virus es.

5% ,
ID S
▁L ST
▁ser a
▁ser ocon
all enge
▁ar thropod
▁ar tificial
▁identi ty
▁vector .

▁vector s,
▁int ens
▁Z anz
▁Z ambia
▁4 ,
▁4 8
▁can not
rim aquine
▁level ,
eg ative
▁man ip
▁imp ly
▁pos itives
▁system .

ight ly
▁K AP
▁hous e
▁import ation
▁death s.

▁pl ace
▁met agen
▁comple ted
▁conduc t
▁bi osyn
▁As ia,
▁aegypti ,
▁(P BO
▁dep ending
ox ic
▁protec t
▁immun os
▁occ up
▁ge ospatial
▁genetic ally
▁fe ed
▁(95% CI
▁approach ,
▁main tain
▁period s
▁antim icrobial
▁random ly
▁improve ments
▁occur ring
▁frequenc ies
▁exam ination
▁Ind ividual
▁Ind ex
▁testing .

▁statis tic
▁sch izon
▁RNA -seq
▁Com bining
▁ent ry
▁mut ant
▁hete ro
▁contin ue
▁att ended
▁vaccination ,
▁bec ame
tid es
-4 9
ider ing
▁1, 000
▁Im pro
▁Findings We
▁relationship s
SP ER
▁describ ing
▁describ ed
amm al
▁CD 8
▁isol ated
▁ter m
▁Pre valence
11 A
AP )
▁adults .

▁G6PD d
▁Ar t
▁artemisinin -based
▁apicoplast .

▁municip ality
▁Americ a
▁experienc ing
▁histor ical
▁attitud es
▁Gu ang
▁dataset .

▁enhan cing
▁influenc ing
▁prom o
▁aver t
▁unknown .

alle l
▁track ing
▁cost-effec tive
▁mal nutri
▁Europ ean
▁categor ies
▁datase ts
▁adap tive
▁ampl itude
▁phenotyp ic
greg ated
▁reinfec tion
▁(IR R
▁inhibitor s
MM ARY
RO SPER
▁err or
▁underestim ation
▁off ers
▁saliv ary
▁leuc as
bovirus es
▁autom ated
▁antib iotic
▁micron utri
▁homolog ous
▁Pb gd
open ia
akart a
g/k g
▁Estim ating
hap lo
▁coord ination
▁adequ ate
▁accum ulation
▁Cons idering
▁av oid
▁SU MMARY
▁excell ent
ivaria te
▁Prov ince
yanm ar
atell ite
▁deforest ation
▁covaria tes
▁LST M
▁Zanz ib
ROSPER O
- )
. com
3 3
3 ),
4 +
4 %)
5 2
7 4
8 9
B R
B 11A
C N
G -L
H ere
M R
P R
T R
a ud
d ed
f MDA
g ithub
i S
i as
l ies
l ike
m od
r iage
s :
s ;
x iety
▁ round
▁a ce
re am
on e,
ti ary
en ing
▁s .
▁s ector
▁s low
▁in equ
es ter
es s.

es cent
▁m ake
▁m agn
▁d up
▁d ram
▁d irec
is es
is hed
as k
▁f ed
▁f inal
▁f rontline
ic ine
▁re ly
▁re cip
▁re act
▁to ler
us ual
ate st
▁( range
▁n ation
▁n ame
▁P D
▁P V
▁P ak
▁A g
▁we alth
▁we bs
▁C ongo
▁T R
▁T es
▁T MP
um b
qu are
el ec
em erg
▁pro gen
▁pro duced
if feren
▁de ficient
▁S ri
▁S ever
▁S MA
▁S easonal
▁res ol
▁res ting
▁on ce
▁2 .5
▁M et
▁M ain
oc c
ot t
ys i
▁infec tivity
▁dis pl
▁dis pers
▁inc ons
ab las
▁ex port
res olution
iv es
ies is
▁ac ce
▁par allel
pec t
▁co infec
▁co -endemic
▁co astal
se vere
ain -Bar
▁r un
▁dengue -related
▁H sp
▁H LA
▁trans ition
▁se ar
▁se em
▁B io
▁gen es,
las tid
▁mod if
ist osome
▁wh ose
▁ef fort
▁cl ient
pl en
ill ain-Bar
▁health .

▁inter s
▁inter act
▁E merg
ulation s
▁sh ock
▁F ore
▁N on
▁ca ge
ell come
est ational
▁control ling
ide osome
5% )
▁L im
▁sp ac
▁ser ve
▁under go
▁sign atures
▁spec ial
-s er
▁un it
▁un ex
▁un infec
▁population -level
▁low -d
▁rel ation
▁G e
▁sub tropical
▁4 .
▁4 0
▁4 4
▁qu ar
▁202 1,
▁prov ision
▁5 00
▁He te
▁DENV 1
▁6 2
▁6 3
▁6 4
▁pos itivity
▁pres s
▁loc ated
▁appro ved
▁most ly
▁partic les
▁prevalence .

▁age .

▁hous ing
-c are
▁impact .

▁cons ult
▁group .

▁var ies
▁Conclusion This
▁med ication
▁comb at
▁1. 9
▁need ed.

▁tra p
▁sup erv
▁sup eri
▁As ia.

CR 4
ability ,
▁Ch i
▁Dengue ,
ogen ic
ogen esis
▁detection ,
▁(1 5
▁(1 8
-l ived
ines e
▁season .

▁St ruct
▁spread ing
▁(2 2
▁(2 7
▁complex ity
▁knowlesi .

▁lim iting
▁method s.

ienc ies
▁p=0. 000
▁single -cell
▁correl ates
of lavivirus
▁prevention .

▁non- us
▁mo tif
MI C
▁(I TN
▁disc overed
▁spati o
▁Africa :
▁analyz ing
▁fem al
▁gre atest
▁Pro tein
▁sch istosome
▁diagnosis .

▁site s,
▁severity .

▁syn erg
▁prop ag
go v
▁att end
▁vaccination .

▁access ibility
▁18 S
▁high- resolution
▁haem oglobin
▁state s.

▁characteristic s,
▁(DENV ),
▁(aOR =
▁alle lic
▁commun ities.

▁integ ration
▁cal ibration
▁Summary Dengue
▁phen otypes
▁min ute
▁min ority
▁summary Dengue
▁negative ly
▁CD 4+
▁plasm ablas
▁ter tiary
▁equ ival
▁ques tions
▁aut o
▁aut ophagy
▁assays ,
▁allow ing
▁emp ir
▁cult ured
▁preven ted
ios ensor
▁vol um
▁evolution ary
▁attitud e
▁Gu illain-Bar
▁observ ations
▁Dis cus
▁young er
▁bacter ia
▁i RBC
▁influenc ed
rest ing
▁pur pose
▁compon ents
ish man
▁gl ideosome
▁decl ined
.\n\nM ethodology
▁ref lect
▁gly c
▁recr udescence
▁power ful
▁nutri tional
▁secre tion
▁medic ine
▁mis diagnos
▁late st
▁adap ted
▁polymorph isms
▁connec ted
▁discus s
▁Diseas e
▁prolif eration
▁Mozamb iqu
-th ird
▁Inc re
TH OR
▁eluc idate
▁Sp ain
▁Lo D
▁emph as
▁guidel ines
▁inferen ces
▁bel ong
▁exc lud
▁compartment al
▁scienti fic
ucose -6
▁parasit aemia
▁meth aemoglobin
▁elect ronic
▁Not ably,
▁specif ically
▁veget ation
▁epitop es
▁8-aminoquinol ine
▁fib rosis
▁Id enti
▁remark able
▁(WHO )
▁histolytic a
▁commerc ial
▁congen ital
▁CD8 +
▁Pak istan
▁webs ite
▁Guillain-Bar re
▁Discus sion
- I
- e
. S
/ g
0 .

5 8
6 6
8 2
9 3
? O_LI
A CT
C E
F rom
I A
N et
O C
P V
R e
S C
V ac
X P
[ &
a ive
a ves
b y
b ic
c lass
e ed
f ir
n ce
n et
o )
p ens
p act
s ian
t omological
u fficient
v acc
w ing
x id
z y
▁a qu
▁t ail
re nd
ti ally
ti fication
he sion
▁o v
▁s iz
▁s per
▁in h
▁in st
▁in duc
▁p ip
▁p ron
ar ,
▁m ig
▁m ef
▁m ammal
▁d im
▁d ual
▁d ied
▁w ar
▁w ind
▁w estern
er ic
▁f av
▁f ores
it an
▁re ason
▁h ar
id ates
▁e as
▁e th
▁e ave
▁( 0
▁( U
▁( v
▁( w
▁( 19
▁( AR
▁( CR
ac ti
▁th rom
ur ance
ur ban
▁n g/mL
▁n aive
▁P Q
▁P ow
▁P CI
▁P oly
▁P acific
▁A S
▁A ag
▁for ce
▁st och
▁T g
▁T rend
▁g old
ol in
ol low
ol itan
▁malaria :
▁malaria e.

▁malaria -associated
ri ed
ri end
▁that ,
▁de fec
▁S us
▁S AR
▁S ES
▁I BD
▁2 .2
op o
op ro
▁M M
▁M ex
▁M ixed
ren ch
▁D RC
▁D ALY
▁D UP
▁us er
ine -
▁im mature
▁dis order
▁dis pens
ab aud
▁ch abaud
▁ex ist
▁W ellcome
▁ass ign
pec tively
▁he patitis
▁he nce
▁comp rom
▁al titud
▁al one.

▁mos quitos
▁trans fer
▁B etween
▁gen der
▁20 %
▁ad oles
▁per ceived
▁In tern
▁inter fer
▁inter rup
▁inter mediate
▁mosquito ,
▁3 0%
▁3 3%
▁F ac
▁parasite .

▁parasite mia
▁ca ve
ial og
og le
▁k ine
tec tion
▁ser ology
gn ant
▁sign ificance
▁rec over
-s ensitive
velop ing
▁anti pyre
▁rel iab
▁G lob
▁G enetic
▁ag es
▁U .S
di tive
rib ut
▁mon ocyte
▁human s,
▁sc hed
▁man ifest
▁202 0,
▁5 2
0% .

▁caus ative
▁201 2
▁pres erved
▁predic tor
▁outbreak s,
▁use ,
-t yp
-t argeted
▁num erous
▁non -malarial
▁severe ly
▁7 2
▁age -
-c ycle
ization .

▁group ,
▁col l
▁rem o
▁perform ances
▁comb ine
ef ined
▁cor rec
▁conduc ting
▁vaccine ,
▁within -host
▁rate s.

▁rate s,
▁collec t
▁(P PF
▁end po
-C OVID-19
▁mortality ,
▁burden ,
.6 %,
▁inform ed
.8 %,
▁(1 3
ek ing
-l ife
▁host -parasite
▁diagnostic s
▁test .

▁selec t
▁nets .

▁method ology
anc ed
▁p=0. 03
ten ance
▁facil ities.

▁non- ph
▁grow ing
▁antimalarial s
▁survey ed
▁line ages
▁antibodies .

▁change ,
▁dri ven
crib ed
▁management .

▁pool s
▁C_LI 

▁microscop ic
▁pathogen s.

-0. 9
▁geograph ically
▁techn ique
▁prob able
▁poss ibly
▁Im plications
▁(M ean
▁quality ,
▁fore st
▁challeng ing
▁coh or
▁(n= 2
▁def ine
▁address ing
▁effor ts.

hens i
▁transcrip ts
osis .

-res ponse
▁Ugand a,
▁Ugand a.

▁ver tebrate
▁district .

DA )
▁short -term
▁p=0.00 1)
▁diver gent
▁independent ly
▁Gu ine
▁relap ses
▁express ing
▁2022 .

▁paper s
▁clon al
bor n
▁ec ology
▁cent res
-se eking
-of f
-of -care
▁diabe tic
▁sex ual
▁Stud ies
▁nucle ic
▁defic iencies
▁exhib it
▁point -of-care
▁inflamm ation
▁simulation s
▁now c
▁PM V
▁Europ e
▁[& le;]
▁docum ented
▁restric tions
▁datase ts.

▁insect -specific
▁highligh ted
▁Malays ia,
▁cat ch
▁Nor thern
▁Effec ts
▁reinfec tions
▁connec tivity
▁adapt ation
co vid19
▁const rain
▁ster ile
▁stra tified
▁Care St
▁Soc io
▁Min istry
▁2000 -201
▁Diseas es
95% :
arn itine
▁humidity ,
▁trig g
▁hep at
▁Inte resting
▁Anti bod
▁probabil istic
▁transcriptom es
▁abnormal ities
▁profession als
▁build ing
▁hotsp ots
▁orth oflavivirus
▁extreme ly
▁tog ether
▁https:// github
▁eg gs
▁Epidemi ological
▁NPI s
D42 02
▁tw ice
▁agre ement
▁(CI 95%:
▁calibr ated
▁neurolog ical
▁hydro xychloroquine
▁stakehold ers
▁put ative
▁SL EV
▁Rem oscop
▁sub-t ropical
inform atic
▁ookine te
▁proph yl
▁Slf n
▁name ly
▁incons istent
▁Hete rogen
▁superi or
▁plasmablas ts
▁equival ent
▁sper m
▁mef lo
▁stoch astic
▁altitud e
▁Glob al
▁CareSt art
▁https://github .com
- E
- fe
. or
1 %)
6 2
A d
C OVID19
D es
E )
H z
H IV
L )
L V
L HIV
M ,
M Ws
O I
V P
a res
b ilirubin
e loid
f h
f lamm
g r
g ence
g roup
o unc
s ide
u ang
w ise
x x
x im
z uel
▁ ly
▁ ir
▁ ence
▁ 5%
▁t ur
▁t aking
▁t uberculosis
on ge
al k
al .

en eg
▁o xid
▁s ide
▁s kill
▁in acti
▁c en
▁c od
▁c reated
nd emic
▁p ol
▁p <0.000
▁p lastid
▁the r
▁m it
▁m eg
▁m arg
▁m ental
▁m ember
or al
or ylation
is ,
er atin
▁f ing
▁f ast
it ation,
ic omplex
ec ause
▁re in
▁re ticulocyte
id ed
▁e t
os ite
▁( in
▁th ous
lo red
▁n M
▁n ight
▁P e
▁P l
▁P ub
▁P au
▁P rimary
▁A L
▁A ge
▁st ages.

▁C Y
▁C ity
▁C ost
▁C ross
▁C -term
▁C ule
▁T ogether,
▁an xiety
▁con ditional
ol er
▁pro xy
▁pro ced
ver ty
ud ied
▁S A
▁S ARS
▁S SA
▁S eneg
▁res olution
▁is ,
▁I C
▁I f
am ple
ge red
▁2 .
▁M I
▁M b
▁M ar
st inal
▁1 )
▁was ting
▁D rug
▁D ifferen
ment ation
▁im mediate
▁dis ag
▁inc ome
▁ch rom
▁ex it
▁ex cept
▁ex ceed
▁be g
res pond
▁R c
▁R T-
▁co inc
ting u
▁comp osition
▁r ich
▁r ising
▁cont ag
▁al ter
▁trans lation
▁se ts
▁B lood
▁B iosensor
▁ad ditive
▁model -based
▁per m
tim ib
▁In formation
▁inter nal
▁mosquito .

▁E V
▁E arly
▁E BV
▁E vidence
▁E XP
▁ind uce
ak ary
ak ers
▁high -transmission
▁le ver
▁le arn
▁reg ular
▁O ther
ch allenge
▁F irst
▁F rench
▁N K
▁N CT
▁k e
▁k m
▁k Hz
▁k eratin
▁ap tam
fic iency
▁L atin
▁sp le
▁0. 02
▁0. 99
ome ter
▁rec overed
▁spec imens
▁un t
▁un able
▁risk ,
▁ar rest
▁am ino
▁G re
▁vector s.

▁ag gressive
▁sub jec
▁4 3
▁can cer
▁ins tit
▁inv est
▁qu ick
-2 019
▁imp oses
▁202 4
▁ev olved
▁5 4
▁5 5
-1 0
-1 4
-1 .3
▁6 0%
▁protein ,
▁protein s.

▁protein -c
▁Res istance
▁po verty
so ,
▁system ic
-t reatment
▁non -s
▁7 ,
▁7 0
▁dec ade
.1 %)
-p re
▁public ly
rial s.
▁mic ros
ization ,
▁8 0
▁pl ant
-in ter
▁med ium
▁1. 7
▁cor respond
▁sup pression
▁bi ases
▁rate .

▁gener ating
▁collec tions
ces s.

unc il
▁dep artment
▁end othelial
▁provid er
-spec ies
▁(D HF
▁Ch inese
▁respec t
ass ays
▁care .

▁ext en
▁ext ra
▁development ,
▁development al
▁particip ated
▁remain ing
ek ong
▁symptom s,
▁St r
vironment al
▁cluster ing
▁main tenance
▁correl ate
▁(S D
▁ill ness.

▁tr ypan
▁inte stinal
▁emerg ed
▁elim inate
▁(I C
▁assay ,
▁app ly
▁inhib ited
-st rand
▁statis tics
ty l
▁pa ired
▁elimination ,
▁elimination .

tes unate
▁contin ues
NS O
oph il
▁illness ,
▁HIV /A
▁dri ving
▁implement ing
▁bec oming
▁process ing
▁19 9
▁measure ment
▁measure ments
▁IgG .

▁days )
ene zuel
▁environmental ,
▁commun ic
▁techn ology
▁cap able
▁(OR :
▁phen omen
▁Im port
▁Findings The
▁intro duce
▁approac he
TS B
▁Keny an
▁Keny a.

▁pregnanc y,
▁di ar
▁demographic ,
IR D
▁util ized
▁util izing
▁integr ity
▁allow ed
▁Ghan a,
-trans mitted
▁optim ize
ier arch
▁Mod elling
▁consider ing
▁consider ably
▁person -year
▁Introduction The
▁concern s
▁der ive
▁experienc es
▁En g
▁histor y
▁fund am
▁neon ates
▁attitud es,
rec ted
▁pathway .

▁hyper bilirubin
▁go als
▁metabol ism
▁resid ing
▁admission s
▁half -life
▁represent ing
-de ficient
▁System atic
▁Ethiop ia.

▁though t
▁Sc ience
▁require ment
tam oe
▁ACT s
{+/-} 0.
▁Cent re
▁transcri pt
▁merozoite s
▁vill ages
▁2016 .

▁Chin a,
BP II
▁(K AP)
▁Malays ia
-gen eration
▁cat tle
▁re- emerg
▁discrim inate
-ph osphate
▁my osin
▁my eloid
-H AT
▁{micro} g/mL
ai lored
▁gap s
▁sw it
▁err ors
▁trig gered
▁mess age
▁sustain able
yc in
▁(e.g .

immun e
▁rol es
▁te am
▁advant ages
▁(i. e
▁fatal ities
▁understood .

▁ult r
▁AU C
▁anophe line
▁LO D
▁researcher s
▁pric e
▁miss ed
▁knock down
▁PfG CN
▁(RDT s)
▁STAT A
▁algorith m
▁uncle ar.

▁Prog ram
vcr t
ze timib
▁competi tion
▁Individual s
▁schizon t
▁malnutri tion
▁micronutri ent
G-L AMP
▁dram atically
▁low-d ensity
ucose-6 -phosphate
vacc inated
▁aqu atic
▁pip eline
▁Aag 2
▁Trend s
▁assign ed
▁cave olin
▁reliab ly
▁U.S .
ribut able
▁Interesting ly,
▁Slfn 11
▁meflo quine
ounc ed
▁ence phal
onge vity
▁meg akary
▁fing er
▁Pau lo
▁Cule x
▁RT- qPCR
▁protein-c oding
rials. gov
▁HIV/A IDS
tamoe ba
zetimib e
- K
- di
- NS
- na
1 /
1 .2
2 %)
6 8
9 5
9 p
A D
A F
A l
C h
D V
D -T
F -RDT
G B
H D
H b
L O
O _
P re
S M
S ).

S PT
T 3
U I
W AS
X T
a }
a im
a rent
b ocyt
c ar
d om
f t
f lu
i or
i .

i em
k s
m ic
o .

p -Seq
r act
s s
u ated
u ous
u tional
w orm
x yp
z ard
▁ {
▁a way
▁t rim
▁t ailored
re r
on ym
he ck
▁s tem
▁s ym
▁s olution
▁s we
▁s ession
▁in g
▁in patient
▁c ord
▁c urve
▁p op
▁p rincipal
▁m aterial
▁d orm
▁d ang
or age
or tal
or bidity
▁w inter
▁w aves
as tig
▁f ight
▁f lex
it us
ro g
an y
ic ide
at ch
▁b ur
▁b ud
▁b ind
▁b reak
ve olar
ia quine
▁h am
▁h ind
le med
le vant
▁e mer
os m
os ystem
▁( <
▁( O
▁( l
▁( re
▁( ar
ur ate
im als
od es
od el
od emic
▁n orm
▁P art
▁P MC
▁A re
▁we b
▁we t
▁we ak
▁we ighted
▁st aff
▁st orage
▁C NV
▁C enter
um ,
el le
el imination
▁an ticip
▁con val
▁con str
▁con cept
ol l
em etine
et ,
et ting
▁pro cess.

▁l ost
▁l ibr
▁l ongevity
ud e
if y
if ically,
▁de form
▁S ab
▁S ens
▁S ier
▁S NP
▁S ignificant
▁pre ference
▁on ward
▁2 )
▁2 .3
▁2 {middle
▁M R
▁M e
▁M ethod
▁M G-LAMP
▁1 0,000
▁The y
▁D H
▁D a
▁D ar
▁D BA
▁D TP
▁dis charge
▁dis tingu
▁ex o-
▁ex pect
▁W estern
por ter
por ally
▁par ts
▁par tially
0. 0%
0. 3%
red ible
▁co re
▁comp osite
ain ed
▁r fMDA
▁r -HAT
▁H D
▁H CT
ance .

▁trans ferred
▁trans porter
▁B -cell
▁B ecause
ous ehold
mis s
ore a
▁wh y
▁ad hesion
ure ,
ill ary
tim ate
▁In v
▁In 9p
▁E .
▁E R
▁E m
▁E WS
ric ts
▁le thal
▁reg ulation
▁3 0,
▁O F
▁O d
ch aracter
▁F as
▁F ollow
▁out patient
▁N ex
▁N etwork
og y
▁k in
▁ap plic
fic acy
▁effec tor
vi an
▁dif fered
ple te
▁analys es.

gn os
ath ogen
▁rec onstr
▁spec t
ase ,
-s quare
▁un like
▁un usual
▁ar temether
-b y
-b urden
▁9 2
▁9 5
▁G T
▁G overnment
now ledge
▁vector ,
▁hum oral
▁Th ree
▁Th rough
▁year ,
▁ins tead
▁ins ufficient
▁vivax -
▁gro und
-2 )
ian s
▁ev ol
▁He p
▁treatment s
-1 ,
▁6 6
▁dist anc
▁dist ributed
▁201 0
▁loc us
▁system ,
-d ose
-d ep
▁multi -
▁non e
▁7 5%
▁7 .5
▁dec ay
▁dem and
mer ase
ograph y
▁K orea
▁age -specific
▁inf rast
plic it
▁meas uring
▁Methods T
▁Methods The
▁Methods Using
▁cons ensus
▁species -specific
-S CD
▁8 3
▁years ],
▁new born
▁setting ,
▁1. 06
▁1. 21
▁tra de
▁indic ator
▁sup por
-m osquito
▁epidemic s.

01 6
▁character izing
▁identified .

▁determ ining
▁reported .

▁effic ac
zo le
▁Ch aracter
▁trial s.

▁val idate
.6 )
.6 6
▁ext ended
▁exper t
ort heast
▁local ize
.8 %)
▁(1 7
▁season s
▁genetic s
▁fe ature
▁[ 0.
▁[ CI
▁review ed
▁LLIN s,
.9 %)
▁community -level
▁complex es
▁main taining
▁sequenc ed
▁environment s
▁method .

anc ial
▁(C OVID-19
▁arbovirus es,
▁(S pear
▁ill ust
▁non- re
▁variab les.

▁influ enza
▁car riage
ok ed
▁(I PTp
▁app arent
▁spati ally
▁included .

▁distribution .

▁insecticide -based
▁Pro ject
▁propor tions
-re ported
▁COVID19 .

▁site s.

roscop y
▁RNA -Seq
▁pa ir
▁invol ves
▁Co uncil
▁severity ,
▁syn thetic
loc al
▁mut ants
▁performed .

▁contain ed
▁att ributable
▁Al so,
▁dri ver
▁Ap pro
▁18 0
osom es
▁microscop y,
▁Y F
-0. 7
▁(3 4
50 )
▁techn ologies
▁me iotic
▁Summary The
▁lif e.

▁summary A
▁Im pact
▁(M DA)
▁status ,
▁birth weight
▁intro duc
▁cyt ot
▁small er
▁> 2
▁ter min
▁200 2
▁micro haplo
▁interaction s.

▁organ elle
▁integr ate
▁deploy ed
▁z one
▁z ones
▁via bility
▁produc es
▁produc ts
▁spra y
▁erythroc ytic
▁Sout hern
▁person al
-con fir
plo rer
▁cycle .

.0% )
▁map ping
abit ants
▁En tomological
man s
▁bite s.

▁unc on
▁decision s
kin a
▁cur ated
▁ST T3
▁Ins tead
▁C_LIO_LI The
▁intensity .

▁assum ing
ores cence
▁paper ,
▁sulfadoxine-pyrimethamine ,
▁sporozoite s
▁clon es
▁therapeu tics
▁behavior al
▁ec osystem
▁nor th
▁resid ent
▁interval s
▁influenc es
▁vir ul
-A Q
▁seropos itive
▁valid ation
▁vi ol
▁Ob jectives
▁Ex per
▁decl ining
ov ative
tam ethrin
▁complete ly
▁mitig ation
▁read ily
▁nutri ent
▁HC V
▁adv anced
▁impac ted
▁secre ted
▁US $
▁phosph orylation
▁mis class
▁pros pectively
▁co- ex
▁intra erythrocytic
-gen ome
▁land sc
▁discrim inating
greg ation
▁gain s
▁along side
▁discus sions
▁prioritiz ed
{degrees}C .
-pro tein
▁pep tide
▁weight ,
▁RA CD
▁Out break
▁recomb ination
▁don ors
▁hundred s
▁prolif er
▁atten tion
▁manner ,
▁hypnozoite s
▁iss ue
▁Bi ophysical
▁Inc idence
▁probabil ities
.\n\nConclusions /Significance
▁(e.g .,
▁CDPK 5
▁assump tion
▁hotsp ot
▁AD Rs
▁adj ust
▁subs id
▁subs tit
▁(CH IKV)
▁Assess ing
▁Assess ment
▁(i. e.

▁neighbor hood
▁sl ightly
▁pack age
▁socio- economic
▁persist ence
▁circumc ision
▁MS3 34
▁Diagnos tic
▁compet ence
▁aff ord
vas ive
▁cop y
▁Tr ust
▁Go ogle
▁Vacc ine
▁ubiquity lation
▁fin ancial
▁prep rin
▁Lank a
▁morph ological
▁upd ated
▁depression ,
▁cluster-random ized
▁mak es
▁Dep artment
▁serocon version
▁arthropod -borne
▁metagen omic
▁ace tyl
▁nation wide
▁TR AP
ysi ological
▁displ ayed
▁coinfec tion
▁uninfec ted
▁spatio temporal
▁empir ical
.\n\nMethodology /Principal
/g Hb
▁inh abitants
▁mammal ian
▁wind ow
▁Poly nes
▁DUP 4
▁comprom ised
▁adoles cents
▁Intern ational
▁antipyre tic
▁(PPF )
▁cohor ts
▁https://github.com /
Des pite
▁Pub M
▁CY D-T
▁fundam ental
▁hyperbilirubin aemia
▁transcript ome
-na ive
▁swe ep
lemed icine
▁emer ge
▁Sab ah
▁Sier ra
▁DBA /2
▁exo- erythrocytic
▁infrast ruct
-confir med
▁landsc ap
▁CYD-T DV
( R)
- F
- es
- qu
- mer
- test
/ p
/ pro
1 ;
2 00
5 1
6 %)
6 %),
8 %)
= 9
C H
C _LI
D E
E CT
E LC
G 6PD
H C
H T
I NG
J d
M O
M RI
N 3D
P C
P S
R H5
T rials.gov
U /gHb
a am
a vail
c ast
d ens
d -LLIN
e tic
e ed,
f ying
g ra
g ous
h as
h ou
i ating
i atus
k it
k ey
l .
l en
l ind
m a
m atic
n ial
p in
p ress
p soni
r r
u ed
u tical
v atic
w an
w ired
y lo
z hou
~ ]
▁ +
in ess
▁t et
▁t ake
on ential
he um
te e
te p
▁s ent
▁s ol
▁s tim
▁s yl
▁c ut
▁c ub
es p
▁p ain
▁p lasmodium
▁p iperaquine
▁the ory
ar i
ar ling
▁m ell
▁d ys
▁d arling
▁w or
▁w ard
as al
as es,
as ons
▁f if
ec u
▁re per
▁re ach
▁re asons
at ological
▁b al
▁b ott
▁h old
▁h osts.

▁h ierarch
id in
id ences
▁e SPT
▁( as
▁( qPCR
▁( adjusted
▁( -)
ac tions
▁th in
▁v ast
▁v illo
ur b
ul ed
ul ates
ul ld
il st
il ience
▁P an
▁P ri
▁P lasm
▁P opulation
▁P AN
▁P LHIV
ted ,
▁A im
▁A HME
▁A IP
▁st op
▁st ability
▁st abil
▁st d-LLIN
ig m
▁C T
▁C ri
▁C ell
▁C NS
▁C SP
▁T est
▁T ime
um p
ter ior
▁g ive
▁g land
▁g rad
qu ef
fec t
fec ted
▁an c
▁an imals
ol a
ol iv
ol ute
▁pro ved
▁malaria -SCD
▁l ung
▁l umb
ri p
ri es
▁S ant
▁S uch
▁com mod
▁res ur
▁res olved
▁I I
▁2 .4
▁2 .0
▁were :
▁M A
▁M or
▁M eas
▁M olecular
▁M ED
▁M AG
▁M aterial
▁1 1,
oc al
ren nial
▁D ue
▁us e.

▁us ually
ment .

▁im ages
▁ex plicit
▁ac ous
▁R 0
▁R and
▁R T-PCR
▁R VP
ad ing
ad ication
▁co vid19
▁co variate
▁r =
tor al
▁H ig
▁ne ither
▁B el
▁B am
▁B oliv
▁gen om
ific ation.

▁lo op
and ing
ist rative
▁cl one
ure r
▁per ception
ill on
▁E valu
▁E astern
▁E NSO
▁E rr
ric ult
▁reg ulating
▁sh ared
▁sh ares
▁3 5%
▁F uture
▁ha zard
▁N ep
▁virus -host
ph i
▁k it
▁L SM
ost atistical
▁fac ed
▁fac ade
▁0. 04
▁under weight
able ,
-s ource
▁un lock
▁tre ating
▁ar ise
▁cell -cycle
▁not able
▁low ,
▁9 1
▁9 7
▁rel ies
▁G H
▁G aus
▁exp onential
▁ag ricult
▁U p
▁sub -p
▁sub group
bo ard
▁4 7
▁4 00
▁4 0%
▁year ly
▁mon ocytes
▁mon key
▁level s,
▁man uf
▁epid er
▁5 ,
▁among st
▁COVID-19 ,
-1 )
-1 .1
▁Con v
▁caus al
▁201 4,
▁results ,
▁outbreak ,
▁po ints
▁bo x
-d ist
lec ting
▁7 3
▁7 7
-p ron
▁ro ute
▁insec ts
▁public ation
▁inf odemic
-c arnitine
▁Background A
.\n C_LI
▁mic e.

▁cons ecu
▁V er
▁V MWs
▁V enezuel
▁8 4
▁8 9
▁death .

ord ers
.\n\n The
000 )
▁strateg ic
▁household s.

▁As car
▁- -
▁sim psoni
▁Zika .

▁dep art
-C OVID19
▁conc er
▁intervention .

▁hospital s
irc um
▁local ities
▁observed ,
▁protec ted
▁conf ound
▁particip ation
▁particip ant
▁op tions
-l umefantrine
-l inked
▁ge ostatistical
▁season ,
▁St and
.7 %,
▁review s
▁ran k
.2 %)
▁soc iet
.9 %,
▁community .

▁approach .

▁sequenc ing.

tiven ess.

▁nets ,
▁method s,
▁(A CT
▁(C Q
▁respons es.

▁facil ities,
▁correl ations
of f
▁reveal ing
▁participants ,
▁efficacy ,
▁To ol
▁cri tically
▁car bo
▁endemic ity
av ir
▁app e
▁post -third
▁Ind ian
▁Ind ones
ace utical
▁compar able
▁Pro f
▁propor tional
▁contrib utions
▁oval e.

▁exposure ,
▁foc al
▁labor ator
▁neg lected
▁att ributed
▁change .

▁dri ves
▁Ap p
▁immunity ,
▁immunity .

▁14 %
▁14 .8%,
▁days ,
▁microscop y.

▁(aOR :
▁Y ogy
▁morbidity .

-0. 8
.5% ,
arm aceutical
▁(3 2
▁density .

▁lif esp
▁summary The
▁dot} 5%
▁Reg ard
▁differenti ally
▁cyt ometry
▁initi ally
▁100 ,000
▁small -for
▁diversity ,
▁Keny a,
▁equ al
▁equ ip
▁Pre to
▁reac tion
▁200 7
▁expl an
▁worldwide ,
me iotic
varia ble
▁(6 9
▁record s
RI M
▁experim ent
▁rang es
-h ospital
▁upt ak
▁real istic
▁neutral izing
▁produc ing
▁produc tivity
▁Niger ia.

▁servic es,
-effec t
▁ben ch
▁accurate ly
▁person nel
-P Y
▁polic ym
▁ver tical
▁En tamoeba
▁2015 -201
HF V
▁cand idates
▁incorpor ated
▁Cl imate
▁fail ed
▁intensity ,
▁quantif ying
▁broad er
▁Ser oprevalence
▁bar c
▁subsequent ly
▁metabol omics
▁er adication
▁(G 6PD
▁problem .

▁categ ory
▁promis e
▁school -age
onth ly
▁Ph il
-de hydro
▁profil ing
▁RBC s
▁Ethiop ia,
▁habitat s,
▁gl ucose-6-phosphate
▁Gen omic
▁limit ations
▁2017 .

▁albopict us,
asc iatus
▁PM R
▁haplo type
▁Bangladesh .

▁Colombia ,
ob ium
▁HC Ws
▁socioeconomic ,
▁hem orrhagic
▁date ,
▁95%CI: 0.
▁pharmac ies
▁mac roph
▁mac aqu
▁flavivirus es
▁Pv -pLDH
▁compr ised
▁open -source
▁haemat obium
orb ent
▁criter ia.

▁Acc ess
▁Epid emic
▁0.05 ).

▁step hensi
-g estational
▁ster ility
▁domain s
▁stra tif
▁RA B11A
▁plac es
▁parameter s.

▁recommend s
▁campaign s
▁campaign s.

▁lymph ocyte
▁(maximum ),
-w orld
▁CC HFV
▁Spec ifically,
▁simultaneous ly
▁Mozamb ique
▁air way
▁mess ages
▁iss ues
▁regul ates
▁depend s
-line ar
▁arrival s
▁Infec tion
▁profession al
▁te lemedicine
▁pass ive
▁(US$ 12
▁adj uvant
▁advant age
▁differ ing
▁ResultsO f
▁dra wn
▁recogn ition
▁neighbor ing
▁undersc ore
▁pack ages
▁Current ly,
▁NT D
▁quin quef
▁repell ent
▁defin ition
▁Qu antitative
▁circumc ised
▁ear lier
▁dead ly
▁Spati al
▁precip itation
▁chaper one
▁Valle y
▁conclud e
▁channel s
▁contribut ing
{micro}m 2
▁Compar ative
▁mA bs
▁feas ibility
▁resourc es.

▁signal ing
▁carry ing
▁example ,
▁minim ize
▁Associa tions
▁pi RNA
▁hard wired
▁start le
▁seg ments
▁FFR s
▁apicomplex an
▁decision-m aking
▁C.I ;
▁Second ary
opath y
protec tin
▁(PBO )
▁(95%CI :
▁Impro ved
▁Zanzib ar
▁magn itude
▁PD MC
▁Sever al
▁synerg ist
▁volum e
▁Mozambiqu e.

▁pron ounced
▁dim in
▁war ran
▁throm bocyt
▁Tg ELC
riend ly
▁Mex ico
ine- rich
▁chabaud i
▁Fac tors
▁kine tics
-typ e
▁(Mean =3
▁nowc asting
-fe eding
flamm atory
▁cen ters
▁marg inal
▁Pe ak
▁C-term inal
▁SSA .

▁beg in
▁subjec ts
▁micros atellite
▁correspond ing
▁phenomen on
▁(i.e .,
▁PfGCN 5
onym ous
▁dorm ant
▁Sens itivity
▁Inv estig
gnos tic
▁trade -off
▁efficac ious
▁acetyl -carnitine
Jd RP
▁syl vatic
▁mell itus
▁reper to
▁villo us
▁MAG T
▁Rand om
▁Gaus sian
▁manuf act
▁depart ments
▁small-for -gestational
▁quinquef asciatus
- ad
- af
- lasting
- adjusted
- optimal
/ m
/ RNA
1 :
1 -3
1 .5%)
2 b
2 ),
4 6
4 8
5 ;
6 0
7 2
7 5
8 4
8 -1
B I
E T-PCR
F P
G S
H I
I G
I MA
M AR
N D
N O
O C)
O TE
P G
R T
R SS
U AC
V ax
Z P
] ;
] ).

b A
b ion
b ated
b ean
c sp
c utaneous
d r
d ay
f fic
f low
g rad
i -
i tical
i iS
k y
l ig
l inical
l ines
l onal
m ec
n ic
n atal
o y
o ug
s up
t rans
u ,
u z
u illon
v o
v is
w ater
y C
z ith
{ sup
▁ ign
in a
in oph
in opathy
▁a zith
▁t rop
re porting
ti v
al y
al king
en ed
en tical
te ch
▁o wing
▁s em
▁s ourc
▁in -dep
▁c enter
▁p <
▁p =
▁p up
▁p olar
▁p ediatric
▁p rag
ar a
ar ies
ar atus
▁m g
▁m ur
▁m im
▁d ro
▁d ialog
or or
is hes
is ition
▁w it
▁w om
as it
as ome
▁f ine
▁f ront
▁f ixed
▁f aster
it able
it rap
ro w
ro cal
an a
ic ens
ed ical
ec tic
▁re ared
▁re ferred
at ocys
▁b and
▁b ase
▁b ackground
us e
us ing
ia bility
▁h or
om y
om plete
id ing
id den
id ae
▁e astern
os urve
▁( "
▁( of
▁( MI
ac tion
ac ch
ac ility
▁v ascular
im ited
od iaquine
il ed
il ib
▁P -value
▁P ROSPERO
▁P yC
▁A ra
▁A RI
▁A MM
▁A TSB
▁st re
▁C ase
▁C RI
▁T yp
▁T ox
▁T fh
qu ence
▁pro xim
ver y
▁l icens
if t
ri um
▁de al
▁de ple
▁de vic
▁S ingle
▁S put
▁S inoph
▁res usc
▁res ilience
▁is op
uc oc
▁I V
▁I -d
▁I quitos
▁I {sup
am a
am ination
▁2 }
▁2 .8
▁2 .7
▁2 3%
▁M at
▁M ad
▁M ass
▁1 3%
▁1 7,
oc rit
ot al
ot osyn
▁The n
▁D E
▁D I
▁D P
▁us ual
ran t
ine ering
▁im plicated
▁im aging
▁dis orders
▁inc ur
▁inc enti
ip p
ite ct
▁comp ute
▁r ing
▁r heum
ub le
▁H is
▁H ost
▁trans cutaneous
▁mod ulate
yp tic
up ple
ven ous
iti v
▁wh at
▁20 30
pl es
tim ately
▁In flu
▁inter fe
▁inter pret
▁E ven
▁E PI
ak age
19 %
ik a
▁high ,
▁high -burden
▁le akage
▁reg ulate
▁sh or
▁sh op
▁sh are
▁3 .8
▁3 0%,
ch ang
▁F 2
▁F ive
▁F lavivirus
▁F N3D
▁N TS
▁transmission :
og istic
est ation
▁control s.

▁control s,
ag g
ag os
enc ed
ers cript
ID I
▁L it
▁L ung
▁L MIC
▁L ocal
▁L ogistic
ost atus
▁effec tiveness.

▁fac t
ib bean
ax is
vi rosis
▁0. 0
▁0. 03
▁0. 64
▁0. 18
▁Plasmodium ,
▁ra b
▁spec iation
-s elec
-s ample
▁un its
▁sur round
▁sur rog
all ing
▁ar tesunate
▁id entical
▁9 ,
▁9 4
▁9 4%
▁am ount
▁anti -R
▁anti -ser
▁rel iability
▁U pon
ugh t
▁4 .7
▁vacc ines.

▁year -
▁en ter
▁en able
▁inv ade
ap pro
ap opulation
-2 4
yn onymous
▁man age
▁blood me
▁202 5
▁202 4,
▁ob jectives
▁ev ident
▁ev oked
▁5 1
▁5 3
▁5 9
▁5 -17
▁DENV -specific
-1 2
-1 00
urren ces
▁caus ality
▁tes tes
▁201 1
▁201 7,
▁pres cribed
▁found ation
▁no ted
▁predic ts
▁po in
▁diagnos ing
▁bo uillon
-t he
-t wo
▁num er
▁partic le
-d ate
-d ay
▁multi -c
▁multi level
▁multi gra
▁dec omp
▁time -con
▁ro se
▁K ins
▁K nowledge
▁infections )
▁Background E
▁meas les
▁cons titute
▁V ol
-S MAR
▁8 8
=0. 00
rel ation
rel ative
▁pl ays
▁met ron
ater al
rough t
▁Results From
AR T
▁med ia
▁med iated
▁surveillance ,
▁sup ply
▁ph ases
▁vaccine .

.4 )
.4 6
01 ),
▁identified ,
▁gam bi
▁demonstr ating
▁(D F
▁(D BS
▁case -control
▁Ch Ad
▁conc urrent
▁trial ,
▁sens itiz
-f ree
ass ing
▁findings We
irc ulation
▁cross es
▁local izes
▁arbo virosis
▁tool ,
▁tool s.

▁protec ting
▁conf lic
▁respectively ).

▁immun ode
▁work ,
▁work er
▁work flow
.3 2
▁strategies ,
▁symptom s.

▁season ally
▁cy cl
▁struct urally
▁St atistical
▁[ 95%
▁[ ~]
▁J akarta
▁cluster s,
▁community ,
▁main land
▁environment ,
▁environment s,
rin s
▁method ,
▁p=0. 02
▁p=0. 04
ten sion
▁(p -value
▁(p <0.000
▁effects ,
▁effects .

fer ral
▁(S ARS-CoV-2
▁interac tive
▁interac ting
▁temperature .

▁temperature -dependent
▁efficacy .

▁non- severe
emb les
▁variab les,
▁del ay
▁hyp ere
▁(I F
▁assay .

▁genome .

▁app ra
▁app rec
▁app lying
▁app aratus
▁inhib iting
▁mark et
▁analyz ed.

▁world s
▁Ind ia,
▁program me
-infec tion
▁12 %
▁12 0
▁oval e,
crip tion
-re levant
▁class es
▁em b
▁RNA s
▁design ing
▁effectiveness ,
▁Ad ded
▁syn thes
▁women ,
loc king
▁ent om
▁access ible
▁HIV ,
▁country -specific
▁su icide
MP s
▁Ap icomplex
▁18 8
▁bir d
▁focus es
▁characteristic s.

▁decre ases
▁Y ellow
▁me et
05 ).

▁cal protectin
▁Summary A
▁similar ity
▁memb ran
▁dos es.

SP I
SP R
▁them ,
▁coverage ,
▁pers pec
▁differenti ated
▁cyt ok
FR )
▁admin istrative
▁limited .

▁challeng ing.

▁educ ation,
▁general ,
▁(5 7
▁structure .

▁threshold s.

▁Cam bod
▁conte x
▁lack ing
▁200 9
▁ret ur
▁ret inopathy
▁carri ers
IR S
-M yanmar
▁his tid
▁optim ized
▁invasion .

99 5
▁stage -specific
▁projec t
▁apicoplast -targeted
▁annual ly
▁Q ual
▁peak s
-effec ts
▁Americ a,
▁Des criptive
▁chlor oplas
▁phase ,
▁pan -pLDH
▁polic ies
NT 16
▁threat s
▁De tection
▁proble ms
▁coun ter
▁district ,
az ine
▁26 %
▁necess it
▁ST H
▁comparison ,
▁moderate ly
▁observ ation
▁vit amin
▁assum ed
▁regard less
ibility ,
▁hyper tension
▁ste ad
▁Region s
▁Region al
▁go ing
▁Hospital ,
▁abs olute
▁facilit ating
▁randomized ,
▁er adic
▁Dist ricts
▁employ ing
▁vir ion
▁genotyp ed
▁capt ured
▁pur ified
▁doub ling
▁guid ance
▁Ph ylog
▁condition s,
▁2018 .

-de veloping
▁plate lets
▁planning .

▁Peru ,
▁Peru vian
ish uang
▁IFR 2
▁literature .

▁Ex p
▁Gen eral
▁det ox
omes tic
▁questionna ires
▁prote asome
▁j a
ash board
▁read mission
▁adv ance
▁adv ances
▁whole -genome
▁secre tory
▁enc our
▁enc omp
▁enc oun
▁call s
▁scale -up
▁mansoni ,
▁medic ations
▁phosph at
▁barri er
▁co- occ
▁intra venous
▁non-f rontline
▁behaviour al
▁lag ged
▁haemat ological
▁polymorph ic
▁polymorph ism
-ph ase
cl inical
▁monke ys
{degrees}C ,
▁cynomolgi -specific
▁X ishuang
▁{micro} g
▁pep tides
▁star ted
▁const ant
▁chain s
▁double -b
▁Ac ross
▁later al
▁Sal aam
▁prec eding
▁Multi ple
▁acqu isition
▁scal able
▁poly merase
▁boos ting
▁ownership ,
▁lockdown s
▁Cor onavirus
▁globally .

▁(mean ),
▁offer ing
▁CC S
▁Trans mission
▁Sh ield
▁Man y
▁Man agement
▁atten uated
▁Ne ut
▁relapse ,
ler ated
▁Inte gr
▁space -time
-17 D
▁infer red
▁transcriptom ic
▁saliv a
▁Trial s
▁isolate s,
▁assump tions
▁dimension al
thal m
▁decad es.

▁ResultsO ver
▁great ly
▁emph asis
▁YFV -17D
▁situ ation
tr um
▁author ities
▁p<0.00 1).

▁separ ately
▁orth olog
▁ult ra
▁AU THOR
oplasm a
▁Bur kina
▁PfH RP2
▁marked ly
▁Cr l
▁Se vere
▁shar ply
▁metabolite s
FI G
O_ST_ABS Wh
▁inn ate
▁inn ovative
▁mA b
▁feas ible
▁Car ibbean
▁dele tions
▁resourc es,
▁IL -6
▁3.4 %,
▁enab les
▁Bangkok ,
▁degrad ation
ida zole
▁gra di
▁lig and
▁upreg ulation
▁upreg ulated
▁famil ies
▁self-med ic
▁self-med ication
▁eukary otic
L1 C
▁ul timately
▁rib bon
▁san itation
▁inverse ly
▁hrp 2
▁(Y FV
▁vesic le
▁lat ent
▁Mon itor
▁biosyn thesis
▁immunos orbent
▁Guang zhou
▁avoid ance
▁dup lic
▁recip rocal
▁Ag -RDT
▁resol ve
▁Hsp 70
▁sear ched
▁unex pected
▁quar ter
▁press ure
▁Chi -square
▁minute s
▁auto immune
▁Incre asing
▁Identi fication
[& ge;]
▁tail oring
▁ov itrap
▁eas ily
▁MM V
▁interfer on
▁remo ved
▁endpo int
▁catch ment
▁Antibod y
▁Heterogen eity
▁ly s
▁tur n
alk iiS
▁cod on
▁contag ion
▁perm ethrin
▁sple en
▁invest ment
▁Import ant
▁re-emerg ing
-di rected
xyp rimaquine
▁sym bion
▁norm ally
▁conval escent
character ized
▁Follow ing
▁Nex t,
▁Hep atocys
▁(Spear mans
▁illust r
▁termin al
▁STT3 B
▁misclass ification
▁prolifer ating
▁infrastruct ure
len ec
▁darling i
▁bott lenec
▁resur gence
▁MED LIN
▁genom es,
▁Err or
▁agricult ural
-pron e
▁Ascar is
ircum c
▁carbo xyprimaquine
▁appe ared
▁lifesp an
▁uptak e.

▁bench mark
▁dimin ished
▁MAGT 1
mec tin
oug ou
▁azith rom
▁in-dep th
▁prag matic
▁mur ine
▁wom ens
▁front -line
ilib rium
▁ARI MA
▁CRI SPR
▁Tox oplasma
▁Sinoph arm
ucoc utaneous
▁I-d omain
▁I{sup erscript
otosyn thetic
▁surrog ate
▁anti-R H5
▁anti-ser um
▁multigra vid
▁Kins has
▁metron idazole
▁gambi ense
▁hypere ndemic
NT16 2b
▁Xishuang ban
▁Hepatocys tis
" .

, 3
- G
- or
- at
- tal
- BS
- we
- III
- Vac
0 8),
1 {middle
2 5
3 5
3 8
3 R
4 0%
4 0,
5 80
6 .4%
6 3)
7 6).

7 0)
8 ;
9 ).

A M
A m
A BA
B )
B y
B etween
C om
D 7
E ST
E vidence
F or
G )
I C
K A
L ,
L D
M osquito
N e
N C)
P LO
R ]
R a
R II
R NT
S R
S MA
T T
T M)
T P)
T alkiiS
U nder
V ,
W 1
Z .

Z ika
] .

] ),
a ved
b ack
c on
c idin
d ent
d ong
d onal
f ric
f RNA
h ing
h ment
h ak
h uman
i tions
i i)
k ary
l os
l ong
l erate
m g
m o
m osp
n om
n ik
n ers
n ership
o tes
p ://
r ys
s h
s por
u a
u h
u ge
u es.

u age
v ents
v ax
w h
w estern
x .

{ cents
▁ $
▁ ite
▁ econ
▁ \"
in el
▁t y
▁t ax
▁t ask
re ach
on trol
on ucle
on egative
ti es.

he rap
he astern
te ,
▁o lig
▁s he
▁s om
▁s un
▁s ectional
▁in duction
▁in version
▁in -hospital
▁c ame
▁c osts.

▁c heck
▁c redible
▁p f
▁p y
▁p ul
▁p ig
▁p orph
ar o
ar s
ar di
▁m ul
▁m ature
▁m ekong
▁d est
▁d rop
▁d ense
▁d omestic
or ous
er ,
er ve
er bated
as 9
as ts
▁f ra
▁f ill
it ations
an i
an n
an s,
ic an
ic idal
ic um,
ec tion
▁re tained
▁re ferral
▁b re
▁b ivariate
▁b atch
us h
us ed
ia c
▁h all
▁h idden
om n
id ation
id ated
▁e ase
▁e zetimibe
ate ,
os ing
os ts,
▁( or
▁( rec
ac donal
ac erbated
ly set
▁th or
lo ad
ur a
ur is
ur ation
im ental
ul i
▁n ar
▁n an
il t
▁P at
▁P over
▁P ET-PCR
▁A BV
▁st ay
▁st all
▁st ock
▁st ool
ig enous
▁C X
▁C ox
▁C QR
▁T ex
▁T ropical
▁T ER
▁T aken
▁T ai
▁T reatment
▁T oror
um mer
▁g ut
el ian
▁an ch
▁con ver
ol ate
et ary
▁pro of
▁pro gnostic
▁pro kary
▁l i
▁l ay
▁l ang
▁l ines
▁l umefantrine
if orm
if ying
ri e
▁S ind
▁S IV
▁S ignificance
▁S igm
▁S JdRP
▁com orbidity
▁pre vents
▁I D
▁I ts
▁I tal
▁I ll
▁I ZP
am p
am -C
▁on es
op olitan
▁M E
▁M L
▁M end
▁M ap
▁M ale
▁M emb
▁M unicip
▁M atrix-M
▁M yanmar
▁M UAC
▁1 :
▁1 19
▁1 5%
▁1 0%
oc )
ot ing
ot herap
ow ered
▁D hak
ran g
ment ary
▁im ages.

▁infec tive
▁inc ident
▁inc omplete
▁ch am
▁ex ported
▁ex ists
▁ex acerbated
res ent
iv ax
▁ac ad
▁R o
▁R p
▁R ed
▁R el
▁R 21
▁R oss
▁R ins
▁R OTE
▁R ift
▁stud ents
eas e
0. 2
▁he ight
▁comp l
▁r h
▁r ig
▁r ight
▁r ED
▁cont amination
▁H ow
▁H ub
▁H ill
▁H MC
▁H MI
▁H Ds
▁H aem
▁H uh
▁B es
▁B CR
▁mod ul
00 )
▁at tem
ore g
ore gressive
▁study ing
▁study -level
and ed
▁wh om
▁per mit
pl ies
▁We b
log ous
▁inter pre
▁E ach
▁E HT
▁ind igenous
19 ,
ric k
ric oid
olog ists
▁data -driven
▁le ishman
▁le ft
▁reg istration
▁3 00
▁3 Ra
▁O _
▁F our
▁F laviv
▁F OI
▁out reach
▁N am
▁N 95
▁N ortheast
▁N MPs
end s
ell ed
▁ap ical
5% ).

5% ),
▁und iagnos
▁L a
▁L ow
▁L AMP
▁L F-RDT
▁falciparum -pLDH
▁sp illo
▁sp eed
▁ser osurve
▁ser ostatus
OVID -Vac
▁0. 06
▁under t
▁under reporting
▁analys ed.

form ed
▁disease ;
ross -sectional
-s c
-s ite
▁un vaccinated
▁un avail
▁sur fac
all eng
▁ar che
▁it .

▁population -based
▁low -res
-b inding
▁am oe
▁am oun
▁anti -parasite
▁G IA
▁G WAS
▁vector -control
▁U l
ugh ter
▁sub jective
▁sub -reg
▁sub -dist
▁int en
act ating
bo ut
bo uring
rib ute
▁ins er
▁ins ight
▁mon o
▁identif ies
pon icum,
▁vivax )
▁region -specific
-2 00
▁sc ales
▁sc ores
▁man us
▁blood ,
▁imp air
▁202 2,
▁over d
▁count ,
▁count rys
▁prov inc
▁5 7
▁5 0.
ard iac
0% ),
▁DENV ,
▁An ophe
▁COVID-19 :
-1 5
▁Con c
▁6 9
▁6 2%
▁assess ments
▁tes ts.

▁dist ress
ep i
ep tide
▁pos ed
▁201 8,
▁201 6,
▁loc ally
▁no tified
▁mor b
▁system s,
▁set tle
-d ays
-d imension
-d efined
▁non -linear
▁drug s,
▁7 1
▁7 9
▁7 0%,
▁dec ades
.1 )
▁other s
ized .

-p rim
▁ro dent
▁insec urity
ld er
▁K E
ants .

-c o
-c ount
▁Background L
tain able
▁V E
▁8 6
▁8 7
▁8 8%
anti ty
▁month s)
▁prim ing
▁obser ve
▁pl aus
▁met apopulation
yte s
stand ard
▁Results In
-in f
-in vasive
▁Conclusion A
▁comb inations
▁1. 01
uct u
▁tra in
▁tra ffic
▁sup press
▁bi os
▁tem porally
▁ph ys
▁ph ysical
▁vaccine es
▁there by
▁sim pl
▁sim ulated
▁sim ulating
▁epidemic ,
01 86
▁character ise
ne ts
▁collec ting
▁(P M
▁(P ow
▁(P oc)
▁gam e
unc tional
▁dep ressive
ability .

-C or
▁(D F)
▁conc ord
jec ted
▁hospital .

▁hospital izations
▁conducted .

-f ed
-f ace
-f riendly
▁val idity
ass ay
▁investig ations
ynamic s
▁important ly,
▁observed .

▁tool kit
▁Malaria ,
ogen etic
.8 )
.8 3%
▁temper ate
▁Pf csp
-l actate
.3 %,
▁Health care
▁response ,
hem ical
▁review ,
▁Brazil :
▁(2 5
lass ical
▁complex ,
▁complex es.

▁aim ing
▁Ig A
▁lim itation
▁method ologies
ienc es
▁sensitivity ,
▁present ation
▁single -strand
▁(S MC)
▁increas es.

▁typ ical
▁available ,
▁available .

▁tr ust
▁tr iage
ey a
▁prevention ,
▁non- net
▁influ ential
▁occur .

▁inte res
CT )
▁estimate s.

▁elim inating
.5 )
▁(I FR)
▁disc ard
▁post -inter
▁ZIKV ,
▁Ind ic
▁Ind oor
▁Ind ia.

▁survey ,
▁survey .

▁testing ,
til ity
▁network s,
▁Pro tocol
-re c
▁(R BC
▁form al
▁diagnosis ,
-L ,
▁growth .

ty -two
▁insecticid es,
=1 .1
▁targe ts.

-3 4
▁Am p-Seq
▁invol vement
▁strain s.

▁Co verage
▁pyrethroid s
▁research .

▁antibodies ,
▁vis ited
▁activ ated
▁activ ities.

▁rele ases
▁contain er
▁att ract
▁access ,
verse ly,
▁add ing
▁illness es
▁less er
▁su f
▁process es,
▁tested .

tro ph
▁ed iting
osom iasis
▁focus ing
▁state s,
alys es
▁gu ardi
▁pathogen s,
-0. 99
▁(3 0.0%
▁geograph y
▁Un it
▁poss ess
▁systematic ally
▁activity ,
▁activity .

▁range :
▁(OR ;
▁NS1 -specific
▁Im mun
▁Im ple
▁protection ,
▁status .

▁2019 .

▁gamet ogenesis
▁dot} 9
▁them .

▁coverage .

▁initi ated
▁initi atives
▁standard ized
▁Tanzan ia,
▁CD C
iven ess
▁co-infec ted
▁effor ts,
▁equ ation
▁equ ally
meric an
▁repres ented
▁cr yptic
▁reac hed
▁reac tivity
▁threshold .

▁200 6
▁plan ned
osph o
▁(0. 00
▁(0. 01
▁(0. 17
▁link s
▁interaction .

RP 17
▁ret rie
▁transcrip ts,
EP -G
-M acdonal
34 C
▁real -world
▁Par ame
▁optim izing
▁invasion ,
▁< 1.

▁framework ,
▁Ar boviruses
▁deploy ing
▁apicoplast ,
▁z ero
▁via ble
▁servic es.

▁Americ a.

▁anaemia ,
▁anaemia .

▁Des ign
▁consider able
▁consider ations
▁phase .

▁sulf asal
▁concern .

▁selection ,
▁selection .

<0.00 1)
▁mixed -m
▁map ped
▁De ep
▁compound s.

▁Ass ay
▁accuracy .

▁PCR -based
▁parasites/ l
▁epidemiology .

▁challenge .

▁da ughter
▁complic ated
▁reporting ,
▁histor ically
▁incorpor ate
/1 00,000
▁pre- erythrocytic
▁Ins ectic
▁capacity .

▁Inter ventions
▁sec urity
▁mass ive
▁Ser um
▁0.7 0
▁investigated .

▁occurred .

▁city ,
▁clon ally
▁abs ent
▁cent ur
▁deg rees
▁inhibition ,
▁prom p
▁prom ote
▁prom oting
▁(E LISA
▁studied .

▁Ef ficacy
▁MethodsA n
▁planning ,
▁sout heast
▁IR R
▁sex ,
▁biology .

▁Malawi .

▁parasites/{micro}L ;
▁Sc iences
▁accept ability
▁Ex pl
▁require ments
▁mobility ,
▁calc ulating
-D ENV
-D WS
▁sa ving
▁ref lecting
▁protocol s
▁profile ,
▁concentration s.

went y
▁(W TP)
▁prote omic
▁haplo id
▁CHIKV ,
▁circum spor
▁track ed
▁rainf all,
▁clear ing
▁clear ance
tt p://
▁j oint
▁Model s
▁US D
▁medic ines
▁restric ted
,S -dehydro
BP RII
BP -Cor
▁co- local
▁CHMI ,
▁arm .

▁haemat ocrit
▁Effec tive
▁co-circ ulating
▁Long -lasting
-month s
▁recep tors
▁(IR S)
▁X TalkiiS
▁tit re
▁const rained
▁expand ing
▁Thailand .

▁Thailand -Myanmar
▁dissem inate
▁hybrid s
▁Soc ial
▁Soc iety
▁prec ise
▁Multi plex
▁0.2 0
▁scal e.

▁poly cl
▁plac ent
▁(Pf )
▁don or
▁bod ies
▁Predic tion
▁Predic tive
▁Predic ting
▁DF x
▁clinic s
▁State ment
▁far nes
▁(Z IKV
▁Sh ort
▁yield ed
▁hypothes is
ocyt osis
▁disrup t
▁transmit ting
▁recurrence .

▁Interpretation The
▁El imination
▁Covid19 Vax
▁visual izations
▁mixt ures
▁bites /d
EN -I
▁AD R
▁next -generation
▁adop tion
▁Lo Ds
▁arch ived
▁arch itect
▁decad es,
▁synchron y
▁synchron ous
▁guidel ines.

/s ignificance
▁mar ried
ime ter
▁well- known
▁undersc oring
▁psych osis
▁tog ether,
▁shap ing
▁rare ly
▁non-c lassical
struct ural
struct ured
▁PfH op
▁pathogenesis .

▁Qu anti
▁lipid -based
che s,
▁SP SS
▁Spati o-temporal
▁precip itation,
▁shif ts
▁serotyp es.

▁event s.

▁PfG RP17
▁(p<0.00 1)
▁document ation
O_ST_ABS Evidence
▁ide al
▁ide ation,
▁TH E
▁trajector ies
▁correct ly
▁supple ments
▁utilis ation
▁Associa tion
▁degrad e
▁cre ate
▁pi lo
▁bio informatic
▁act ual
0.9 %,
▁immuno assays
▁apicomplex ans
▁strengthen ing
-n ull
-n egative
C_ST_ABS O_LI
▁sick le
▁injur y
▁injur y.

▁fl uctu
▁replac ement
▁stunting ,
▁manip ulation
▁immunos up
▁hetero logous
▁Guang dong
▁Pbgd -null
BR >
Here ,
lies t
▁toler ance
▁TMP RSS
▁progen y
▁acce lerated
▁inters pec
▁Emerg ing
▁consult ations
▁Struct ural
▁non-us ers
▁femal es,
▁propag ation
▁glyc olysis
▁misdiagnos ed
▁exclud ing
SC PLO
▁fav our
▁(0 -1
▁(w ith
▁PCI Net
opo iesis
▁Mixed -effect
▁DRC .

▁non-ph otosynthetic
▁constrain ts
▁trigg ers
.or g
▁pol itical
▁ther mal
▁rein for
▁Pl ate
▁Cost a
▁IC U
▁Mb eya
▁Rc ase
▁EV Es
▁EXP 2
▁aptam er
▁Gre ater
▁non-s ynonymous
▁exten sion
▁Str ateg
▁trypan osomiasis
▁(IC 50
▁approache s.

▁swit ches
▁ultr ason
▁encephal itis
AF 1
ss RNA
▁session s
astig ote
▁flex ible
▁bud ge
osm opolitan
▁CNV s
▁anticip ate
▁constr uc
▁DTP 3
▁In9p vcrt
▁kin ases
▁artemether -lumefantrine
▁[CI ]
▁(COVID-19 )
▁>2 000
▁viability .

▁uncon ventional
▁Instead ,
▁virul ent
-protein -2
▁Sabah ,
▁landscap e
-qu antity
G6PD -BS
PC 1
▁hierarch ical
▁(qPCR )
▁lumb ricoid
rip e
▁MA Y
▁Material s
▁acous tic
▁RVP -based
▁Evalu ation
▁GH {cents
.\nC_LI O_LI
▁societ al
▁App lying
▁Yogy akarta
▁Phil ipp
▁thrombocyt openia
ine-rich -protein-2
▁Investig ating
▁manufact urer
BI BP-Cor
▁sourc es.

▁PyC CR4
▁Ara bic
▁proxim ity
▁licens ed
▁deple tion
▁Sput nik
▁Iquitos ,
▁2030 .

▁EPI COVID19
▁shor ter
▁rab ies
▁surround ing
-SMAR RT
▁sensitiz ation
▁immunode ficiency
rins ic
▁histid ine-rich-protein-2
▁stead y
▁Phylog enetic
▁proteasome -like
▁ja ponicum,
▁co-occ urrence
▁double-b lind
▁Neut 50
▁Crl =1
O_ST_ABSWh at
▁vesicle -like
▁Important ly,
NT162b 2
Under standing
fric a
▁pig ment
▁mekong i
▁hall mark
▁(rec r
▁Pover ty
▁Tai wan
▁conver gent
▁prokary otic
▁lang uage
▁SIV EP-G
▁Sigm oid
am-C OVID-Vac
▁Mend elian
otherap y
▁acad emic
▁Ross -Macdonal
▁ROTE M
▁HMI S
▁interpre ted
▁low-res ource
▁amoun ts
-dimension al
▁post-inter vention
▁sulfasal azine
▁circumspor ozoite
▁Covid19Vax plorer
▁bites/d ay
▁architect ure
▁TMPRSS 2
SCPLO W
▁lumbricoid es,
▁GH{cents }
▁SIVEP-G ripe
▁Ross-Macdonal d
" ,
- he
- as
- going
/ L
/ ad
/ {micro}L
/ NO
0 {middle
1 4,
2 0
2 6
3 .

3 4,
3 13
4 1
6 1
6 7
7 7
7 %)
7 .9
7 2,
7 24
8 3
8 .

8 %),
9 4
9 ),
: effec
A K
A /S
A ACT
B L
B .

B ST
B AS
C L
C _
C OVID-19
C ross-sectional
D s)
D BPII
D DE
E AL
F indings
H ousehold
I N
I g
M el
M ),
M S)
N )
O ne
P A
P f
P lasmodium
S I
S L
S GS
U T
U THOR
V ),
W s.

X t
Z S
] )
a :
a ut
a ren
a e.

a -an
b .

b et
b ors
b iasis
b reeding
c ending
c lusive
d )
d .
d ers
e /
e pers
f ied
g ,
h igh
h ort
i h
i hydroartemisinin
j uvant
k -1
l ers
l arg
m end
m ia.

m g/kg
n a,
n itine
o al
o ost
o bia
o ok
p en
p osed
p resent
r he
r ban
r itor
s a
s um
t age
t ozo
t oxic
t urb
v es,
w .
w id
w ord
x 10
y lp
y go
y gi
y oA
z a,
▁ x
▁ %,
▁ -2)
in ity
in ute
in atory
in flammatory
▁a ud
▁t ick
▁t rich
▁t -test
re quent
ti se
ti fic
en vironmental
te l
te ro
te s,
te ome
▁o ph
▁s qu
▁s plen
▁s fRNA
▁in breeding
▁c ry
▁c ust
▁c ities.

▁c itiz
▁c utaneous
▁c ardiac
es ters
▁p ne
▁p ort
▁the ore
▁the ms
ar id
ar ra
ar se
▁m m
▁m el
▁m ated
▁m sp
▁m g/kg
▁d il
▁d oll
▁d ashboard
▁of fic
or relation
is al
is um
is ter
is ts,
▁w ider
▁w Mel
as ,
as oph
▁f ec
▁f ear
▁f all
▁f rag
it ation.

ro log
ro bor
an es
ic a
ec e
ec ological
▁re establis
▁re plen
▁re challenge
at ent
at ab
at ural
▁b ig
▁b ack
▁b illion
ve red
▁h it
▁h uge
▁h ook
▁h ygi
le ,
ate s.

▁( +
▁( Q
▁( g
▁( am
▁( end
▁( all
▁( 42
ac u
ac he
ac tic
ur ring
ur pos
th ,
th s
▁n =
il ome
▁P en
▁P res
▁P rop
▁P ort
▁P RI
▁P <0.05
ted .

▁A verage
▁A ust
▁A bout
▁st ream
ir a
ir ida
▁C y
▁C an
▁C ore
▁C lass
▁C osts
▁C AF1
▁T e
▁T em
▁T ik
▁T rich
▁T PR
um on
um ina
▁g ast
▁g reen
▁g ave
▁g ives
qu antitative
un a
▁as k
el f
▁con struct
et ail
et ry
▁pro c
▁pro long
▁pro tozo
▁malaria -positive
▁malaria -naive
▁l iv
▁l ist
ud y
if ier
▁S ur
▁S ome
▁S ix
▁S cale
▁com e
▁I MP
am et
am oy
▁2 0.
▁2 .6
▁2 50
▁2 8%
und ity
▁M ark
▁M ade
▁M MS
st ag
st age
st ream
▁1 %,
oc lonal
eng vax
▁was te
▁D o
▁D ire
▁D irect
▁D BS
▁D 23
▁D BPRII
▁D EN-I
▁D atab
rom e
ment al
ment s.

ment ation,
▁im age
▁dis ability
▁dis par
▁inc idences
ab el
ab les
▁ex ception
▁ac tions
▁ac tin
▁W omen
▁W here
▁R ati
▁R iver
▁R OC
▁are a,
0. 4
0. 000
▁co ugh
▁co vered
▁comp ens
▁r s
ant ine
▁al .

▁al ways
▁al one,
▁al veolar
▁H om
▁H TM
▁ne ver
▁ne are
▁trans amin
▁se ed
▁se ps
▁B G
▁B l
▁B al
▁B as
▁B us
▁B ag
▁B ox
▁B MI
▁mod est
▁mod ification
yp ical
00 ,
ati tis
val ences
▁at ov
▁at mosp
▁at ypical
▁lo ok
▁wh ilst
▁cl ade
▁cl aim
▁per imeter
▁per turb
pl ay
ay ment
▁In iti
▁In hib
▁In vas
▁inter face
▁inter pretation
▁inter play
▁E 1
▁E b
▁E v
▁E nd
▁E uro
▁E DS
▁E -K
▁ind eed
ulation .

▁le uk
▁reg ulated
ary n
▁3 V
▁3 .3
▁3 .5
▁3 -year
▁3 2%
▁3 D7
cip ients
▁O man
▁F c
▁F ound
▁F ull
▁F unctional
▁F SGS
ros ine
▁out we
▁out -of
▁N I
▁N um
▁N CD
▁ca ught
per son
▁k -mer
▁k ilome
▁ap plications
5% .

ag ers
▁L ine
▁L abor
▁L RIM
ost asis
▁sp ike
▁sp arse
▁ser ves
▁ser ologic
▁ser onegative
▁0. 000
▁0. 50
▁0. 21
▁0. 65
▁under to
▁ra ises
▁sign alling
▁rec ap
form ance
▁spec trum
▁str ing
ally .

-s il
-s tep
-s upple
▁un pre
▁un chang
▁tre es
▁ar ising
▁ar gue
▁not .

▁cases )
▁cases :
▁low .

▁low -endemic
-b orn
▁9 %
▁9 8%
▁am a
▁am plic
▁anti -malaria
▁rel ating
▁G Y
▁G ambia
▁G rand
▁G iem
▁ag gregated
▁U I
▁U til
▁U LV
▁sub un
▁sub national
▁sub clinical
▁int ense
▁4 %
▁4 .6
▁4 0.3%
▁vacc ines,
▁ins urance
▁mon oclonal
pon ent
▁children s
▁en velop
▁en ough
▁en rich
ast ,
▁detec ts
ap pa
▁sc ans
▁blood -feeding
▁these ,
▁202 4.

▁202 5.

▁over c
▁ob taining
▁prov ince
▁5 8
▁5 .3
0% ).

▁An k-1
-1 1
-1 8
-1 0.
-1 .6
-1 .2
-1 .9
▁Con f
▁Con versely,
▁6 5%
▁6 6%
▁6 1.5%)
▁protein .

▁protein /ad
▁tes ts,
▁individual -level
▁pos ition
▁201 5,
▁pres sing
▁loc ation
ult ure
▁no tification
▁Res ource
▁po ore
▁po ison
quenc ing
-t rained
ser ved
▁multi stage
▁drug .

▁drug s.

gen ic
gen itor
▁7 4
▁7 5
▁7 8
▁7 3%
▁7 6%
▁other s.

ograph ical
▁K an
▁K ing
▁K il
▁K ay
▁K nock
▁K isum
-c ost
▁Background T
▁Background V
▁Methods D
▁Methods In
tain ment
▁cons ent
▁cons ol
▁cons isting
▁V al
-S NP
.\n\n S
.\n\n We
▁prim ers
▁met rop
▁comple ten
▁Results S
▁Conclusion Our
rac tive
▁med iating
▁1. 5
▁need ed,
▁tra it
▁tra dition
▁cor robor
▁number ,
▁bi ased
▁bi ophysical
▁ph ot
▁ph one
▁- 3
▁there af
▁there fore,
-m inute
▁path oph
▁well ,
▁well .

▁well -st
▁epidemic -prone
.4 %,
01 5
▁character ising
▁collec tion.

▁evalu ates
▁(P v
▁(P lasmodium
▁long -lived
▁pe er
▁pe rennial
unc tion
▁dep ri
▁dep ended
▁provid ers
-C OV
▁(D ALY
▁Ch alleng
▁intervention ,
ness ed
▁sens itiv
rop ic
▁hospital ,
▁care ful
lis h
▁ext end
▁ext rap
▁ext inc
▁exper tise
▁inform ing
▁cross -tal
▁local ized
▁local ised
▁conf ers
.8 8
.8 %),
▁immun of
▁immun ogenic
▁ur g
▁(1 )
▁(1 2
▁op in
▁rep air
▁Pf RH5
▁Pf -SMARRT
▁host .

.7 8
iod emographic
▁target .

hem oglobin
ocyte -prim
.2 )
rain ing
▁spread .

▁(2 )
▁(2 3
▁(2 .5
▁(2 .66
▁cluster ,
▁complex .

▁CH AT
▁period s,
▁knowlesi -specific
anc er
anc ing
▁epidemi ologic
▁p=0. 0
▁(A n
▁(A r
▁(A NC)
▁effect .

▁(p <0.05
▁respons ive
▁arbovirus es.

fer ring
▁quanti le
▁(S E
▁typ es.

▁random ization
▁non- endemic
-Co unt
▁people ,
itor s;
▁del ine
▁del ays
▁del tamethrin
▁Conclusions We
▁Conclusions This
▁car bon
▁car nitine
▁emerg enc
▁detected .

av age
▁disc over
▁assay s.

▁genome ,
1, 5
▁frequenc ies,
-st ate
-st ained
▁post -
▁post -treatment
▁post -COVID19
▁exam ines
▁survey s.

▁program s.

abor ative
<0. 01
▁essential ,
ace in
▁distribution ,
▁reduction ,
▁insecticide .

▁four th
▁Pro cess
-re view
▁COVID19 -related
▁exposure -response
▁site .

▁therap y.

▁therap ies.

▁(a IR
roscop ic
▁growth ,
▁em etine
▁pa ediatric
▁pa rent
▁dose ,
▁dose -response
-3 III
4, 000
establis hed
▁Am pl
▁invol ve
▁expression ,
▁Ad v
▁Ad ditional
▁key word
▁mat ter
▁pattern s.

▁rele v
▁rele ased
▁contain s
▁att ack
oph obia
▁add s
▁Al t
▁HIV -1
▁country ,
.0 -9
▁dri ve
▁sequ el
▁sequ ential
▁sequ esters
▁implement ation,
▁19 8
tro viral
osom al
▁Mal i
▁pool ;
▁state ,
▁(aOR =2
AT )
▁Y et,
▁week s.

▁particular ,
.5% ).

▁prac tical
arm ac
▁techn olog
▁stand ing
▁South west
▁cap ital
▁cap illary
.\n\nA UTHOR
▁(OR =
▁(OR =0.
▁Summary S
▁1, 5
▁Wh ole
ern at
▁lif est
▁summary In
▁RDT ,
▁RDT s,
▁protection .

ors hip
ie tic
land in
o- pro
▁fit ting
▁pers isted
▁spp .
▁differenti ate
▁initi ation
▁(H R
▁(n= 3
▁standard ised
▁ann ot
▁> 7
▁> 10
▁def ining
.4% ;
.4% ).

▁address ed
▁co-infec tion.

▁addition ally
▁Keny as
pati ents
reg ulated
▁equ ilibrium
▁Pre vention
▁structure ,
▁structure s.

AP L1C
▁cr ude
▁(N T
▁threshold -based
▁Cam pin
▁200 3
▁17 th
▁expl or
▁micro v
▁micro bi
▁micro arra
der mal
▁detect able
▁evaluated .

g/ day
▁old ,
▁Re porting
▁record s.

▁carri es
▁ratio ,
IR )
▁ens embles
▁integr ating
-h uman
BO X
▁Par asit
▁gametocyte s.

ced ented
▁antigen ically
▁deploy ments
▁functional ity
▁z on
▁z -sc
▁field .

▁produc t
▁Niger ias
▁value :
▁context ,
▁context -specific
▁nec tin
CD )
▁ele ment
▁person s
▁Introduction Dengue
plo red
▁cle aved
▁der iv
▁water .

ona Vac
▁threat ens
▁achie ving
▁En s
▁En vironmental
▁varian ts,
▁Ass ociated
21 0,
pr ising
the less
▁serotype -specific
▁2015 .

▁bias es.

▁epidemiology ,
7% .

man ent
▁complic ation
▁complic ations,
▁complic ations.

▁short -lived
▁unc over
▁unc ircumc
▁p=0.00 7)
▁histor y.

/1 80
▁cur ves
▁Cl inic
▁ST 313
▁block s
▁travel ,
▁travel ers
▁fail ures
▁Eth ics
▁practic es.

▁Over all
▁relap sing
▁hyper par
▁ste ps
▁life tim
▁sulfadoxine-pyrimethamine .

▁doc tor
▁Med ian
▁load s,
▁clon ed
▁clon e.

▁self -reported
▁facilit ated
▁appear ance
▁establish ing
▁i CC
▁(G am-COVID-Vac
▁index ,
▁determin istic
▁explain ing
-A I
-A frica
ke epers
▁pur ch
▁lar vic
▁school s
▁represent ation
▁represent ative
-5 9
▁saf et
▁enzym es
▁implemented .

▁aver ting
ond on
▁(8 2
▁vi rolog
▁proper ly
▁IR F
▁IFR 1
▁(AOR =1
10 ).

▁so le
▁so il
▁pharm acy
▁abund ant
▁circulation .

/2 63)
▁wave .

▁dihydroartemisinin -
▁IPTp-SP .

▁mitig ating
▁flu orescence
▁(W NV
▁prote ase
▁Bangladesh ,
▁difficult y
{degrees} C)
79 )
▁reproduc ible
▁Model ing
▁enc oding
▁With out
▁hem at
▁hem oglobin
▁Europ e.

▁mechanism s.

▁necessary .

▁survival ,
▁restric tion
▁restric ting
▁bu ilt
▁22 .8
▁22 .0%)
▁intra -
▁non-f acility
▁synthesis ,
▁abundance .

cRNA -Seq
▁qPCR .

▁oper ate
▁oper ating
▁oper ational
▁flavivirus es,
▁re- challenge
▁bed nets
▁Pv W1
▁At las
▁hypn ozo
okine tic
▁haemat opo
▁Effec t
▁Effec tiveness
▁biomark er
▁Amazon ,
49 1
ME NT
och ond
▁ConclusionsThe se
▁prioritiz e
▁prioritiz ation
▁scenarios .

-H bA
▁Acc urate
▁0.05 )
▁Thailand ,
▁1.0 9
▁1.0 2,
▁Ghana :
▁questionnaire .

▁rainfall .

▁prec edes
▁Min ority
▁recommend ations
▁Recent ly,
▁District ,
▁sw arm
▁software .

▁fil tering
▁(B BIBP-Cor
▁(s uch
-202 2,
▁opportun ities
▁(n=1 6),
▁(n=1 08),
▁policy -relevant
▁detail s
▁underestim ate
-T MP
▁pay ment
▁conse quence
▁SD -DWS
▁Spec ies
▁Spec ial
▁indirect ly
▁Ne ural
▁mob il
▁culture s.

▁hypothes ized
▁Vietnam ,
-th reat
/3 3
AN CE
gs c
▁replic ation.

▁disrup tion
▁hep atic
▁hep cidin
▁regul ator
▁regul atory
▁semi- nom
▁semi- quantitative
-v ector
▁hand ,
▁Infec tions
▁extensive ly
▁abnormal ities,
▁(p=0. 04
▁epit helial
▁CDPK 4
▁isolate s.

/C CR4
/C as9
▁her itable
▁pass ed
▁top ic
▁home ostasis
▁CR T
▁CR D4202
▁animal s.

▁head ache
▁adop t
▁adop ted
▁ConclusionThe se
▁careg iver
▁(CH MI
▁Americas ,
=3 .1
▁iron -supple
▁p<0.00 1)
▁p<0.00 1),
▁pyriproxyfen ,
▁dra w
▁bel ie
▁separ ated
▁0.01 %
-reg ression
▁smear s
▁Objective To
▁Island s
MS E
TE XT
▁psych iatric
▁eg g
▁anophe lines
▁Del ta
▁NT BC
▁LO Ds
▁socio- environmental
▁defin itions
▁Epidemi ology
▁eng agement
▁CO NT
▁anthrop ogenic
▁Sm SPI
▁Diagnos is
▁compet ing
▁transl ational
▁transl ation,
▁shar ing,
▁shif t
▁contribut or
▁North west
▁Janeiro ,
kill ed
▁sil ence
▁(c ontrol
▁Mic ron
▁Mic roscopy
▁cover ing
▁98 .83%
▁41 .7%
▁enab ling
▁trajector y
exp osed
▁(RR :
▁Count ries
▁visit s,
▁minim ally
▁organism s.

▁Benin .

▁reservoir s
Wh ile
▁domin ated
▁bilirubin ometer
▁(f rom
▁lig ands
▁MV -infected
▁Op tim
▁0.1 19%
▁complement ary
▁cluster-random ised
▁chlorfenapyr ,
▁disadvant age
▁disadvant aged
ww w.
▁tox oplasm
▁elic itation
▁SE A
▁Sim ilar
▁imper fect
▁identity -by
▁biosyn thetic
▁occup ation
▁occup ations
▁statistic s.

▁Art -TMP
▁promo ter
▁(IRR :
boviruses )
▁Pbgd -deficient
▁Province ,
iS eq
▁round s
▁inequ ities
▁dup lex
▁react ogenicity
▁Tes ting
▁progen itors;
▁seem s
▁Bio tech
▁spac es
▁special ized
▁quar antine
▁64 .1%)
▁press ures
▁medication s,
▁superv ised
▁superv ision
▁(22 .0
▁motif s
▁(ITN s)
▁femal es.

▁attend ance
▁misdiagnos is
▁Incre ased
▁emphas izes
-e ight
Re port
zy go
zy gous
▁inst ance,
▁induc es
▁mig ration
▁reason able
▁(CR D4202
▁AS -AQ
▁Sus tainable
▁SAR IMA
▁user -friendly
▁sched ule
▁manifest ations
▁coll ateral
▁correc tion
▁non-ph armaceutical
▁Socio economic
▁trigg er
▁hepat ocytes.

▁orthoflavivirus es
▁Remoscop e
▁prophyl axis
▁oxid ative
▁inacti vated
▁inacti vation
▁mit ochond
▁thous and
▁thous ands
▁proced ure
▁proced ures
▁Seneg al
▁disag gregated
▁chrom osome
▁ke ep
▁keratin ocytes
▁keratin ocytes.

▁quick ly
▁(DHF )
▁communic ated
▁diar rhe
▁Eng lish
▁team s
▁megakary opoiesis
▁megakary ocyte-prim
▁finger p
-NS 1
1/ APL1C
Ch aracter
▁trim ester
▁stem /pro
▁ing red
▁pop ulated
▁dang erous
▁bind s
▁hind ered
▁Da wa
▁distingu ish
miss ible
▁Network s
▁effector :effec
▁reconstr uction
▁evol ving
▁7.5 7%
▁MethodsT en
▁newborn s
▁1.21 %)
▁suppor ts
▁non-re cipients
▁pair wise
▁Council ,
▁cytot oxic
▁viol acein
▁Exper imental
▁co-ex pression
▁RACD ,
▁subsid ized
▁substit utions
▁neighborhood s
▁preprin ts
▁Polynes ia.

▁PubM ed,
-es cal
▁sent inel
▁cut off
▁bal ance
▁hold s
ulld own
▁Pri or
▁anc est
▁Hig her
▁Bam end
▁Boliv ar,
▁Nep al
▁Up per
▁subgroup s
▁epider mis
▁Conv Ne
▁consecu tive
▁concer ning
▁Regard less
▁explan ation
▁policym akers
▁macroph age
▁begin ning
▁reperto ires
-af fected
▁p< 0,
▁mim ick
▁dro ve
▁dialog ue
▁wit nessed
▁fine -scale
▁band wid
▁2} =9
▁incur red
▁incenti ves
▁Lit toral
▁0.64 0%)
▁0.18 0%
-selec ted
▁bloodme al
▁time-con sum
▁Knowledge ,
▁(SARS-CoV-2 )
▁emb ed
▁entom ology
▁perspec tives
▁cytok ines
▁Cambod ia
995 F
▁counter par
▁eradic ate
▁detox ification
▁encomp assing
▁Monitor ing
▁duplic ate
▁azithrom ycin
▁CRISPR /Cas9
▁Xishuangban na,
▁ite ms
▁econ om
▁ty rosine
omn ia
▁CX Rs
▁anch ored
▁Ill umina
▁cham bers
▁rED III
▁leishman iasis
▁Flaviv irida
▁undiagnos ed
▁La os
▁spillo ver
▁sub-dist rict
▁manus cript
▁plaus ible
▁simpl er
▁game te
▁discard ed
▁attract ant
▁Imple mentation
▁(0.00 491
▁(0.01 21
▁retrie ved
▁Insectic ide
▁centur y
▁(ELISA )
▁Expl oring
▁polycl onal
▁PfGRP17 0
▁interspec ies
▁construc ted
▁(recr udescence
/NO T
bet a}
▁trich i
▁cust om
▁pne umon
▁port able
▁theore tical
▁thems el
asoph aryn
▁fec undity
▁reestablis hment
▁replen ishes
▁hook worm
▁(end ),
▁Port ug
▁Aust ral
▁CAF1 /CCR4
▁Tik o
▁Trich uris
▁gast ro
▁prolong ed
▁protozo an
amoy o,
stag landin
▁Datab ase
▁disability -adjusted
▁neare st
▁Bag amoyo,
▁Invas ion
▁Euro immun
▁kilome ters
▁underto ok
▁recap it
▁unpre cedented
▁amplic ons
▁Grand e
▁Giem sa
▁protein/ad juvant
▁Knock down
▁Kisum u
▁tradition ally
▁thereaf ter
▁well-st udied
▁sensitiv ities
▁immunof lu
▁PfRH5 -specific
-3III _
▁microarra y
▁Parasit ology
▁nectin -4
theless ,
▁uncircumc ised
▁haematopo ietic
▁semi-nom adic
▁iron-supple ments
TEXT BOX
▁megakaryocyte-prim ed
▁stem/pro genitor
▁effector:effec tor
▁ConvNe Xt
▁bandwid th
▁CAF1/CCR4 /NOT
" )
% ).

( 2
) -based
+ ,
- ,
- Y
- ar
- le
- eas
- read
- PCR
- 50
- way
- 80
- ready
. d
. ac
. uk
. b.

. high
/ 6
/ T
/ k
/ re
/ min
/ L)
0 ).

0 ),
0 -5
0 89
0 {degrees}C.
1 19
1 .6
1 .3
1 -H
1 05).

2 ;
2 .9
3 {micro}m2
4 4
4 g
4 -0.
5 /
5 5
6 88
6 2)
6 .7%)
9 6
9 7
: 00
: 30
= -0.
? C_ST_ABSO_LI
A V
A b
A 1-H
B ank
C M
C S
C r
C omp
D ,
D L
D P
E MENT
F P)
G Y
G en
G -b
G EN
H P
H -19
I m
I t
I BD
I vo
K )
K BP
L P
L Y
L ID
M ).

M AS
M BAS
N on
N ew
N TS
N 724
O P
O X
O ut
O ver
O I)
R x
S ,
S NG
T ,
T A
U K
U CI
X 2
Z o
[ R]
a uc
a eg
a ited
a ving
a e,
b ott
c y
c es,
c iated
d is
d ing
e v
e ts
e alth
e ven
e per
e utral
e za,
f f
f l
f ter
g u
g le
g un
g amm
g ona
g .high
h yp
h oid
i j
i ol
i ot
i ance
i quit
i ers
i osis
j ing
k a
k A1-H
l .

l ac
l am
l ip
l ist
l ined
l inked
m m
m p
m ended
m orph
n o
n ozoite
n icity
o ted
o uc
o D)
o -malaria
p ,
p i
p as
p ass
p loy
p uts
r .
r u
s w
s te
s ed
t )
t l.
u er
u ate
u ag
u icidal
w ire
w atin
w ins
w here
x ia
y a
y e
y le
y ork
y osin
{ gamm
▁ .
▁ iver
▁ =0.
▁ erythro
▁ <0.00
▁ <0.05
▁ {degrees}C.
in /
in f
in ants
▁a )
▁a .
▁a OR
▁t able
▁t roph
▁t ightly
re quenc
on y
on om
ti tion
ti es,
he ad
he red
te xt
▁o ve
▁s or
▁s ul
▁s odium
▁s tif
▁s hel
▁s ummer
▁in acc
▁in ner
▁in exp
▁c itation
▁c ensus
es ted
▁p yre
▁p rincip
▁p ick
▁p ict
▁p <0.05
▁p ush
▁p owered
ar val
ar tile
▁m ent
▁m ot
▁m ucocutaneous
▁d en
▁d ip
▁d ynam
▁d ivers
▁d Ivo
▁of ,
▁of fered
or able
or ient
is en
is ation,
is tory
is o-pro
▁w orm
▁w alking
as i
as .

as es.

as ound
as itic
▁f et
▁f ix
▁f ading
it tent
ro se
an ,
an e
an ge
an og
an ned
ec t
▁re -in
▁re tro
▁re vers
at s
at tor
at ocytes
▁b )
▁b l
▁b r
▁b us
▁b im
▁b ron
▁b orne
▁b inary
▁b orn
▁to ,
us es
ia .org
▁h ol
▁h ut
▁h its
▁h arm
om pl
om iting
le ge
id enti
id es,
id ome
▁e .g
▁e lder
os ive
▁( t
▁( st
▁( and
▁( ind
▁( MC
▁( IV
▁( NS
▁( EP
▁( very
▁( relative
ac ts
ac ting
ac cept
ly cophorin
▁th io
▁th ick
lo ut
▁v enti
▁v ag
▁v acu
▁v omiting
ur nal
ur pose
im ent
ul a
th ri
th ron
▁n =1
▁n asopharyn
il ities
il arly
▁P ap
▁P ep
▁P hen
▁P ern
▁P AS
▁P yriproxyfen
▁P ositive
▁P athogen
▁P HC
▁P RNT
▁P uer
▁A ,
▁A P
▁A IRD
▁for med
▁st ri
▁st aging
ig ence
ig ure
▁C 1
▁C _
▁C q
▁C uc
▁C ap
▁C lus
▁C ord
▁C han
▁C ER
▁C och
▁C x.

▁C osmopolitan
▁C ZS
▁C auc
▁T a
▁T ra
▁T ow
▁T arget
▁T RI
▁T argeted
▁T uberculosis
▁T erm
▁T wins
um ba
▁g ather
▁g etting
ion e
tic le
tic s.

el agos
▁an sw
▁con ce
▁con dens
ol utional
ut umba
et -level
▁pro ven
▁malaria -c
▁malaria -HbA
▁l ati
▁l ines.

▁l oses
▁l ives
▁l avage
if ies
▁de b
▁de gen
▁de terior
▁de eper
▁S o
▁S am
▁S up
▁S cop
▁S RP
▁S ero
▁S yndrom
▁S etting
▁S una
▁com mit
▁res c
▁res ide
▁pre feren
▁pre par
▁pre ferred
▁pre meiotic
uc ity
▁I 2
am eth
ge al
▁on .

▁2 %
▁2 .9
▁2 1,
▁2 -4
▁2 34
▁2 .9%
op y
op hen
und er
▁M O
▁M el
▁M ult
▁M iddle
▁M emory
▁M ekong
▁M onthly
st ac
▁1 -2
▁1 02
▁1 5%,
oc y
oc um
oc ial
oc hemical
oc orrelation
ot gun
▁was ted
▁was hing
▁D V
▁D ual
▁D BPII
▁D ABA
▁D ynamics
▁D ihydroartemisinin
▁D engvax
▁D r.
ran ce
rom etry
▁infec ts
ess ,
engue ,
ab ol
ab iting
▁ch ar
▁ch ym
▁ch arge
ip ortal
ip elagos
iv able
▁ac ting
▁ac tively
▁W ater
▁R ain
▁R out
▁R ES
▁R ico
▁stud ent
▁stud ys
ad ical
ad ougou
0. 3
0. 47
her ic
▁ass ured
▁ass isted
pec tion
red it
▁co -m
▁co herence
▁co aching
▁he al
▁he ard
▁comp iled
▁dengue -like
▁dengue -risk
▁cont r
▁cont racted
ub -
▁al ph
▁H R
▁H em
▁H op
▁H ence
▁H ong
▁H orn
▁H BR
▁H ousehold
ug gle
▁se e
▁B ou
▁B ei
▁B TM
▁B NT162b2
▁B attor
▁mod e
ific ity
ific ation,
up e
▁at :
▁study C_ST_ABS
iz able
▁20 3
▁20 7
ure ment
▁per me
▁per -pro
▁per fusion
▁per i-
▁In term
▁inter med
▁inter ference
▁inter linked
▁E N
▁E qu
▁E zetimibe
▁E MBAS
ak ing,
ric hed
ik ed
▁high -dose
▁sh ield
ary ing
▁3 .0
▁3 4%
▁3 .6%
▁3 .0%,
▁3 0.9%,
▁O ST
▁O MO
▁O lyset
▁O uag
ch ool
ch oal
ch ange
▁F ield
▁F 15
▁F KBP
▁F rance
▁out put
▁out patients
▁out puts
▁parasite mia.

▁N G
▁N M
▁N d
▁N ever
▁N ino
▁N iem
▁N IRS
▁N PC1
▁N atural
▁anal ytes
orm ous
ph adoxine-pyrimethamine
ell es
per ature
est ock
▁k ind
▁k dr
ag asc
enc ing
enc ies
tec tive
▁associa tes
▁L ate
▁L iving
▁L ock
▁L ife
▁L TR
▁L anding
▁L ih
pid emi
▁fac epi
▁falciparum -endemic
▁sp eed,
ib ling
▁0. 11
▁0. 24
▁under lies
▁under -reported
▁Plasmodium .

▁ra ised
▁ra ising
▁sign s,
▁rec urrences
▁str ata
▁str uggle
▁un f
▁un st
▁un adjusted
▁un iform
ich ia
▁tre e
▁incre mental
▁ar rang
ind ia.org
▁low -cost
-b locking
-b aited
▁9 6
▁9 9
▁9 3%
▁9 7%
▁9 6%
ach oma
▁am odiaquine
▁anti -S
▁anti -DENV
▁G roup
tal eza,
▁U SA
▁U rban
▁used .

▁sub types
▁sub optimal
▁sub -optimal
▁int ensive
▁Th ai
bo ur
bo ok
▁4 /
▁4 0.
▁4 5%
▁4 .4
▁4 50
▁4 4%
▁4 88
▁4 -ph
▁ins ide
▁ins ignificant
▁tim es.

▁mon ocytes.

▁mon onucle
▁human ,
▁human -to
ll igence
our nal
our ced
▁children ;
▁en tering
▁en larg
▁en riched
▁en ormous
ast ating
ological ly
ap se
ap pre
▁qu en
▁qu ite
-2 5
-2 .6
-2 .0
-2 %),
▁during -COVID-19
eg lected
▁sc ar
▁sc at
▁sc hem
▁sc Al
yn chron
▁imp a
▁imp ed
▁imp lying
▁ob vious
▁ob stac
▁5 6
▁5 .5
▁5 2%
▁5 .9%,
▁He patitis
ard ef
▁An g
▁clinical ,
▁treatment s.

▁treatment s,
▁treatment -seeking
-1 .0
▁Con text
▁6 .1
▁6 .5
▁6 4%
▁pos terior
▁201 3,
▁pres crip
NA emia
NA /RNA
▁found ,
▁Res idual
▁Res ult
▁reduc tional
▁gene ,
term inants
uth rin
-d escent
▁multi -stage
▁multi variable
▁non -S
▁non line
▁non -pre
▁drug ,
▁7 .7
.1 ,
▁other wise
ptom ic
-p ull
-p yriproxyfen
-p athogen
-p ulldown
▁time -v
▁pot ency
ator ial
▁CI )
▁insec ts.

▁different ly,
▁public ations
▁public ations,
▁K w
▁K in
▁K it
▁K ong
▁K -S
▁K ey
▁K ES
▁age ;
▁inf ant
▁inf estation
▁impact ,
plic ity
▁Background R
▁Background Zo
OR T
ire mia
str ate
▁cons um
▁cons ist
▁cons ists
▁V aria
▁V gsc
▁8 3%
▁8 4%
▁8 49
▁up -to
▁years )
▁years ),
▁col lap
io tics
▁month )
▁rem ove
▁perform s
▁met hemoglobin
▁comple ting
ater n
com es
com mended
▁Results D
ung a
AR D
rac ts
▁med iation
▁fol ic
▁fol ate
▁first -line
▁comb ines
▁1. 4
▁1. 3%
▁tra ps
▁indic ative
▁household s,
▁sup ernat
▁bi op
▁As ymptomatic
▁95% Cr
▁ph ylo
▁one -third
-m odel
▁sim ulate
▁path ology
▁Zika )
fore cast
▁increased .

▁evalu ations
▁determ ines
▁(9 2
▁(9 9
▁(P I)
▁(P kA1-H
▁potential .

ron tal
-C SP
-C ongo
▁total ,
▁(D R
▁(D NA/RNA
▁case ,
▁conc lusive
jec tion
▁respec tive
▁hospital -based
-f ield
hes us
ass ive
▁findings ?O_LI
.6 0{degrees}C.
▁ext racellular
▁exper ts
▁inform ative
▁cross -species
▁local ization
▁samples )
ox icity
▁el se
mon ary
ogen ous
.8 9
▁particip ating
▁ur ine
▁ur inary
▁(1 2/
cri ptomic
▁rep ression
-l ag
-l imited
.3 ,
.3 ).

▁season s,
DT LV
▁St age
▁St ress
.7 )
.7 ,
.7 3
.7 ),
ning ,
ery thron
▁[ 8
▁[ H
▁[ I
▁J o
▁J ose
▁soc iodemographic
▁spread s
▁(2 4
▁(2 8
▁(2 .3
▁(2 02
▁LLIN ,
▁increase ,
▁only .

▁diagnostic s.

ms p
▁Here in,
▁period ic
▁period s.

▁positive -strand
▁selec ting
▁lim its
▁common ,
rin -1
anc y
▁(A e.

▁(A HME
▁(C D
▁(C I)
▁(C UI
▁(C FP)
▁acute ly
▁single -c
▁association s.

▁expos ures
▁quanti ties
▁(S I
▁(S MA
icro haplo
▁interac ts
▁circ ulate
▁tr achoma
▁non- n
▁non- oph
▁non- vaccinated
▁non- structural
▁urban ized
▁mo tile
▁mo tility
▁effective .

▁vari ance
rogen ital
▁inte lligence
▁Conclusions D
▁Conclusions S
▁Conclusions Our
▁Conclusions /significance
▁climate ,
▁antimalarial .

.5 4
.5 7
reen ing
▁assay ;
▁assay ed
1, 000
1, 016
▁post grad
▁post natal
▁world ,
▁program s,
aran tee
▁gre y
-infec tions
-infec tious
▁regression ,
▁network ,
▁network .

olic ited
▁NS 5
-re commended
▁(R T)
▁form at
▁form ulated
▁COVID19 ,
▁assessed .

▁distric ts.

▁class ify
▁class ification.

▁chikunguny a.

▁screen ing,
{micro} l.
▁sm art
▁pa ren
▁pa ucity
▁dose .

▁variation ,
▁design ,
-3 0
-3 8
-3 6%),
4, 24
▁Com mit
▁Com ponent
▁Am plicon
ward s
▁Co te
▁Co -infection
PD SI
▁pyrethroid -resistant
▁pyrethroid -pyriproxyfen
▁Ad min
▁For taleza,
loc ation
▁research ,
▁15 6
▁15 th
▁15 -2
▁months ),
▁mat rix
▁mat ched
▁mat ching
▁mut ations,
▁vis ible
▁vis iting
▁vis cRNA-Seq
▁activ ate
▁activ ation.

▁neg atives
▁att raction
▁att ractive
▁access ing
▁Al upe
▁Al location
▁10 -fold
▁10 -34
▁HIV .

▁country -wide
.0 )
▁su ite
▁(L oD)
▁sequ entially
▁(m RDT
▁(m any
▁process ,
▁18 ,
▁19 0
▁19 90
▁management ,
▁IgG ,
tro duc
▁u rogenital
▁ed itor
osom es.

▁C_LI O_
▁laboratory -confirmed
▁gu arantee
▁16 ,
▁chang ing
▁chang ed
▁chang es.

▁before .

▁decre asing
▁Y ap
▁five -year
cep tions
▁morbidity ,
-0. 2
.5% .

.5% ),
▁prac tition
arm ing
▁ep ic
▁(3 )
▁(3 6
▁(3 9
▁(3 .1%
-4 )
-4 %),
vic e
▁prob ably
▁poss ibility
▁part nership
▁combined .

▁Summary Malaria
▁1, 2
▁1, 200
▁strong er
▁heterogen ous
▁min or
▁min imal
▁RDT .

▁Findings A
aus ing
▁(M M
▁(M RI
▁dot} 4
▁dot} 6
▁dot} 8
▁dot} 0%
7, 000
SP 40
▁Reg istration
▁pers ists
▁differenti ating
▁cyt os
▁cyt ological
▁cyt okine
▁cyt ometer
▁initi ating
▁(H C
▁challeng es.

▁(n= 6).

▁(n= 22
▁educ ational
▁standard s
▁Tanzan ian
▁plasm id
▁11 32
▁meta -trans
▁meta -regression
▁general ised
▁pregnanc y.

-6 9
reg ular
▁Pre gnant
▁specificity ,
▁specificity .

▁Wolbachia -mediated
▁cr is
▁di hydro
▁di urnal
▁threshold s,
▁200 8
▁expl osive
▁adults ,
▁2021 ).

▁demographic s,
▁plan ners
▁(0. 02
▁(0. 46
▁link age
▁evaluated :
▁interaction s,
▁old .

▁(6 .4%
▁Re al
▁Re ticulocyte
12 6
12 8
IR A
▁organ ize
▁organ isms
▁organ elles
▁Further ,
-h istory
-h ub-
▁real -tim
▁optim um
▁optim ization
▁gametocyte s,
▁Ar temisinin
▁Ar temether
▁stage ,
▁annual ly,
06 ),
▁Q U
▁z onal
▁produc tive
▁assessment .

▁peak s,
▁context .

heren t
▁municip al
▁Americ an
▁Mod ule
▁consider ation
▁phase -III
▁ele vation
▁AN KA
istosom iasis
▁person -to-
▁Introduction Malaria
▁sample ,
▁sample .

-con taining
▁cohort ,
-P h
-P ic
-P ick
-P BO
-R ,S-dehydro
wa ves
▁cle an
▁cle arly
▁pan ning,
▁der m
▁der mal
▁social ,
cepti ble
▁spor adic
▁threat ,
▁13 0
▁13 0.47
▁help s
▁PCR .

▁PCR -confirmed
▁coun s
sequent ly,
▁parasites/ {micro}l.
▁challenge ,
▁district -level
7% ).

▁unc overed
▁p=0.00 1).

▁episod e
▁episod es.

▁episod es,
▁pregnancy :
▁histor ies
▁necess arily
▁incorpor ation
/1 0
/1 4
/P ow
▁cur b
▁vol unt
▁pre- elimination
▁Ins urance
▁travel -history
▁comparison s
▁attitud e,
▁Inter val
▁Inter actions
▁observ ation,
roph osphate
▁broad ly
▁25 th
▁dataset ,
▁0.7 7
▁quantitative ly
▁quantitative -PCR
▁hyper co
▁surveys ,
▁2022 -202
▁considered .

▁life -threat
▁Region ,
▁usage .

▁Rec urrent
▁load ,
-201 7
-201 4.

▁progress ing
▁progress ed
▁progress ive
▁facilit ates
▁establish ments
17 9
ES S
rh oe
▁i )
▁i .
▁i i)
▁cent re
▁(i )
▁(i i)
▁Sub -Count
▁24 4,24
▁24 .5%.

▁appl ies
▁surv iv
▁determin ant
abil ities
▁genotyp e,
▁admission .

▁entire ),
▁pur pos
▁hom o
▁hom ophobia
▁lar v
▁Mo i
▁guid ing
▁guid ed
▁syndrom e,
▁(E B
▁(E PCR
▁Ph ys
▁Ph ase
▁liver -stage
▁23 7
▁valid ating
▁valid ation.

.6% ).

▁Peru .

▁candidate ,
6% ).

DS ).

hel ian
▁diabe tes,
▁vi rome
▁System s
▁IFR s
▁training ,
▁(AOR :
▁(AOR =0.
▁(AOR =2
▁variant ,
▁Malawi ,
▁vitro ;
▁vitro .

▁Sc ot
▁Sc enar
amb uc
▁accept ance
▁WHO ,
▁rad iation
▁decl ared
▁decl ines
-D NAemia
▁sa fer
▁wave let
▁ref lected
▁prevalent .

▁exhib its
▁0.8 8%
▁inflamm ation,
▁Asia :
15 6
▁normal ization
▁normal -like
▁PM Rs
▁prote omics
▁Is lam
▁regimen ,
▁regimen .

▁useful ness
▁circum st
▁programm atic
▁Colombia .

▁j ournal
▁widespread ,
▁nutri tion
▁conser v
▁diss ec
▁HC MC
▁HC Ws.

▁neuro toxic
▁adv oc
▁Es cher
▁Es watin
▁expansion ,
▁appropriate ly
▁Chikunguny a,
▁release .

▁suit ability
po ints
po iesis
▁With in
▁hem orrh
▁scale ,
▁phosph opro
▁phosph oreg
▁categor ized
59 6
59 -fold
▁maternal ,
▁free ly
▁(r =0.
▁datase ts,
▁ELISA /T
▁facility -based
▁2014 -19
▁temperatures ,
▁CHMI .

▁behaviour .

▁Clinical Trials.gov
▁pharmac okinetic
-B ased
1% ;
lif e
▁oper ates
▁re- orient
▁land ings
▁course .

▁neigh bouring
▁unde tec
▁arm ,
▁ampl ified
▁ampl ification
▁agent -based
▁discrim ination
▁discrim inatory
▁phenotyp e.

▁co-circ ulate
itic idal
▁my al
▁gain ed
▁gain s.

▁DHF .

▁outdoor s.

▁discus sion
▁-tubulin-1 ,
▁pep tic
▁pep tid
▁div ided
▁Po int
▁Acc ra
▁Acc ording
eli ef
▁resource -limited
▁respir ators
▁IF A/S
▁27 59-fold
▁0.00 1),
▁0.05 ),
▁2013 .

▁seropositivity .

-g roup
▁Ac ute
▁later .

▁prec ision
▁heat w
▁34 .6%,
▁OR OV
▁0.2 %,
▁scal ed
▁scal ability
▁plac ed
▁(Pf 3D
▁enrolled :
▁climatic ,
▁fil m
▁fil ter
▁Cor onaVac
▁DF .

▁follow-up ,
▁valu es.

▁confirm ing
▁confirm ation
▁enzyme -linked
▁awareness ,
▁bleeding ,
▁pay ments
▁wild -type
▁yield s
▁Le vel
▁Le one
▁Le ishman
▁underst udied
▁anti- viral
▁8- iso-pro
▁efficient ly
▁urgent ly
▁relapse .

▁hypnozoite s.

AN D
RA CT
RA B11A
ncRNA s)
▁replic ate
▁replic ates
▁anemia ,
▁comput ation
▁perip ortal
▁Anti -Pic
▁Vector s
▁semi- structured
▁semi- arid
▁midgut .

-v acc
yc ling
▁ub iquit
▁hand le
▁Infec tious
▁El igible
▁45 4g
▁eluc idated
▁Covid19 .

▁visual ized
▁visual ization
▁explored .

▁allele ,
▁meal .

▁assump tions.

▁gondii ,
▁rol lout
▁south west
▁machine -le
▁dimension s
▁(US$ 105).

▁CR 1
▁CR D42
▁37 .1%
▁arch ipelagos
▁overlap ping
▁decad e.

▁ResultsO ut
▁occurrence .

▁working -age
▁seasonality ,
▁typh o-malaria
▁synchron ization
▁situ ations
/s uicidal
CC M)
cr d.
▁rash .

▁HM OX
▁separ ate
▁38 .60{degrees}C.
▁recogn ized
▁antib iotics
▁potent ly
▁well- established
▁homolog s
▁undersc ores
AG R
test inal
▁Pb RAB11A
▁lncRNA s
▁onset .

▁2.1 0,
▁Mosquito es
▁Bur ma
itis ed
▁clos ure
▁clos ures
▁clos ure,
▁Fever ,
▁NT Ds
▁93 7.9
▁non-c oding
▁repell ency
▁PfH sp
▁defin ite
g/k g/day
▁alignment ,
▁alignment .

▁FREP1 -pulldown
▁eng ineering
▁ear ly,
▁ear liest
▁(> 9
▁anthrop ometric
▁Sm all
▁1% -2%),
▁chaper ones
▁serotyp e.

▁extraction .

▁(p<0.00 1).

{micro}m ,
▁Compar ing
▁Compar ison
▁North -E
▁division s
▁maxim ize
▁maxim ise
▁summar ised
▁summar ize
▁cop ies
▁fold ed
▁PPF .

▁And es
▁Tr ypan
▁dev ising
▁dev astating
▁dele tion
▁residence ,
▁agre ed
▁trajector ies,
▁p=0.01 6)
▁Count y
▁continent ,
▁continent .

▁utilis ation,
▁calibr ate
▁neurolog ic
.\n\nResults The
An opheles
▁cre ating
▁domin ance
▁finding s.

ceed ed
▁Poc /Pow
▁weather ,
▁gra vity
unate ly,
▁act ually
▁algorith ms
▁3. 00
▁uncle ar
-to- severe
▁ResultsP lac
▁confer ring
▁immuno informatic
▁immuno assay
▁perspective ,
▁scenario ,
▁PBO-LLIN s
▁helminth s
▁catalytic ally
▁eukary ote
5.2 %)
▁ul cer
▁tri ple
▁trac e
▁trac ing.

▁p-value =
▁tox icity
▁elic ited
▁(Y F)
▁vesic ular
▁Cal i
utral izing
▁Sim ulations
▁imper ative
▁RT .

▁transfusion .

▁3% -4%),
▁serocon ver
▁intens ities
▁4, 8
▁imply ?O_LI
▁metagen omics
▁Province .

▁recip ients
▁Tes o
▁Sever ity
▁dispers al
▁dispers ed
▁dispers al,
▁acce lerate
▁seem ed
▁Fore st
▁Fore cast
▁Lim a,
▁spac e.

▁unex plored
▁Ge ographical
▁(22 .4%
▁p=0.000 6)
▁non-us e
▁synerg istic
▁auto inflammatory
▁discuss ed
▁Mozambiqu e,
▁emphas izing
▁belong ed
▁Identi fying
▁commercial ised
▁Discussion The
[& le;]
▁ov ip
▁siz e.

▁siz e,
▁fores ted
▁fores ts
▁(v s.
▁(AR DS).

▁defec tive
▁defec ts,
▁SAR DDE
▁2.2 0
opro tein
▁MM D
▁DALY s
▁disorder s,
▁dispens ability
▁gender ,
▁interfer ing
▁interrup t
▁33% -36%),
▁monocyte s,
▁sched uled
▁52 %,
▁Guine a
▁Socio -demographic
▁Antibod ies
▁prophyl actic
▁Heterogen eous
▁sperm atocytes
.or g/
▁ir regular
▁tuberculosis ,
▁p<0.000 1)
▁p<0.000 1),
▁ther m
▁SA Es
▁SA UCI
▁Differen tial
▁immediate ly
▁chrom osomes
▁exceed s
▁coinc ide
▁internal ized
▁EV E
▁lever ages
▁aptam ers
▁unt argeted
▁instit utions
▁54 %,
▁poverty ,
▁exten sions
▁Str ong
▁trypan olysis
▁approache s,
▁{micro}g/mL ;
▁Program me
vcrt -
▁caveolin -1
dom inal
▁trim eric
▁dang er
▁bur st
▁bur dens
▁break down
▁ham per
▁(l ncRNAs)
▁(ar bo
▁(ar boviruses)
▁Are a
▁concept ual
▁libr ary
▁deform ations
▁SNP s
▁10,000 -fold
▁HD C
▁Fas o
▁applic ability
▁spect rometry
▁evol ve
▁distanc ing
▁multi- omics
▁(IPTp )
▁introduc es
▁introduc tions
▁cytot oxicity
▁microhaplo typ
▁microhaplo types
▁viol ence
▁US$ 210,
▁co-ex ist
▁adjust ment
▁substit ution
▁TRAP -CSP
▁window s
▁sol uble
▁stim uli
▁pain ,
▁fif ty-two
▁(-) -R,S-dehydro
▁Plasm o
▁stop ped
▁Cri tical
▁gland s
▁Sant a
▁Sant o
▁commod ities
▁covariate s,
▁sub-p atent
▁Ver tical
▁Venezuel a
▁confound ing
▁Stand ard
▁Stand G6PD-BS
▁Indones ia
▁Indones ia,
▁laborator ies
▁cytometry .

▁2015-201 7
▁(G6PD )
▁professional s,
▁(US$12 6),
▁(US$12 7),
▁TgELC 1
PG P
ky rin-1
linical Trials.gov
trans fer
▁trop ics
aly z
▁sem inal
▁polar ity
▁hor izon
omy ia
acch ar
▁stre et-level
▁devic es
▁resusc itation
▁isop ent
▁Mad agasc
▁DE NG
▁Influ enza
▁interfe re
▁shop keepers
IDI AP
▁year- round
▁poin ted
▁numer ical
▁(DBS ).

▁ChAd 63
▁conflic t
.32 {micro}m
▁cycl es.

▁appra isal
▁apprec iable
▁suicide /suicidal
▁Apicomplex an
▁contex ts
▁retur ned
▁Qual ity
▁chloroplas ts,
▁hypertension ,
▁encour aging
▁encoun ter
▁Salaam ,
▁Shield TM)
▁ResultsOver all,
▁ortholog s
▁ultra -sensitive
▁gradi ents
▁MMV 688
▁lys osome
▁symbion t
▁illustr ate
▁MEDLIN E,
▁multigravid ae.

▁Kinshas a
▁metronidazole .

▁som atic
▁py rophosphate
▁pul monary
▁mul tic
▁dest r
▁dense ly
▁thor ough
▁Pat tern
▁stall ed
▁Toror o
▁Sind h
▁IZP s
▁ML N724
▁Map ping
▁119 .32{micro}m
▁Dhak a
▁Red uc
▁Rel ated
▁Huh -7
▁Nam utumba
▁LF-RDT s
▁0.06 3%
▁undert aken
▁unavail able
▁sub-reg ions
▁inten tion
▁morb idities
-count ry
standard ized
▁(Pow )
▁interes ted
▁guardi ans
ospho erythron
▁Parame ters
▁farnes ylation
▁(ZIKV ),
▁Quanti fying
▁pilo ted
▁bioinformatic s
▁immunosup pression
▁reinfor cing
▁budge ts,
▁[CI] :
▁MAY V
▁Philipp ines
▁double-blind ,
▁bites/day ).

a-an alysis
▁splen ic
▁mel anog
▁dil ution
▁(am ong
▁Pen ang
▁PRI SMA
▁P<0.05 .

▁Class ifier
etail ed
▁liv estock
▁Sur prising
amet ocyte
▁Made ira
▁D23 580
▁atov aqu
▁Inhib ition
▁Eb ola
▁Ev a,
▁NI H-19
▁Labor atory
▁unchang ed
▁enrich ment
▁Conf idence
▁poore r
▁King dom
▁Kay unga
.\n\nS ignificance
▁pathoph ysiological
▁peer -review
▁depri vation
▁(DALY s)
▁Challeng es
▁extinc tion
▁cross-tal ks
.88 {micro}m2
▁urg ency
▁opin ion
▁(p<0.05 ).

▁deline ate
▁(aIR R
▁Ampl iSeq
▁keyword s
▁relev ance
▁Alt ogether,
▁sequel ae
▁spp. -positive
▁microv ascular
▁z-sc ore
/180 )
▁sole ly
▁intra- erythrocytic
▁hypnozo iticidal
▁Minority Report
▁SmSPI -3
▁Micron es
▁toxoplasm osis.

▁mitochond rial
▁diarrhe al
-escal ation,
▁Bamend a,
▁embed ded
▁counterpar ts
▁Flavivirida e,
▁trichi ura
▁Portug al,
▁Austral ian
▁Giemsa -stained
▁immunoflu orescence
-3III_ B
-Y ear
.d tl.
.ac .uk
/min ute
Comp ared
G-b ox
MAS ID
Rx iv
aeg L
fl uthrin
gona ute
g.high wire
mm IBD
york .ac.uk
{gamm a}
▁iver mectin
▁erythro poiesis
▁troph ozoite
▁ove restim
▁sul phadoxine-pyrimethamine
▁inexp ensive
▁push -pull
▁mot or
▁dynam ical
▁dIvo ire
▁bus iness
▁bron choal
▁(ind oor
▁thio ester
▁vacu ole
▁Pap ua
▁Pep tides
▁Pern ambuc
▁PAS C
▁Puer to
▁stri king
▁Cuc ut
▁Cord ob
▁Tow ard
▁Twins UK
▁malaria-HbA A
▁lati t
▁degen erate
▁SRP K
▁Syndrom e
▁chym ase
▁Rout ine
▁Bei jing
▁per-pro tocol
▁peri- urban
▁Interm ittent
▁OMO P
▁Ouag adougou
▁F15 34C
▁Never theless,
▁NPC1 L1
▁Lih ir
▁facepi ece
▁arrang ement
▁488 g,
▁mononucle ar
▁human-to -mosquito
appre ciated
▁scAl ign
ardef @
▁non-S MC
▁nonline ar
▁non-pre gnant
▁time-v arying
▁K-S e
▁BackgroundZo onotic
▁up-to -date
▁95%Cr I
▁(PkA1-H .1)
DTLV ardef@
▁(AHME s)
icrohaplo type
▁non-oph thalm
▁postgrad uate
▁(n=22 ),
▁1132 .88{micro}m2
▁meta-trans criptomic
▁person-to- person
▁130.47 {micro}m,
▁hyperco ag
▁Escher ichia
▁ELISA/T .b.

▁landings /minute
▁(Pf3D 7)
▁8-iso-pro staglandin
crd. york.ac.uk
▁HMOX 1
▁937.9 3{micro}m2
▁ResultsPlac ental
▁SAUCI E,
▁(-)-R,S-dehydro emetine
▁MLN724 3
▁melanog aster
▁Surprising ly,
▁NIH-19 93
▁peer-review ed
.dtl. DTLVardef@
g.highwire .dtl.DTLVardef@
▁bronchoal veolar
% ;
% .

( 6
( R
( n
( s)
) 

) )
) ssRNA
+ SP
- /
- J
- O
- ing
- em
- am
- ite
- and
- enc
- ind
- out
- ang
- ne
- art
- TS
- national
- aged
- usual
- elimination
- forecast
. n
. io
. 02
. crd.york.ac.uk
/ 4
/ 5
/ E
/ c
/ l
/ r
/ 21
/ 30
/ Ig
0 7
0 -4
0 {+/-}
1 1)
1 %),
1 8,
1 .9%
1 016
2 :
2 B
2 R
2 f
2 ).

3 19
3 .1
3 %)
3 .6
4 ;
4 00
4 3,
4 87
4 40
5 .1
5 -3
5 {degrees}C,
6 ]
6 -6
6 63
7 ;
7 5,
8 00
8 -19
8 %,
8 59
8 100
9 %)
9 2,
A /
A r
A ll
A HO
A 8100
B M
B ased
B MC
B Ds
B lood
C 6
C SP
C M)
C ount
C linicalTrials.gov
D 2
D M
D .

D OR
E n
E x
E AR
E s)
E AS
E UP
E XT
F D
F F
G G
G T
G p
H C)
I ,
I F
I A)
K D
L MM
M D
M W
M .

M ic
M ulti
M yoA
N I
N N
N R
N W
N s
N ase
N CL
O M
O x
O LD
P MI
P PD
P V)
Q )
R .

R ec
R CT
R ES
S U
S V
S S)
T -R
T R)
T RA
T T)
U C
U E
U L
V A
V acc
W ater
W hen
Y -only
_ 1
a w
a is
a virus
a RNA
a its
a ediatric
a helian
b ,
b al
b el
b ination
b ability
b ase,
c re
c lp
d a
d eng
e .
e es
e at
e vere
e havi
e rennial
f y
f ers
f ram
f eld
f CSP
g es
g us
g ia
g ly
g est
g ium
g raph
h ar
h ich
h ospital
h ds
h rp
h lers
i i
i ar
i oc
i ant
i ented
i ters
i hood
i ense
j ug
j ib
j oint
k b
l a
l s
l lo
l afen
l inary
l transfer
m ong
m ey
o z
o in
o bo
o vid19
o C)
o unting
o immune
o hds
p p
p es
p ri
p icomplex
p mp
p 126
r d
r ig
r ong
s in
s ate
s ts
s und
s pec
s ense
s tep
s acchar
t and
t ensive
u y
u lop
u han
w e,
y th
y ard
y raz
y ere
y o)
y gous
z ia
{ beta}
’ s
▁ ~
▁ iv
▁ -2
▁ iod
▁ 0,
▁ 03
▁ {degrees}C)
in ally
in ces
in ogen
in testinal
▁a ug
▁a ware
▁a eti
▁a head
▁a rose
▁t and
▁t rib
▁t rough
▁t RNA
▁t ended
▁t iter
▁t ank
▁t agg
▁t ends
▁t iters
re te
re ported
re troviral
on s,
on avir
ti vation
he ri
he ther
he tical
al ified
al ytic
en s,
en able
en ef
en -like
te g
te re
▁s tic
▁s ort
▁s atis
▁s ynd
▁s ense
▁s atellite
▁in ver
▁in put
▁in active
▁in -per
▁in timate
▁in herent
▁c he
▁c lo
▁c ys
▁c las
▁c ulti
▁c ef
▁c sp
▁c oding
▁c lock
▁c ease
es tion
▁p ent
▁p un
▁p se
▁p ure
ar ian
▁m ir
▁m and
▁m ining
▁m olec
▁m 18
▁m ask
▁m g/kg/day
▁d ie
▁d rought
▁d B.

or ran
or aim
or ff
or g.highwire.dtl.DTLVardef@
is .

is ation.

is ts.

▁w ays
▁w rit
▁w ww
er .

er ated
er ral
er iportal
as one
as tically
as king
tion ed
▁f a
▁f res
▁f og
▁f ung
▁f ilar
▁f laviv
▁f inally,
▁f lood
▁f uel
▁f osm
▁f ru
▁f rontal
it a
it ro
it ant
it ating
it amin
it ored
ro red
ro tein
ro xychloroquine
an .

an us
an tic
an los
ing ap
ic le
ic able
ic o,
ic ious
ed ougou
ec e,
▁re v
▁re nal
▁re nder
▁re plicated
at ched
at hered
▁b ol
▁b one
▁b rought
▁b elief
▁to -date
ia tes
ia mey
▁h ot
▁h ors
▁h osts,
▁h ttp://
▁h mmIBD
om er
om ber
om eric
om ycin
om edical
om atitis
le lic
id omycin
▁e mission
▁e ast
▁e lec
▁e mitted
▁e -D
▁e CC
▁e lusive
ate s,
ent re
ent ric
ent ang
os en
os itor
os acch
ation ale
▁( J
▁( {
▁( on
▁( per
▁( ID
▁( di
▁( 0,
▁( 50
▁( known
▁( 88
▁( inter
▁( using
▁( [&ge;]
▁( X2
ac a
ac hes
lo t
▁v 2
▁v end
▁v RNA
▁v ice
▁v entric
ur acy
ur ance,
im as
im ulations
ce eding
ul es
ul as
ul ic
ul ator
ul atory
th ing
th ality
od ed
od omain
▁n om
▁n ative
▁n ations
▁n erv
▁n ortheast
▁n ested
il s
il ient
il ty
il inogen
il itating
▁P C
▁P G
▁P ain
▁P ost
▁P ath
▁P rac
▁P olic
▁P ER
▁P PR
▁P =0.00
▁P <0.001)
▁P AHO
▁A 1
▁A I
▁A den
▁A ST
▁A tt
▁A TP
▁A O_
▁A A8100
▁A BDs
▁we igh
▁for mer
▁st rict
▁st ages,
▁st ained
▁st agg
▁st omatitis
ir ty
ir ds
ir idae
ir ls
ig en
ig ital
ig uous
ig uration
▁C ,
▁C E
▁C ath
▁C rim
▁C hem
▁C RP
▁C yt
▁C ity,
▁C ancer
▁C AV
▁C AGR
▁T O
▁T en
▁T ain
▁T og
▁T aj
▁T echn
▁T TN
▁T RA
▁T gs
▁T ND
▁T otal
▁T raining
um e
um n
um bia
ter ans
▁g ol
▁g lass
▁g iving
▁g /d
▁g estational
▁g /L)
▁g irls
qu ality
qu ired
qu artile
qu alified
▁as cending
ion ,
fec ycle
tic erc
el ong
el ch
el phi
▁an opheles
▁an kyrin-1
▁con v
▁con ven
▁con form
▁con com
ol ation
ol ip
ol a,
em e
em en
em ents
ut ath
et hel
▁pro x
▁pro ve
▁pro min
▁pro ceeded
ver mectin
▁l es
▁l ived
▁l actating
ud icious
if e,
ri or
▁de ference
▁de amin
▁S ul
▁S ector
▁S ek
▁S earch
▁S ARS-Co
▁S ulf
▁S IR
▁S pread
▁S oftware
▁S IRD
▁S FP
▁S ahelian
▁S ingap
▁com m
▁pre n
▁pre -p
▁pre vail
▁pre -l
▁pre mature
▁pre -treatment
▁pre natal
▁pre valences
▁pre fers
▁I ,
▁I MC
▁I TS
▁I HME
▁I PV
▁I 1,016
▁I vermectin
am ed
am pl
▁on e.

▁on to
▁on -going
▁2 5%
▁2 3,
▁2 -3
▁2 11
▁2 4%
▁2 -5
op er
op oly
op eration
▁M ac
▁M OR
▁M ajor
▁M aternal
▁M achine
▁M BR>
st ric
st one
st ablis
▁1 -
▁1 2,
▁1 34
▁1 0%.

▁1 0186
▁1 b,
oc co
ot rans
ot ometry
▁D ros
▁D ex
▁D omin
▁D iss
▁D uf
▁D TA
▁D etailed
▁D jib
▁D igital
ran ean
ys ;
ated ,
ated .

ine ered
▁im plies
ess ary
▁dis pro
▁dis ulf
▁inc ub
ab ad
▁ch i
▁ch ance
▁ch ick
▁ch osen
▁ex er
▁ex ocytosis
▁be ad
▁be gan
res s.

res s,
▁ac tion,
▁W ild
▁W ork
▁W arning
▁W RA
▁W uhan
▁W hether
▁R R
▁R h
▁R t
▁R ap
▁R ef
▁R CT
▁R t,
▁R t.

▁R ica
▁R MSE
▁R =-0.
▁R Nase
▁R SV
por tion
ite -specific
ite mark
ad o
ad ed
0. 5
0. 01),
▁ass ist
pec ts
▁co f
▁co ag
▁co ast
▁co -transmission
▁co iled
▁he art
▁he av
se x
se en
▁comp ati
▁comp lier
▁r hesus
ant yre
▁dengue )
▁dengue ;
▁H O
▁H b
▁H o
▁H ybrid
▁H EAL
ance Malaria
▁trans fec
▁trans ient
▁trans pa
▁trans cribed
▁trans missible
▁trans fluthrin
▁se gregated
▁se gregation
▁B ,
▁B ut
▁B lock
▁B ivariate
▁B SL
▁B ehavi
▁B itemark
▁mod ulation
▁mod ular
yp t
yp erm
00 1).

ati vity
▁at tainment
ore feren
ore to
iti ated
iti s,
iz og
iz ons
iz ygous
▁20 ,000
▁model ed
▁per miss
pl ies.

tim ation
rol ide
pro duc
▁In n
▁In ferring
▁or ders
▁inter n
▁inter genic
▁E W
▁E g
▁E ight
▁E xt
▁E ps
▁E lect
▁E MR
▁E PG
▁E BR>
▁E CM
▁E pi
▁E hlers
ear son
ens ation
ak a,
ak e,
asite mia
olog ists,
▁high -dimensional
▁data -trained
▁data points
▁le pro
▁le verage
▁le thality
▁reg ister
▁this .

▁sh otgun
eth ylp
ary ltransfer
▁3 )
▁3 .1
▁3 .6
▁3 .9
▁3 42
▁3 1%
▁3 Rs
▁3 UT
▁3 7,000
▁3 rd
cip linary
▁O N
▁O ce
▁O rop
▁O AT
▁O dds
ch istosomiasis
▁F I
▁F alciparum
▁F OR
▁F ort
▁F ood
▁F ace
▁F raction
▁F oz
▁out .

▁out let
▁N ation
▁N one
▁N ether
▁N oma
▁N iamey
▁ca ution
vel ihood
▁anal og
per sion
per fusion
per manent
▁ap ex
▁ap art
5% ;
ag ong
enc y.

tec ting
ild hood
▁L R
▁L ast
▁L ike
▁L actate
▁L uang
▁L GB
▁L agos
▁L 995F
▁L DL
mun icable
▁effec tors
▁fac t,
▁falciparum ;
▁sp iked
ib ilities
▁ser o
▁ser one
vi ating
▁0. 8%
▁0. 42
▁0. 88
▁0. 2%
▁0. 49
▁0. 16
▁under m
▁under line
▁under going
▁under appreciated
▁Plasmodium -specific
▁analys es,
▁es cal
▁ra w
▁sign s.

▁sign als
▁rec all
▁rec ycling
▁spec troph
▁disease -specific
-s urve
-s chool
▁un m
▁un ion
▁un ified
▁un int
▁un related
▁un nec
▁un ivariate
▁un characterized
▁un accept
▁tre mend
▁ar res
▁ar isen
▁ar thri
▁cell .

▁cell s)
▁id eas
▁not ,
▁not ably
▁cases ).

▁low -level
▁low -income
-b order
-b oost
▁9 .9
▁9 99
▁9 2%
▁9 0%,
▁9 9%
▁am b
▁am astigote
▁am enable
tem porally
▁anti ser
▁anti -p
▁anti -P
▁anti -dis
▁anti -mosquito
▁anti hyp
▁anti retroviral
▁rel ied
▁G l
▁G AP
▁G BS
▁G ithub
▁G PR
▁G DP
▁ag ar
▁ag end
▁ag greg
▁ag encies
▁U se
lic ular
▁show ,
▁dur able
▁dur ations
▁dur ation.

▁sub -c
▁sub ject
▁sub urban
▁Z am
▁Z one,
act o
act able
▁Th 3R
▁Th 2R
old ,
di ov
▁estim ation,
bo .

▁4 6
▁4 %,
▁4 .2
▁4 3%
▁4 .5%
▁4 5,
▁4 11
▁4 06
▁4 22
ew ed
rib utions
▁ins ured
▁ins pection
▁ins urance,
▁significant ,
▁significant .

▁tim es,
▁mon itored
pon ses
our se
▁en tered
▁en erg
▁en velopment
▁vivax -specific
ap ter
ap ular
ap pear
ap anes
▁region :
lus ter
-2 9
-2 .9
-2 04
▁sc RNA
▁sc ience
▁sc ored
▁sc aff
▁sc PDSI
▁compared .

yn yl
▁man ual
▁man aging
▁man ually
▁man agers
▁blood -based
▁over w
▁ev idences
▁count .

▁prov inces
▁5 th
▁5 5%
▁5 4%
▁5 8,
▁5 14
▁5 39
▁pred omin
▁DENV .

▁DENV -3
▁DENV -4
▁DENV -NS
▁An .
▁An other
▁An throp
▁An tenatal
-1 .
-1 6
-1 .4
-1 1%;
▁Con t
▁Con tr
otyp ing
otyp ed
▁6 ,
▁6 7
▁6 %,
▁6 3%
▁6 ,3
▁dist ance
▁dist ances
▁studies ).

▁factor ,
ep sin
▁dr astic
▁dr astically
▁pres um
▁repor ter
▁repor ts.

▁loc ations.

▁incidence /1
▁Res ponse
iver y
▁mor ning
▁gene -sil
▁higher .

▁higher -level
▁higher -risk
ile ,
-t hen
-t oler
ser v
▁partic les.

-d ynamic
-d ata
-d rug
▁multi -level
▁multi -resistant
▁multi -face
▁multi -SNP
▁multi -drug
▁non -l
▁non -COVID-19
▁non -invasive
▁drug -resistant
gen ase
▁7 %,
▁7 8%
▁7 4%
▁7 65
▁dec ip
-p yrethroid
-p oly
-p rimary
▁time -c
▁time ly,
▁time -dependent
▁time fram
▁K +
▁K ar
▁K or
▁K 13
▁K ulld
▁inf lated
▁inf requent
-c lass
-c ause
-c yperm
▁all ,
▁all -cause
urrent ly,
▁Background U
▁Background Res
▁Background To
▁Background An
▁des cent
LIN G
▁import ation.

tively .

▁V enous
▁V AC
▁V 1016
-S ectional
-S IRD
▁8 ,
▁8 2
▁8 1,
▁8 06
▁8 9%
▁8 1.9%
▁up per
▁up load
out hern
▁years :
▁years ].

▁group /p
▁col i
▁col lated
▁col uz
▁new -generation
.\n\n Here
ang es
ang ha
▁prim ates
▁prim ates.

▁rem odel
▁strateg y,
▁setting -specific
▁models :
▁pl ayed
▁pl aqu
▁comple tion
▁Results This
-in formed
-in clusive
-in itiated
AR )
AR IA
▁med iate
▁first -born
▁1. 00
▁1. 03
▁1. 79
ef ficacy
uct ase
▁surveillance ;
ram ethylp
▁conduc ive
▁indic ations
▁sup plies
▁sup plies.

▁bi ochemical
▁ph ysiological
▁vaccine es.

▁vaccine -pre
▁there .

tern al
-m akers
▁sim ilarly
▁well -defined
▁well -toler
▁epidemic s,
.4 3,
.4 );
01 ,
01 8
▁three -year
▁character isation
▁gener ations
▁increased ,
ne y
▁collec tion,
▁evalu ation.

▁through put
ean -Congo
ark ed
istic s
▁reported ,
▁(P D
▁(P CR
▁(P oC)
▁potential ,
▁dep ict
▁dep th,
▁end -pro
▁effic ienc
▁provid ed.

-C are
ality ,
▁(D E
▁(D H
▁(D AS
▁(D RC
▁Ch ok
▁Ch allenge
▁Ch aro
▁Ch anges
▁infected ,
▁infected .

▁significantly .

ness es
▁evidence .

▁evidence The
rop en
rop e/
▁hospital isation.

-f it
-f alciparum
▁Dengue .

▁findings A
▁findings The
.6 4
.6 -6
.6 3).

▁care -seeking
▁ext rinsic
▁investig ation,
▁investig ation.

▁investig ations,
▁inform s
▁cross ed
▁cross -c
▁cross -border
▁specific ,
▁ab str
▁ab dominal
▁el ig
▁el ong
▁important ,
▁important .

▁protec ts
▁conf iguration
▁Malaria -naive
ogen eous
▁respectively )
▁respectively ),
.8 2
▁immun ological
▁immun oglob
▁particip atory
▁(1 00
▁(1 -month
▁(1 1.1
▁op posed
▁occ urrences
▁work ed
▁work ers,
▁rep osition
▁rep urpos
▁rep ositor
▁Pf IV
▁Pf LDH
▁Pf msp
-l oss
▁host ,
▁cy st
▁St ability
▁St ata
.7 0
ban k
cop rotein
▁[ <
▁[ C
▁[ 50
▁[ 30
▁[ [&ge;]
▁[ 40,
▁clus tered
.2 -3
▁J apanes
▁soc iety
▁(2 03
▁(2 0%)
▁increase .

▁cluster .

.9 )
.9 %),
.9 {+/-}
one y
▁test ,
▁test -negative
▁test -then
▁Ig u
▁sequenc es.

▁sequenc ing,
▁estimated .

▁environment .

▁environment s.

▁environment ally
▁knowlesi ),
▁knowlesi -ass
▁common .

▁common alities
rin king
anc es.

▁rapid ,
▁p=0. 70)
▁p=0. 10).

▁(A TSB
▁(C ol
▁(C SP
▁(C SS
▁effect ,
▁sensitivity .

▁(p re
▁(p rimary
▁(p <0.01
▁(p vcrt-
▁(p rior
▁respons iveness
▁acute ,
▁association ,
▁countries :
▁(S A
▁(S P
▁(S SA
▁(S NT
▁(S Q-LNS
▁(S CD)
▁(S tand
▁collected .

ozoite s.

IV E
▁interac ted
▁typ e,
▁circ ular
▁circ ulated
▁participants .

▁random -effects
▁non- essential
▁non- human
▁non- hospital
▁urban ization
▁urban istic
▁urban ization,
▁urban isation,
tit utional
▁mo ving
emb rane
▁effective ,
▁grow n
▁influ en
▁people .

▁patient ,
▁(n on
▁Conclusions H
min istered
▁climate -sensitive
▁detected ,
▁endemic .

▁rece iver
▁estimate s,
▁antimalarial s.

.5 ,
.5 1%
2, 000
av es,
yd roxychloroquine
▁(I MASID
▁(I TT)
▁disc ord
▁app oint
1, 000)
1, 179
▁mark ers,
▁mark ers.

▁post -t
▁post -boost
▁exam ining
▁exam ples
▁ZIKV .

▁Ind eed,
▁chan ces
▁developed .

▁essential ity,
▁gre w
▁prior ities
af ety
▁12 5
▁reduction s,
▁Pro jected
yrethroid -only
vent able
▁sch izog
-re ared
-re stric
▁(R A
▁(R V
▁(R R)
▁(R 0)
▁form s.

▁form ulation
▁form ally
▁known ?C_ST_ABSO_LI
▁exposure .

▁site ,
▁class ification,
▁prof ound
ty }
▁million ,
▁em ulator
▁line ages.

▁pa ves
▁variation .

▁gambia e.

=1 .3
=1 {middle
▁mean ,
▁SARS-CoV-2 ,
▁design .

-3 5
-3 6
-3 9
-3 .4
-3 .7%)
-3 72,
▁foc i
▁strain .

▁strain -specific
▁Co -c
▁Co vid
PD )
▁pyrethroid -PBO
▁Ad ults
▁Ad ult
▁Ad justed
▁Ad equ
▁Ad idome
